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 Marine polycyclic ether natural products have attracted considerable attention 
from the scientific community because of their unique structures and intriguing biological 
activities. Olefinic ester cyclization is a highly efficient way to synthesize cyclic enol 
ethers, which are versatile synthetic precursors to polycyclic ether natural products and 
analogues. Chapter 1 describes our approach for rapid construction of polycyclic ether 
skeletons using a two-directional olefinic ester cyclization strategy.  
 (-)-Brevenal is a pentacyclic polycyclic ether natural product isolated from the 
marine dinoflagellate Karenia brevis. Brevenal has shown to antagonize the toxic effect 
of brevetoxins in vivo, and can be potentially used as a lead compound for therapeutic 
treatment of mucociliary dysfunction. Chapter 2 describes our total synthesis of brevenal 
using a convergent and flexible esterification/olefinic ester cyclization strategy. 
 Yessotoxins are a class of marine polycyclic ether natural products isolated from 
dinoflagellate and/or shellfish. Although over 40 of yessotoxins have been identified and 
characterized, their biological properties are still not clear due to very limited 
availabilities from natural source. Chapter 3 describes our efforts towards the synthesis of 
yessotoxin and one of its analogues, adriatoxin. The A-F and F-I ring systems of 
yessotoxin and adriatoxin were successfully synthesized utilizing both our iterative cyclic 
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CHAPTER 1 
 
RAPID CONSTRUCTION OF POLYCYCLIC ETHER SKELETONS USING  
TWO-DIRECTIONAL OLEFINIC ESTER CYCLIZATION  
 
Introduction 
In 1981, Nakanishi and co-workers reported the isolation and structure of 
brevetoxin B (1.1 , Figure 1.1), which introduced a new class of marine natural products, 
the ladder-shaped polycyclic ethers into the scientific community.
1
 Since then, this family 
of natural products has attracted considerable attention from both synthetic chemists and 
biologists because of their unique structures and intriguing biological properties.
2
 The 














 and brevenal (1.8) (Figure 1.1).
9
 Structurally, they all contain a 
contiguous trans-fused polycyclic ether ring skeleton, which gives them a characteristic 
ladder-shaped appearance. Biologically, despite the common polycyclic ether motif, they 
exhibit very diverse and potent properties. For example, the brevetoxins and ciguatoxins 
display potent neurotoxicity toward fish and human beings, while gambieric acids exhibit 
potent antifungal activity with only moderate toxicity against mammals.
10,11
 These 
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decades. Unfortunately however, the biological properties of many of these polycyclic 
ether natural products still have not been fully investigated because of their very limited 
availability form natural sources. Chemical synthesis may serve as a solution to the 
supply problem of these natural products.  
In addition to the need of polycyclic ether natural products for further biological 
research, there is also a demand for the synthesis of analogues of these natural products 
for the study of their structure-activity relationships (SAR). So far, the target proteins 
have been identified only for the brevetoxins, ciguatoxins, and gambierol.
12,13
 
Brevetoxins and ciguatoxins bind and activate voltage-gated sodium channels of 
excitable membranes,
12
 while gambierol binds and blocks voltage-gated potassium 
channels.
13
 Based on these studies, it has been proposed that polycyclic ether natural 
products apply their biological activity through binding to different ion channels. The 
synthesis and biological evaluation of analogues of polycyclic ether natural products will 
not only provide great insight for the identification of the required structural motifs for 
activity, but they will also be very useful in the study of the behaviors of ion channels. 
Motivated by their unique structures and intriguing biological activities, a number 
of research laboratories have been interested in the chemical synthesis of polycyclic ether 
natural products.
14
 In 1995, Nicolaou and co-workers reported the total synthesis of 
brevetoxin B, which was the first synthesis of a highly complex molecule from the 
polycyclic ether family.
15
 Since then, major progress has been made in this field due to 
the developments of novel synthetic methodologies and coupling strategies from different 
laboratories. These efforts have culminated in the total syntheses of brevetoxin A, 
synthesized independently by Nicolaou (1998)
16




CTX3C by Hirama (2001);
18












gymnocin A by Sasaki (2003);
24





 and Rainier (2011).
27
 
The Rainier laboratory has been active in the synthesis of polycyclic ether natural 
products and their analogues since the 1990s.
28
 Our strategy for constructing the 
contiguous polycyclic ether motif is based on an iterative cyclic enol ether/C-glycoside 
formation sequence (Figure 1.2). Each iteration generally involves 4 steps starting from a 
cyclic enol ether: (1) addition of a carbon nucleophile to a glycal anhydride; (2) 
esterification; (3) olefination of an ester; (4) and ring-closing metathesis. To date, this 


















































Synthesis of Cyclic Enol Ethers Using a Two-Step Protocol 
As shown in Figure 1.2, cyclic enol ethers serve as critical intermediates in our 
approach to polycyclic ether natural products. Meanwhile, they are also very useful 
synthetic precursors to a variety of other cyclic ether containing bioactive natural 
products such as nucleoside antibiotics and carbohydrate derivatives.
31
 There are a 
number of methods that have been developed to synthesize cyclic enol ethers.
32 
Among 
them, the two-step sequence shown in Figure 1.2 consisting of olefination of an ester 
using titanium reagents (Tebbe reagent 1.15 ,
33












 is one of the most efficient ways to make cyclic enol ethers 
(Figures 1.3 and 1.4).  
 
 
Figure 1.3. Titanium reagents used in olefination of esters 
 
 





































Schrock's Catalyst (1.19)Grubbs' 2nd Generation
 Catalyst (1.18)
 7 
In 1994, Grubbs and co-workers first used this two-step strategy to make furan 
and pyran rings. In particular, an antifungal natural product, phytoalexine (1.23) was 
synthesized very efficiently using this approach (Figure 1.5).
32b
 The Takai-Utimoto 
reagent was employed to convert ester 1.20  to acyclic enol ether 1.21 , which was 
subsequently subjected to Schrock’s molybdenum catalyst 1.19 to give cyclic enol ether 
1.22 . Hydrogenolysis of the benzyl ethers generated the natural product phytoalexine in 
excellent yield.  
Since then, this two-step approach has been further developed and applied by a 
number of research groups in their syntheses of natural products, especially of polycyclic 
ether natural products and saccharides.
39
 Depicted in Figure 1.6 are some representative 
examples. In 1996, Nicolaou and co-workers converted olefinic ester 1.24  using Tebbe 
reagent 1.15  under ambient conditions to acyclic enol ether 1.25 , which was then 
transformed to six-membered cyclic enol ether 1.26  using the Tebbe reagent in refluxing 
THF.
39a
  In  1997,  Clark  and co-workers found that a combination of  the Takai-Utimoto  
 
 







TiCl4, THF, TMEDA, Zn,


























































































































































reagent and Schrock’s catalyst 1.19 was also amenable in synthesizing seven-membered 
cyclic enol ethers.
39b
 In all cases published up to 2000, the two reactive motifs, olefin and 
acyclic enol ether, were always attached to an existing ring template, which brought them 
proximal to one another for facile cyclization. Postema and co-workers first reported that 
open chain substrates such as 1.30  could also be used in this strategy to generate C-
disaccharides.
39c
 In 2001, Rainier and co-workers first demonstrated that the Grubbs’ 2
nd
 




Although the described two-step protocol has proven to be very effective in the 
synthesis of cyclic enol ethers, a more efficient and direct strategy would bypass the 
acyclic enol ether intermediate and directly convert an olefinic ester to the corresponding 
cyclic enol ether. There have been only a few examples of direct olefinic ester 




Direct Conversion of Olefinic Esters to Cyclic Enol Ethers 
The first example was from the Grubbs’ laboratory in 1986. In their total 
synthesis of !
(9,12)
-capnellene (1.39), Grubbs and co-workers successfully converted the 
olefinic ester 1.36  to the cyclic enol ether 1.38  through a ring-opening metathesis and 
carbonyl olefination reaction sequence using Tebbe reagent 1.15  (Figure 1.7).
40 
In this 
case, they took advantage of the inherent strain of the norbornene system in the starting 
material. Subsequently in 1993, Grubbs and Fu reported the use of tungsten alkylidene 
reagent 1.41  to generate cyclic enol ether 1.42  directly from olefinic ester 1.40 .
41 
Thus 
far, this is the only report of direct olefinic ester cyclization using a tungsten catalyst. 
 10 
 
Figure 1.7. Direct olefinic ester cyclization from Grubbs’ laboratory 
 
Nicolaou and co-workers later modified the aforementioned Tebbe reagent two-
step olefinic ester cyclization and developed a one-pot tandem methylenation and 
metathesis sequence to synthesize cyclic enol ethers.
39a
 They then applied this strategy in 
the construction of several fragments of maitotoxin (Figure 1.8).
42 
Impressive as 




In 2002, Rainier and co-workers reported that when using a modified Takai-
Utimoto procedure, a mixture of acyclic enol ether 1.48  and cyclic enol ether 1.51  were 
obtained in 3:5 ratio from olefinic ester 1.46  (Figure 1.9).
44 
More interestingly, when 
acyclic enol ether 1.48  was isolated and subsequently resubjected to the same reaction 






Grubbs' approach towards capnellene (1986)
1.36 1.37 1.38
84%



























Figure 1.8. Nicolaou’s synthesis of the OPQ ring system of maitotoxin 
 
 
Figure 1.9.  Direct cyclic enol ether formation from a modified Takai-Utimoto reaction 
 
that the titanium methylidene reagent generated under the reaction conditions 
competitively reacts with both the olefin and the ester. If the initial coupling occurs on 
the olefin, a terminal titanium alkylidene intermediate 1.50  would be generated, which 
then cyclizes onto the ester to give cyclic enol ether 1.51 . On the other hand, coupling of 
the reagent with the ester results in the formation of 1.48 . The resulting enol ether does 










1.15 (4 eq), THF
25 oC, 0.5 h;





























































































The proposed mechanism was further supported by the cyclization results from a 
series of elegantly designed substrates (Table 1.1).
45 
For substrates with sterically 
hindered esters and unhindered olefins such as 1.52 and 1.54 , olefin metathesis was 
more facile than carbonyl olefination, thus cyclic enol ether products 1.53  and 1.55  
were predominantly formed. For substrate 1.56 , because of the angular methyl group, the 
olefin was more hindered than that in 1.54 .  As a result, a 1.3:1 mixture of the cyclic and 
 

















Cyclic enol ether Acyclic enol ether
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acyclic enol ether products was obtained under the reaction conditions. These results 
demonstrated the substrate dependence of the Takai-Utimoto cyclization reaction. 
Despite these previous efforts, there had not been a general reaction procedure for 
direct conversion of olefinic esters to corresponding cyclic enol ethers. All previous 
reactions had been demonstrated to be either substrate-dependent or to give capricious 
results.  
 
Titanium Ethylidene Reagent-Effected One-Step Olefinic Ester Cyclization 
In 2005, in their total synthesis work of the marine polycyclic ether natural 
product gambierol (1.5), Rainier and co-workers reported an interesting result during the 
synthesis of the E ring (Figure 1.10).
21
 When the olefinic ester 1.58 was subjected to the 
Takai-Utimoto conditions using dibromomethane as the titanium alkylidene source, they 
observed  preferential decomposition of  the starting material and  only a small amount of  
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 14 
desired cyclic enol ether product 1.59 (15-30%). When dibromoethane was employed as 
the titanium alkylidene source, a 2:1 mixture of cyclic and acyclic enol ether was 
obtained in good overall yield.  
Subsequently, during their synthesis of the A-E ring fragment of another marine 
polycyclic ether natural product gambieric acid A (1.6), Rainier and co-workers found 
that when olefinic ester 1.61  was subjected to the Takai-Utimoto conditions using 
dibromomethane, only acyclic enol ether 1.62  was generated, while the use of 




Both of the results listed above demonstrated very different reactivity patterns of 
different titanium alkylidene reagents towards olefinic esters and implied that the product 
 
 






















































































distribution (acyclic vs. cyclic enol ether) could be affected by the nature of the 
alkylidene reagents. Combined with the proposed mechanism shown in Figure 1.9, it was 
suggested that the more hindered titanium ethylidene reagent reacted preferentially with 
the olefin rather than the ester in an olefinic ester, thus leading to a predominant 
formation of cyclic enol ether product.  
Rainier and co-workers further investigated the scope of this reaction and found it 
to be general and applicable to a broad range of substrates (Table 1.2).
46
 As mentioned in 
Figure 1.9, when olefinic ester 1.46  was subjected to the Takai-Utimoto conditions using 
dibromomethane, a  3:5 mixture of acyclic  and  cyclic enol ether was obtained.
44
 In sharp 
  
Table 1.2. Comparison of product outcomes using dibromomethane and dibromoethane!
 
TiCl4, THF, TMEDA










C : A = 5 : 3
75%
C : A > 95 : 5
Substrate
70%
C : A = 1 : 1
70%
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contrast, when dibromoethane was used as the titanium alkylidene source, cyclic enol 
ether product 1.51 was exclusively obtained in good yield. More impressively, even 
substrates without a tethered cyclic template such as 1.65  and 1.67  underwent exclusive 
cyclization under the reaction conditions to give six- and seven-membered cyclic enol 
ethers. The finding that substitution on the titanium alkylidene reagent could be used to 
direct reactivity was unprecedented in the literature. 
Rainier and co-workers then applied this methodology to olefinic lactone 
cyclizations and discovered a new way to make all-carbon macrocycles.
47 
Both (-)-
muscone (1.73) and (+)-muscopyridine (1.74) were synthesized using this method 
(Figure 1.12). Also worth mentioning is that the same titanium ethylidene reagent is 
capable of effecting olefinic-amide cyclizations to make cyclic enamines.
48
 
The discovery of the titanium ethylidene-effected olefinic ester cyclization 
reaction has largely facilitated our total synthesis program toward polycyclic ether natural 
 
 










Et3N, THF, rt; DMAP, 45 
oC
81%
TiCl4, THF, TMEDA, Zn, PbCl2,





















 When compared to the formerly used two-step olefination-metathesis 
procedure, the new method not only improves the efficiency by shortening the number of 
steps, but it also eliminates the required column chromatography between the two steps, 
thus generally leads to a better overall yield of cyclic enol ether products. 
 
Previous Two-Directional Approach towards  
Polycyclic Ether Natural Products 
As mentioned previously, biological studies on polycyclic ether natural products 
have been hampered by the limited quantities isolated from natural sources. With the 
newly developed olefinic ester cyclization protocol in mind and also considering the 
inherent symmetrical nature of these molecules, it occurred to us that our iterative 
approach to polycyclic ether frameworks would be even more efficient if it were 
amenable to a two-directional approach where two olefinic esters would undergo 
cyclization to give two new cyclic enol ethers in one flask.  
Several research groups had already demonstrated the power of two-directional 
approaches toward polycyclic ether natural products.
51 
Among them, the strategy of the 
Clark group was the closest to ours in that it involved a two-directional ring-closing 
metathesis reaction from dienes or ene-ynes to make cyclic enol ethers using the Schrock 
or Grubbs’ catalysts. Recently, they have applied this methodology to the synthesis of the 
F-J fragment of gambieric acid A (1.6 , Figure 1.13).
51e
 Their synthesis commenced from 
D-glucal triacetate 1.75 , which consisted of the H ring of gambieric acid A. In ten steps, 
1.75  was converted into dialkynyl ether 1.76 , to which two different cuprate reagents 
were added stepwise by exploiting the steric difference between the alkynes to give 1.77 . 
 18 
 
Figure 1.13. Clark’s two-directional approach to F-J ring system of gambieric acid A 
 
The critical two-directional ring-closing metathesis was then effected using 
Grubbs’ 2
nd
 generation catalyst 1.18  to simultaneously afford the G and I ring of 
gambieric acid A. Compound 1.79  was subsequently obtained after 14 steps, to which 
another two-directional ring-closing metathesis was applied to furnish the F-J fragment of 
gambieric acid A 1.80 .  
Our proposed two-directional approach towards polycyclic ether natural products 
is different from Clark’s in that: (1) the precursors would be olefinic esters rather than 
dienes or ene-ynes; (2) and the alkylidene reagents used to carry out the cyclizations 
would be titanium rather than ruthenium or molybdenum. Herein, we described our 
























CuBr, LiBr, THF, -95 oC    -78 oC, 85%
ii.
CuCN, LiCl, THF, -78 oC, 84%
1.18 (10 mol%)





































Results and Discussions 
We first chose to test the two-directional olefinic ester cyclization on the readily 
available dienyl diester 1.85 , which could be obtained in five steps from the known 
compound 1.81 (Figure 1.14).
51e
 Removal of the silylene protecting group revealed triol 
1.82 , and the primary alcohol was selectively converted into a triflate with the two 
secondary alcohols protected as TES ethers in one flask. Allylcuprate addition to the 
primary triflate and subsequent deprotection of the TES ethers afforded diene 1.84 , 
which upon acetylation gave the dienyl diacetate cyclization precursor 1.85 .
53
  
When dienyl diacetate 1.85  was subjected to our modified Takai-Utimoto 
reaction conditions using dibromoethane as the titanium alkylidene source, we were 
pleased to find that the desired olefinic ester cyclizations proceeded smoothly on both 

























































-78 oC    rt
 20 
 
Figure 1.15. Two-directional olefinic ester cyclization of 1.85  
 
Symmetrical dienyl diester 1.89  and 1.95  were synthesized in a similar fashion 
to test the generality of this transformation. From primary triflate 1.83 , substitution with 
lithium trimethylsilylacetylide and subsequent deprotection afforded diol 1.87 .
51e
 Partial 
hydrogenation using Lindlar’s conditions and acetylation afforded the cyclization 
precursor 1.89 (Figure 1.16).
54 
Cyclization precursor 1.95  was synthesized from 1.81  
(Figure 1.17). Protection of the secondary alcohol as a PMB ether and one carbon 
homologation through a hydroboration, oxidation, and Wittig olefination sequence gave 
alkene 1.92 .
55 
Removal of the PMB group and silylene group afforded triol 1.93 , which 
was converted to 1.94 after selective primary triflate formation and TES protection. 
Coupling of 1.94 with allylcuprate followed by TES removal and acetylation provided 
cyclization precursor 1.95  in good overall yield. 
When dienyl diesters 1.89  and 1.95  were exposed to the titanium ethylidene 
reagent, both symmetrical tricycles 1.96  and 1.97  were obtained in good yield (Figure 
1.18). These results were very exciting to us not only because two new rings could be 
generated in one transformation, but also because the resulting cyclic enol ethers are 

























Figure 1.16. Synthesis of the dienyl diester substrate 1.89  
 
 





















i. nBuLi, TMS, THF,
0 oC; 1.83, HMPA, -78 oC























































































BH3•DMS, THF, 0 oC;
H2O2, NaOH,
90%
iii. Ac2O, Et3N, DMAP, CH2Cl2
4Å MS, CH2Cl2
tBuOK, THF
TESOTf, -78 oC      rt
0 oC    rt 0 oC    rt
 22 
 
Figure 1.18. Two-directional olefinic ester cyclization of 1.89  and 1.95 
  
With the above results in hands, we wanted to expand the substrate scope and test 
our proposition that the generated cyclic enol ethers would undergo further chemical 
manipulations. Cyclization precursor 1.105  was synthesized from 1.90 as outlined in 
Figure 1.19. Removal of the silylene group, selective primary triflate formation and 
protection of the remaining secondary alcohol as TES ether gave 1.99 . Substitition of the 
primary triflate with lithium trimethylsilylacetylide and removal of the TES and TMS 
groups afforded hydroxy alkyne 1.100 . Partial hydrogenation using Lindlar’s Pd catalyst 
gave 1.101 , which was coupled with known acid 1.102
56 
using DCC and DMAP to 
provide ester 1.103 . Deprotection of the PMB group and esterification with acid 
1.104
57 
afforded dienyl diester cyclization precursor 1.105 .  
When 1.105  was subjected to our modified Takai-Utimoto reaction conditions, 


















































Figure 1.19. Synthesis of the dienyl diester substrate 1.105 
 
to exploit the cyclization product, we oxidized both enol ethers using DMDO to give the 
corresponding epoxides, which were subsequently reduced in situ with iBu2AlH to 
generate a mixture of diols.
58 
Oxidation and equilibration of the resulting ketones with 
DBU at elevated temperature generated an 8:1 mixture of diketones with 1.108  as the 
major diastereomer. Reduction of this mixture using Luche’s conditions gave the best 
stereoselectivity in terms of  the synthesis of diol 1.109 .
59 






































































i. nBuLi, TMS, THF,
0 oC; 1.99, HMPA, -78 oC






Tf2O, 2,6-lutidine, CH2Cl2, -78
 oC;
TESOTf, -78 oC      rt
 24 
 
Figure 1.20. Two-directional approach towards pentacycle 1.110 
 
PPTS, pyridine and heat, both alcohols cyclized onto the pendant acetals and eliminated a 
molecule of methanol to give the pentacyclic compound 1.110  as a single 
stereoisomer.
60 
Thus, by combining the titanium ethylidene-effected olefinic ester 
cyclization and the acid-promoted hydroxy acetal cyclization, trans-fused pentacycle 
1.110 was formed in only six steps from the monocyclic C-glycoside 1.105 . The 
efficient synthesis of pentacycle 1.110  clearly demonstrated the power of the two-
directional olefinic ester cyclization reaction in the synthesis of polycyclic ether 









































i. TPAP, NMO, 4Å MS, CH2Cl2


























PPTS, pyridine, PhCl, 135 oC



















In our previous syntheses of complex marine polycyclic ether natural products 
and analogues, we developed a convergent strategy that involved esterification between 
two cyclic ether precursors, olefinic ester cyclization, and reductive cyclization to 
generate two new cyclic ether rings in the course of coupling (Figure 1.21).
21
 With this in 
mind, it occurred to us that if we could incorporate the two-directional olefinic ester 
cyclization into the above strategy, we would be able to generate more elaborate 
polycyclic ether structures rapidly.  
To test this proposition, we chose the heptacyclic compound 1.117  as the 
synthetic target, and the retrosynthetic analysis is shown in Figure 1.22. The B ring and F 
ring were envisioned to come from 1.118 through reductive cyclization. The C ring and 
E ring would be generated using the pivotal two-directional olefinic ester cyclization 
reaction from dienyl diester 1.119 , which could be obtained from the coupling of three 
functionalized subunits 1.110, 1.121,  and 1.101 . 
 
 










































































Figure 1.22. Retrosynthetic analysis of heptacycle 1.117  
 
The A ring acid 1.120  was synthesized from the known D-glucal derivative 
1.122 (Figure 1.23).
51e
 Epoxidation of the enol ether with DMDO and in situ reduction 
of the resulted epoxide with iBu2AlH generated secondary alcohol 1.123 , which was 
subsequently protected as a benzyl ether. The silylene protecting group was removed 
using HF•Py to give diol 1.124 , in which the primary alcohol was converted into a 



































































































Figure 1.23. Synthesis of the A ring coupling precursor 1.120 
 
triflate with lithium trimethylsilylacetylide, removal of the TMS group, and partial 
hydrogenation provided alkene 1.127 . The alkene was then oxidatively cleaved using 
ozonolysis to give the corresponding aldehyde, which was further oxidized using 
Pinnick’s conditions to provide the A ring coupling precursor 1.120 .
61
 
The synthesis of the G ring acid 1.121  commenced from known compound 
1.129 (Figure 1.24).
28
 Protection of the secondary alcohol as a TBS ether and 
subsequent oxidative cleavage of the alkene generated aldehyde 1.131 , which was 
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Figure 1.24. Synthesis of the G ring coupling precursor 1.121 
 
The coupling started from the central D ring alcohol 1.101  and the G ring acid 
1.121 (Figure 1.25). Esterification under Yamaguchi’s conditions successfully furnished 
ester 1.132  in 87% yield.
62 
After removal of the PMB group using DDQ, a second 
Yamaguchi esterification with the A ring acid 1.120  was performed to give dienyl 
diester 1.119 . When 1.119  was subjected to the titanium ethylidene reagent, the two-
directional olefinic ester cyclization proceeded smoothly to give the tricyclic compound 
1.134  in 50% yield.  
With the CDE ring in hand, both enol ethers in 1.134  were oxidized using 
DMDO to give the corresponding epoxides, which were subsequently reduced in situ 
with iBu2AlH to give diol 1.135 in 65% yield as a single stereoisomer (Figure 1.26). 
Interestingly, under the same reaction conditions, the corresponding diols were obtained 
as a mixture of diastereomers in the case of bis-enol ether 1.106 (Figure 1.20). The 
stereochemistry of 1.135  was confirmed using 
1
H NMR after converting the secondary 
alcohols into the corresponding acetates.  
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 NaH2PO4, NaClO2, THF/tBuOH/H2O




Figure 1.25. Coupling of the three subunits 1.101 , 1.120 , and 1.121 
 
 



































































































TiCl4, THF, TMEDA, Zn, PbCl2, CH3CHBr2
CH2Cl2, 65 
oC, 50%
2,4,6-Cl3C6H2COCl, Et3N, THF, 40 
oC;
1.121, DMAP, toluene, 40 oC, 87%
CH2Cl2/H2O
Et3N, THF, 40 
oC;
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J16,17  =  10.7 Hz
C D E
1.135    R = H
1.136    R = AcTBS TBS
 94%
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Oxidation of diol 1.135  revealed diketone 1.118 (Figure 1.27). The TBS groups 
on both sides were removed using HF•Py, and the generated free alcohols simultaneously 
cyclized onto the corresponding ketones to form bis-hemiketal 1.137 . Upon treatment 
with Zn(OTf)2 and EtSH, both hemiketals in 1.137 were converted to O,S-mixed ketals, 
which were subsequently reduced under free radical conditions using Ph3SnH and AIBN 
to give the heptacyclic compound 1.117  with good overall yield.
63 
Thus by utilizing the 
highly efficient two-directional strategy, only six synthetic transformations were required 
to convert the monocyclic C-glycoside precursor 1.119  to the heptacyclic compound 
1.117 . 
With this powerful strategy, we are currently in the process of the synthesis of the 
des-methyl analogue of gambierol 1.139  from three coupling subunits 1.143 , 1.144 , 
and 1.145  (Figure 1.28). This synthesis is different from the previous ones in that the 
central subunit 1.144  already contains two fused cyclic ether rings, which we believe 
will provide us with more information on the substrate scope of the two-directional 
olefinic ester cyclization reaction. In addition, we hope the biological tests of the final 
product 1.139  will give us a better understanding of the SAR and the ion channel-
binding behaviors of gambierol analogues. 
 
Conclusion 
To summarize, this chapter has described a highly efficient two-directional 
olefinic ester cyclization strategy towards the synthesis of polycyclic ether frameworks. 
Not only is the strategy promising in the total synthesis of marine polycyclic ether natural 
products and  their analogues,  there is also prospect  to use this strategy  to build libraries 
 31 
 
Figure 1.27. Synthesis of heptacycle 1.117 
 
of polycyclic ether structures to study the binding functions of ion channels. The 
synthesis of a gambierol analogue using this approach is currently underway in our group. 
In addition, we propose that with differently functionalized side chains, differentiation of 
the two terminals can be achieved, which will give us more flexibility and control in the 
synthesis of polycyclic ether architectures. Efforts to verify this proposition are currently 
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NMR spectra were recorded on Varian Inova-400 MHz, Varian Inova-500 MHz 
or Varian VXR-500 MHz spectrometers. Chemical shifts were reported in !, parts per 
million (ppm), relative to benzene (7.16), chloroform (7.27), or dichloromethane (5.32) 
as internal standards. Coupling constants, J, were reported in Hertz (Hz) and refer to 
apparent peak multiplicities and not true coupling constants. Mass spectra were recorded 
at the Mass Spectrometry Facility at the Department of Chemistry of the University of 
Utah at Salt Lake City on a Finnigan MAT 95 mass spectrometer. IR spectra were 
recorded on a Bruker Tensor 27 FT-IR spectrometer. Optical rotations were obtained on a 
Perkin-Elmer Model 343 polarimerter (Na D line) using a microcell with 1 dm path 
length. Solvents were purified according to the guidelines in Purification of Common 
Laboratory Chemicals (Perrin, Armarego, and Perrin: Oxford, 1966).  Dichloromethane, 
2,6-lutidine, triethylamine, TMEDA, chlorobenzene and pyridine were distilled from 
CaH2. Tetrahydrofuran and diethyl ether were dried from the sodium ketyl of 
benzophenone and distilled before use. Zinc dust (<10 µm, Aldrich) was activated by 
washing with 5% hydrochloric acid, H2O, methanol, and ether and dried in vacuo 
overnight. All other reagents were used without further purification. Unless otherwise 
noted, all reactions were performed under a nitrogen atmosphere in flame-dried glassware 
using standard syringe, cannula, and septa apparatus. Concentration refers to removal of 
solvent under reduced pressure (house vacuum at ca. 20mm Hg). Analytical thin–layer 
chromatography (TLC) was performed on silica gel plates (0.25 mm) precoated with a 
fluorescent indicator. Flash chromatography was performed using 40–63 µm silica gel 
(200 X 400 mesh). 
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Procedures and Characterizations  




General procedure for two-directional olefinic ester cyclization.  (As 
0.10 mmol substrate was used.): A two-necked flask fitted with a condenser was cooled 
to 0 
o
C and charged with CH2Cl2 (21 mL) followed by TiCl4 (0.35 mL, 3.20 mmol). To 
the resulting solution was added THF (1.69 mL, 19.2 mmol) dropwise at which time the 
solution turned bright yellow. The addition of THF was followed by the dropwise 
addition of TMEDA (2.90 mL, 19.2 mmol) resulting in the formation of a brown 
solution. The ice bath was removed and the mixture was allowed to stir for 15 min. 
Activated Zn dust (468 mg, 7.20 mmol) and PbCl2 (105 mg, 0.38 mmol) were then 
added. The resulting mixture went through a series of color changes from brown to green 
to purple and finally to blue-green over the course of 3-5 min. To the slurry was 
transferred a solution of the dienyl diester (0.10 mmol) and CH3CHBr2 (0.29 mL, 3.20 
mmol) in CH2Cl2 (5 mL) via cannula. The reaction mixture was then heated to reflux for 
2 h before it was cooled to 0 °C and quenched with sat. K2CO3 (aq., 1.0 mL). After 
stirring for 30 min at 0 °C, the resulting mixture was filtered through a piece of filter 











Preparation of triol 1.82 . To a solution of 1.81
 
(0.17 g, 0.39 mmol) in THF 
(10 mL) at 0 °C in a plastic bottle was added a solution of HF•Py (0.78 mL of 1.0 M 
solution in THF, 0.78 mmol) dropwise. The reaction was quenched after 2 h with sat. 
NaHCO3 (aq., 10 mL). The aqueous phase was extracted with ethyl acetate (3 x 20 mL). 
The organic extracts were combined, dried (Na2SO4), and concentrated. Flash 
chromatography (2:1 to 1:1 hexanes:ethyl acetate) provided 0.11 g 1.82  (97%) as a 
colorless oil. Rf 0.40 (1:1 hexanes:ethyl acetate); [!]
20
D = +3.9° (c = 1.08, THF); 
1
H 
NMR (500 MHz, CDCl3) " 7.41-7.29 (m, 5H), 5.86 (dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, 
1H), 5.15 (dd, J = 17.1, 1.5 Hz, 1H), 5.07 (dd, J = 10.2, 1.0 Hz, 1H), 4.90 (d, J = 11.8 Hz, 
1H), 4.82 (d, J = 11.7 Hz, 1H), 3.80 (dd, J = 11.7, 3.4 Hz, 1H), 3.71 (dd, J = 11.7, 4.4 Hz, 
1H), 3.57 (dd, J = 9.3, 9.3 Hz, 1H), 3.40-3.18 (m, 5H), 2.70-2.50 (m, 3H), 2.24 (ddd, J = 
14.6, 7.4 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) " 138.8, 134.6, 129.0, 128.3, 128.2, 
117.6, 86.6, 79.2, 78.8, 75.1, 73.5, 71.0, 62.6, 36.3; IR (neat) 3408 (broad), 3072, 2912, 
1642, 1497, 1454, 1360, 1213, 1093, 917 cm
-1
; ESI/MS (m/z) calcd for C16H22O5Na 
317.2 (M+Na
+
), found 317.0. 
 
Preparation of diol 1.84 . To a solution of triol 1.82  (0.11 g, 0.38 mmol) and 
2,6-lutidine (0.18 mL, 1.5 mmol) in CH2Cl2 (10 mL) at -78 °C was added 
trifluoromethanesulfonic anhydride (0.067 mL, 0.40 mmol). After 30 min, TESOTf (0.19 
mL, 0.83 mmol) was added. The reaction mixture was then slowly warmed to rt and the 








with CH2Cl2 (3 x 10 mL), the extracts were combined, dried (Na2SO4), and concentrated. 
The resulting residue was passed through a plug of silica gel using 10:1 hexanes:ethyl 
acetate and concentrated. The resulting colorless oil 1.83  was used directly in the next 
reaction without additional purification. 
To a solution of allylmagnesium chloride (1.1 mL, 2.2 mmol) in THF (8 mL) at -
78 °C was added copper(I) iodide (0.232 g, 1.10 mmol). The acetone-dry ice bath was 
then changed to an acetonitrile-dry ice bath. The reaction mixture was slowly warmed to 
0 °C and then cooled back to -40 °C. A solution of 1.83  (0.14 g, 0.22 mmol) in THF (3 
mL) was cannulated into the reaction mixture and then the reaction mixture was warmed 
to rt after which the reaction was quenched with sat. NH4Cl (aq., 20 mL). The aqueous 
phase was extracted with CH2Cl2 (3 x 10 mL) and the combined organic extracts were 
dried (Na2SO4) and concentrated to give a pale yellow oil. The oil was taken into the next 
step without additional purification. 
To a solution of the oil from above in methanol (10 mL) was added CSA (51 mg, 
0.22 mmol). The reaction mixture was stirred for 2 h at rt before the reaction was 
quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL) and the organic extracts were combined, dried (Na2SO4), and 
concentrated. Flash chromatography (3:1 hexanes:ethyl acetate) provided 58 mg of 1.84  




 (c = 
1.38, THF); 
1
H NMR (500 MHz, C6D6) " 7.30 (d, J = 7.3 Hz, 2H), 7.15 (t, J = 7.3 Hz, 
2H), 7.06 (t, J = 7.3 Hz, 1H), 5.97 (dddd, J = 17.1, 10.3, 6.9, 6.9 Hz, 1H), 5.78 (dddd, J = 
17.1, 10.2, 6.9, 6.9 Hz, 1H), 5.10 (dd, J = 17.1, 1.5 Hz, 1H), 5.05 (dd, J = 17.1, 1.5 Hz, 
1H), 5.03 (dd, J = 10.3, 1.0 Hz, 1H), 4.95 (dd, J = 10.3, 1.0 Hz, 1H), 4.76 (s, 2 H), 3.30-
 37 
3.16 (m, 3H), 3.12-3.02 (m, 2H), 2.56 (ddd, J = 14.0, 6.0, 1.4 Hz, 1H), 2.36-2.10 (m, 5H), 
1.94-1.86 (m, 1H), 1.48 (dddd, J = 14.1, 9.2, 9.2, 4.8 Hz, 1H); 
13
C NMR (125 MHz, 
C6D6) ! 139.4, 138.7, 135.2, 128.7, 127.9, 116.8, 114.8, 87.0, 78.9, 78.6, 74.6, 74.2, 36.4, 
31.3, 29.9; IR (neat) 3428, 3075, 2917, 1641, 1497, 1453, 1361, 1090, 1001, 913 cm
-1
; 
ESI/MS (m/z) calcd for C19H26O4Na 341.2 (M+Na
+
), found 341.1. 
 
Preparation of diacetate 1.85. To a solution of 1.84  (22.4 mg, 0.0700          
mmol) in CH2Cl2 (5 mL) was added triethylamine (0.20 mL, 1.4 mmol) and acetic 
anhydride (0.067 mL, 0.70 mmol). The reaction mixture was stirred for 2 h before the 
reaction was quenched with sat. NaHCO3 (aq., 5 mL). The aqueous phase was extracted 
with CH2Cl2 (3 x 5 mL) and the extracts were combined, dried (Na2SO4), and 
concentrated. Flash chromatography (8:1 hexanes:ethyl acetate) provided 27 mg 1.85  
(95%) as a colorless oil. Rf 0.65 (3:1 hexanes:ethyl acetate); ["]
20
D = -4.2° (c = 1.07, 
THF); 
1
H NMR (500 MHz, CDCl3) ! 7.34-7.22 (m, 5H), 5.83 (partially obscured dddd, J 
= 17.1, 10.3, 6.9, 6.9 Hz, 1H), 5.77 (partially obscured dddd, J = 17.1, 10.2, 7.3, 5.8 Hz, 1 
H), 5.07 (dd, J = 17.6, 1.4 Hz, 1 H), 5.06 (dd, J = 8.3, 1.5 Hz, 1 H), 5.01 (dd, J = 17.1, 1.5 
Hz, 1 H), 4.96 (dd, J = 9.7, 0.9 Hz, 1 H), 4.92 (dd, J = 9.8, 9.8 Hz, 1H), 4.90 (dd, J = 9.8, 
9.8 Hz, 1H), 4.59 (s, 2H), 3.62 (dd, J = 9.2, 9.2 Hz, 1H), 3.31 (ddd, J = 9.8, 7.8, 4.9 Hz, 
1H), 3.26 (ddd, J = 9.8, 7.8, 4.4 Hz, 1H), 2.30-2.18 (m, 3H), 2.09 (dddd, J = 15.7, 7.8, 
7.8, 7.8 Hz, 1H), 1.98 (s, 3H), 1.97 (s, 3H), 1.55-1.49 (m, 2H); 
13












CDCl3) ! 169.9, 169.8, 138.4, 138.2, 134.1, 128.6, 127.9, 117.3, 115.3, 82.2, 77.6, 77.0, 
74.0, 36.3, 30.9, 29.5, 21.2; IR (neat) 3078, 2922, 2855, 1747, 1642, 1432, 1376, 1218, 
1119, 1089, 1068 cm
-1
; ESI/MS (m/z) calcd for C23H31O6 403.2 (M+H
+
), found 403.1. 
 
Preparation of tricycle 1.86. The general two-directional olefinic ester 
cyclization protocol was carried out on diester 1.85  (45 mg, 0.11 mmol) to give 25 mg 
1.86  (64%) as a colorless oil. Rf 0.55 (5:1 hexanes:ethyl acetate); ["]
20
D = +68.4° (c = 
1.44, THF); 
1
H NMR (500 MHz, C6D6) ! 7.52 (d, J = 7.8 Hz, 2H), 7.19 (t, J = 7.8 Hz, 
2H), 7.09 (t, J = 7.8 Hz, 1H), 5.02 (s, 2H), 4.64 (dd, J = 5.9, 5.9 Hz, 1H), 4.21 (broad d, J 
= 4.9 Hz, 1H), 3.66-3.62 (m, 2H), 3.52-3.47 (m, 1H), 3.30-3.22 (m, 2H), 2.17 (dddd, J = 
15.6, 5.6, 5.6, 1.5 Hz, 1H), 2.10-2.02 (m, 1H), 2.01-1.95 (m, 1 H), 1.86 (q, J = 5.9 Hz, 
2H), 1.70 (s, 3H), 1.62 (d, J = 1.0 Hz, 3H), 1.48-1.40 (m, 1H); 
13
C NMR (125 MHz, 
C6D6) ! 157.1, 150.6, 139.9, 128.2, 127.9, 127.4, 108.3, 93.6, 83.9, 81.6, 80.0, 79.5, 75.0, 
72.2, 32.6, 27.8, 21.0, 20.8, 19.3; IR (neat) 3062, 2922, 2855, 1679, 1453, 1380, 1309, 
1186, 1127, 1057, 1028 cm
-1
; EI/MS (m/z) calcd for C21H26O4 342.2 (M
 +
), found 342.2. 
 
Preparation of diol 1.87 . To a solution of trimethylsilylacetylene (0.11 mL,   















hexanes, 0.76 mmol). The reaction mixture was stirred at 0 °C for 30 min and then cooled 
to -78 °C. To this solution was added a solution of 1.83  (0.10 g, 0.15 mmol) and HMPA 
(0.13 mL, 0.76 mmol) in THF (2 mL). The reaction mixture was slowly warmed to rt 
over 2 h before the reaction was quenched with sat. NH4Cl (aq., 20 mL). The aqueous 
phase was extracted with CH2Cl2 (3 x 20 mL) and the combined organic extracts were 
dried (Na2SO4) and concentrated. The residue was taken directly into the next step 
without additional purification.  
To a solution of the residue from above in methanol (20 mL) at rt was added CSA 
(40 mg, 0.15 mmol). After the reaction mixture had stirred for 1 h the reaction was 
quenched with potassium carbonate (60 mg, 0.46 mmol) and the resulting mixture was 
stirred for another 12 h at rt. Concentration and flash chromatography (3:2 hexanes:ethyl 
acetate) provided 41 mg 1.87  as a colorless oil (90%, 3 steps). Rf 0.55 (1:1 hexanes:ethyl 
acetate); [!]
20
D = +0.7° (c = 0.79, THF); 
1
H NMR (500 MHz, CDCl3) " 7.40-7.28 (m, 
5H), 5.93 (dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, 1H), 5.13 (dd, J = 17.1 Hz, 1.5 Hz, 1H), 5.07 
(dd, J = 10.2, 1.0 Hz, 1H), 4.87 (d, J = 11.7 Hz, 1H), 4.85 (d, J = 11.7 Hz, 1 H), 3.53 (dd, 
J = 8.8, 8.8 Hz, 1H), 3.40-3.24 (m, 4H), 2.63 (ddd, J = 17.1, 3.9, 2.4 Hz, 1H), 2.57-2.48 
(m, 3H), 2.40 (broad s, 1H), 2.28 (ddd, J = 15.1, 6.8, 6.8 Hz, 1H), 2.08 (dd, J = 2.9 Hz, 
1H); 
13
C NMR (125 MHz, CDCl3) " 138.8, 134.7, 129.0, 128.3, 128.2, 117.4, 86.5, 80.7, 
78.9, 77.0, 75.2, 73.7, 73.5, 70.6, 36.2, 22.3; IR (neat) 3296 (broad), 3072, 3007, 2858, 
1618, 1455, 1420, 1361, 1250, 1091, 1009, 876 cm
-1
; ESI/MS (m/z) calcd for C18H23O4 
303.2 (M+H
 +
), found 303.0. 
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Preparation of diacetate 1.89. To a solution of 1.87 (65 mg, 0.22 mmol) in 
ethyl acetate (5 mL) was added quinoline (13 µL, 0.11 mmol,) and Lindlar’s Pd catalyst 
(10 mg). The reaction mixture was stirred under a balloon of H2 (1 atm) for 2 h before it 
was passed through a celite plug using ethyl acetate. The filtrate was concentrated to give 
a colorless oil which was taken to the next step without additional purification. 
To a solution of the diol from above in CH2Cl2 (5 mL) was added triethylamine 
(0.60 mL, 4.3 mmol) and acetic anhydride (0.20 mL, 2.2 mmol). The reaction mixture 
was stirred for 2 h before the reaction was quenched with sat. NaHCO3 (5 mL). The 
aqueous phase was extracted with CH2Cl2 (3 x 5 mL) and the organic extracts were 
combined, dried (Na2SO4), and concentrated. Flash chromatography (8:1 hexanes:ethyl 
acetate) provided 70 mg 1.89 (84%, 2 steps) as a colorless oil. Rf 0.60 (3:1 hexanes:ethyl 
acetate); 
1
H NMR (500 MHz, CDCl3) ! 7.34-7.20 (m, 5H), 5.81 (dddd, J = 17.1, 10.2, 
6.4, 6.4 Hz, 2H), 5.05 (partially obscured dd, J = 17.8, 1.4 Hz, 2H), 5.04 (partially 
obscured dd, J = 9.8, 1.0 Hz, 2 H), 4.92 (dd, J = 9.3, 9.3 Hz, 2H), 4.59 (s, 2H), 3.63 (dd, J 
= 9.3, 9.3 Hz, 1H), 3.34 (ddd, J = 9.8, 7.3, 4.9 Hz, 2H), 2.26-2.20 (m, 4H), 1.96 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ! 169.8, 138.4, 134.0, 128.6, 127.9, 117.4, 82.2, 77.6, 74.0, 
73.7, 36.3, 21.2; IR (neat) 3087, 2959, 2859, 1747, 1646, 1432, 1226, 1120, 1066 cm
-1
; 
ESI/MS (m/z) calcd for C22H29O6 389.2 (M+H
+













Preparation of PMB ether 1.90 . To a solution of 1.81  (0.27 g, 0.62 mmol) 
in THF (15 mL) was added tBuOK (0.93 mL of 1.0 M solution in THF, 0.93 mmol). The 
reaction mixture was stirred for 0.5 h at rt and then cooled to 0 °C. After the slow 
addition of PMBBr (0.18 mL, 1.2 mmol), the reaction mixture was warmed to rt and 
stirred for 2 h after which the reaction was quenched with sat. NH4Cl (aq., 15 mL). The 
aqueous phase was extracted with CH2Cl2 (3 x 15 mL) and the combined organic extracts 
were dried (Na2SO4), and concentrated. Flash chromatography (10:1 hexanes:ethyl 





 (c =1.25, THF); 
1
H NMR (500 MHz, CDCl3) " 7.49 (d, J = 6.8 
Hz, 2H), 7.39 (dt, J = 6.8, 2.0 Hz, 2H), 7.36-7.32 (m, 1H), 7.28 (d, J = 8.8 Hz, 2H), 6.95-
6.91 (m, 2H), 5.90 (dddd, J =17.1, 10.3, 7.3, 7.3 Hz, 1H), 5.16 (d, J = 9.7 Hz, 1 H), 5.12-
5.10 (m, 2H), 4.93 (d, J = 10.7 Hz, 1H), 4.89 (d, J = 10.7 Hz, 1H), 4.62 (d, J = 10.7 Hz, 
1H), 4.24 (dd, J = 10.2, 4.9 Hz, 1H), 3.97 (dd, J = 9.3, 9.3 Hz, 1H), 3.90 (dd, J = 10.3, 
10.3 Hz, 1H), 3.83 (s, 3H), 3.68 (dd, J = 8.3 Hz, 1H), 3.48-3.42 (m, 2H), 3.33 (dd, J = 
9.3, 9.3 Hz, 1H), 2.65-2.60 (m, 1H), 2.28 (ddd, J = 14.6, 7.3, 7.3 Hz, 1H), 1.16 (s, 9H), 
1.09 (s, 9H); 
13
C NMR (125 MHz, CDCl3) " 159.6, 139.2, 134.8, 129.9, 128.7, 128.5, 
128.0, 117.5, 114.1, 87.0, 80.4, 79.3, 79.1, 75.7, 75.1, 74.7, 66.9, 55.5, 36.3, 28.0, 27.8, 
27.4, 23.0, 20.2; IR (neat) 2935, 2887, 2860, 1613, 1514, 1469, 1390, 1301, 1249, 1167, 
1094 cm
-1
; ESI/MS (m/z) calcd for C32H46O6Si (M
+













Preparation of alcohol 1.91 . To a solution of 1.90  (0.33 g, 0.62 mmol) in 
THF (5 mL) at 0 °C was added BH3•DMS (1.2 mL of 2.0 M solution in THF, 2.5 mmol). 
The reaction mixture was stirred for 2 h at 0 °C before the reaction was quenched with 
H2O (0.1 mL). To the resulting mixture was added NaOH (3.6 mL of 3.0 M aq. solution, 
11 mmol) followed by H2O2 (13 mL of 30% aq. solution). The reaction mixture was then 
allowed to warm to rt and stirred overnight. The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL) and the combined organic extracts were dried (Na2SO4) and 
concentrated. Flash chromatography (3:1 hexanes:ethyl acetate) gave 0.31 g 1.91  (90%) 
as a colorless oil. Rf 0.45 (2:1 hexanes:ethyl acetate); [!]
20
D = -13.9°(c = 1.31, THF); 
1
H 
NMR (500 MHz, CDCl3) " 7.45 (d, J = 6.8 Hz, 2H), 7.36 (t, J = 6.8 Hz, 2H), 7.32-7.28 
(m, 1H), 7.25 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 6.3 Hz, 2H), 5.11 (d, J =10.7 Hz, 1H), 4.89 
(d, J = 10.3 Hz, 1H), 4.85 (d, J = 10.3 Hz, 1H), 4.58 (d, J = 10.7 Hz, 1H), 4.18 (dd, J = 
10.2, 4.9 Hz, 1H), 3.94 (dd, J = 9.3, 9.3 Hz, 1H), 3.86 (dd, J = 10.3, 10.3 Hz, 1H), 3.80 (s, 
3H), 3.63 (dd, J = 8.3, 8.3 Hz, 1H), 3.57 (broad t, J = 6.4 Hz, 2H), 3.40 (ddd, J = 9.8, 9.8, 
4.9 Hz, 1H), 3.34 (dd, J = 9.3, 9.3 Hz, 1H), 3.23 (dd, J = 9.3 Hz, 1H), 2.33 (s, 1H), 1.93 
(ddd, J = 14.2, 7.3, 7.3 Hz, 1H), 1.71-1.57 (m, 2H), 1.48-1.38 (m, 1H), 1.12 (s, 9H), 1.05 
(s, 9H); 
13
C NMR (125 MHz, CDCl3) " 159.6, 139.1, 130.7, 130.0, 128.7, 128.5, 128.0, 
114.1, 86.8, 80.9, 79.7, 79.0, 75.7, 75.3, 74.6, 66.8, 62.8, 55.5, 28.9, 28.5, 27.8, 27.3, 
22.9, 20.2; IR (neat) 3384, 2934, 2860, 1613, 1514, 1469, 1363, 1302, 1249, 1164, 1100, 
826 cm
-1
; ESI/MS (m/z) calcd for C32H48O7SiNa 595.3 (M+Na
+












Preparation of alkene 1.92 . To a solution of 1.91  (0.214 g, 0.374 mmol) in 
CH2Cl2 (10 mL) was added 4Å MS (0.25 g), NMO (0.18 g, 1.5 mmol), and TPAP (5.0 
mg, 0.014 mmol). The reaction mixture was stirred at rt for 2 h before it was transferred 
into a flask containing freshly prepared triphenylphosphonium methylide (6.0 mL of 0.19 
M solution in THF, 1.1 mmol) via cannula. The reaction mixture was then stirred for 2 h 
before the reaction was quenched with sat. NH4Cl (aq., 10 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The combined extracts were dried (Na2SO4) and 
concentrated. Flash chromatography (20:1 hexanes:ethyl acetate) gave 0.13 g 1.92  
(62%) as a colorless oil. Rf 0.45 (10:1 hexanes:ethyl acetate); [!]
20
D = -13.6° (c = 0.73, 
THF); 1H NMR (500 MHz, CDCl3) " 7.47 (d, J = 6.8 Hz, 2H), 7.38 (t, J = 6.8 Hz, 2H), 
7.34-7.32 (m, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 6.3 Hz, 2H), 5.83 (dddd, J =17.1, 
10.2, 6.8, 6.8 Hz, 1H), 5.13 (d, J = 11.2 Hz, 1H), 5.04 (dd, J = 17.1, 1.5 Hz, 1H), 4.99 (d, 
J = 10.2, 1.5 Hz, 1H), 4.90 (d, J = 10.7 Hz, 1H), 4.87 (d, J = 10.7 Hz, 1H), 4.60 (d, J = 
10.7 Hz, 1H), 4.20 (dd, J = 10.2, 4.9 Hz, 1H), 3.95 (dd, J = 9.3, 9.3 Hz, 1H), 3.88 (dd, J = 
10.3, 10.3 Hz, 1H), 3.83 (s, 3H), 3.65 (dd, J = 8.3, 8.3 Hz, 1H), 3.39 (partially obscured 
ddd, J = 9.8, 9.8, 4.9 Hz, 1H), 3.35 (partially obscured ddd, J = 9.3, 9.3, 2.4 Hz, 1H), 3.25 
(dd, J = 9.3, 9.3 Hz, 1H), 2.28-2.21 (m, 1H), 2.12 (dddd, J = 15.2, 7.4, 7.4, 7.4 Hz, 1H), 
1.97-1.90 (m, 1H), 1.48 (dddd, J = 14.2, 9.3, 9.3, 4.9 Hz, 1H), 1.14 (s, 9H), 1.06 (s, 9H); 
13C NMR (125 MHz, CDCl3) " 159.6, 139.2, 138.6, 130.8, 129.9, 128.7, 128.5, 127.9, 










23.0, 20.2; IR (neat) 2933, 2859, 1613, 1514, 1468, 1249, 1094 cm
-1
; ESI/MS (m/z) calcd 
for C33H48O6SiNa 591.3 (M+Na
+
), found 591.1. 
 
Preparation of triol 1.93 . To a solution of 1.92  (0.132 g, 0.232 mmol) in 9:1 
CH2Cl2:H2O (10 mL) was added DDQ (74.0 mg, 0.325 mmol). The reaction mixture was 
stirred for 2 h before the reaction was quenched with sat. NaHCO3 (aq., 5 mL). The 
aqueous phase was extracted with CH2Cl2 (3 x 10 mL) and the combined organic extracts 
were dried (Na2SO4) and concentrated to give a brown oil which was taken into the next 
step without additional purification. 
To a solution of the brown oil from above in THF (10 mL) at 0 °C was added 
HF•Py (0.46 mL of 1.0 M solution in THF, 0.46 mmol). The reaction mixture was stirred 
for 2 h before the reaction was quenched with sat. NaHCO3 (aq., 5 mL). The aqueous 
phase was extracted with ethyl acetate (3 x 10 mL) and the combined organic extracts 
were dried (Na2SO4) and concentrated. Flash chromatography (1:1 hexanes:ethyl acetate) 





 (c = 0.28, THF); 
1
H NMR (500 MHz, CDCl3) " 7.34-7.26 (m, 5H), 5.80 
(dddd, J =17.0, 9.7, 6.8, 6.8 Hz, 1H), 5.02 (d, J = 17.0 Hz, 1H), 4.96 (d, J = 9.7 Hz, 1H), 
4.91 (d, J = 12.2 Hz, 1H), 4.82 (d, J = 12.2 Hz, 1H), 3.80 (dd, J = 11.7, 3.0 Hz, 1H), 3.72 
(dd, J = 11.7, 4.4 Hz, 1H), 3.59 (dd, J = 9.3, 9.3 Hz, 1H), 3.34 (dd, J = 8.3, 8.3 Hz, 1H), 
3.28-3.19 (m, 4H), 2.60 (broad s, 2H), 2.29-2.22 (m, 1H), 2.10 (dddd, J = 15.1, 7.3, 7.3, 











C NMR (125 MHz, CDCl3) ! 138.8, 138.6, 129.0, 128.3, 128.1, 115.0, 86.8, 79.1, 
78.9, 75.1, 74.0, 71.1, 62.7, 31.1, 29.7; IR (neat) 3388 (broad), 2921, 2857, 1641, 1497, 
1362, 1248, 1092, 1027 cm
-1





Preparation of diacetate 1.95 . Prepared from 1.93 (62.1 mg, 0.202 mmol) 
according to the same procedure used for the preparation of 1.85 (53!, 4 steps). Rf 0.70 
(3:1 hexanes:ethyl acetate); 
1
H NMR (500 MHz, CDCl3) ! 7.32 (t, J = 6.8 Hz, 2 H), 7.28-
7.25 (m, 1 H), 7.23 (d, J = 6.9 Hz, 2H), 5.77 (dddd, J = 17.1, 10.3, 7.3, 6.3 Hz, 2H), 5.02 
(dd, J = 17.1, 1.5 Hz, 2H), 4.97 (d, J = 10.2 Hz, 2H), 4.89 (dd, J = 9.3, 9.3 Hz, 2H), 4.59 
(s, 2H), 3.62 (dd, J = 9.3, 9.3 Hz, 1H), 3.25 (ddd, J = 9.8, 7.8, 4.4 Hz, 2H), 2.29 (dddd, J 
= 14.2, 6.4, 6.4, 6.4 Hz, 2H), 2.10 (dddd, J = 15.2, 7.8, 7.8, 7.8 Hz, 2H), 1.98 (s, 6H), 
1.55-1.50 (m, 4H); 
13
C NMR (125 MHz, CDCl3) ! 169.9, 138.2, 128.6, 127.9, 115.3, 
82.2, 77.0, 74.1, 31.0, 29.6, 21.2; IR (neat) 3074, 2951, 2851, 1749, 1452, 1377, 1212, 
1092, 1071, 1032 cm
-1
; ESI/MS (m/z) calcd for C24H33O6 417.2 (M+H
+
), found 417.1. 
 
Preparation of tricycle 1.96. The general two-directional olefinic ester 


















give 36.0 mg 1.96  (65%) as a colorless oil. Rf 0.45 (5:1 hexanes:ethyl acetate); 
1
H NMR 
(500 MHz, CDCl3) ! 7.47 (d, J = 6.9 Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 7.27 (t, J = 7.4 Hz, 
1H), 4.92 (s, 2H), 4.44 (broad d, J = 4.9 Hz, 2H), 3.68 (dd, J = 8.8, 8.8 Hz, 1H), 3.62 (dd, 
J = 9.8, 9.8 Hz, 2H), 3.52 (ddd, J = 9.3, 9.3, 6.4 Hz, 2H), 2.28 (dddd, J = 16.1, 6.8, 6.8, 
1.5 Hz, 2H), 2.11-2.04 (m, 2H), 1.79 (s, 6H); 
13
C NMR (125 MHz, CDCl3) ! 150.8, 
139.2, 128.4, 128.2, 127.7, 93.5, 80.7, 78.8, 74.7, 72.6, 27.6, 19.5; IR (neat) 3052, 2889, 
1676, 1499, 1443, 1376, 1304, 1181, 1092, 1042, 972, 912 cm
-1
; ESI/MS (m/z) calcd for 
C20H25O4 329.2 (M+H
+
), found 329.0. 
 
Preparation of tricycle 1.97. The general two-directional olefinic ester 
cyclization reaction protocol was carried out on diester 1.95  (52 mg, 0.13 mmol) to give 
29 mg 1.97  (65%) as a colorless oil. Rf 0.60 (5:1 hexanes:ethyl acetate); 
1
H NMR (500 
MHz, C6D6) ! 7.52 (dd, J = 7.3, 1.5 Hz, 2H), 7.20 (dt, J = 7.3, 1.9 Hz, 2H), 7.10 (partially 
obscured t, J = 7.3 Hz, 1H), 5.02 (s, 2H), 4.65 (ddd, J = 6.1, 6.1, 0.9 Hz, 2H), 3.62 (dd, J 
= 9.3, 9.3 Hz, 1H), 3.43 (dd, J = 9.3, 9.3 Hz, 2H), 3.23 (ddd, J = 9.3, 7.8, 4.4 Hz, 2H), 
2.22-1.96 (m, 2H), 1.89-1.82 (m, 4H), 1.70 (s, 6H), 1.44 (dddd, J = 13.7, 9.8, 8.3, 4.4 Hz, 
2H); 
13
C NMR (125 MHz, C6D6) ! 157.0, 139.9, 128.3, 128.0, 127.4, 108.3, 84.2, 82.4, 
79.8, 75.7, 32.7, 21.0, 20.8; IR (neat) 3031, 2926, 2893, 2851, 1681, 1430, 1376, 1309, 
1277, 1170, 1088, 1053 cm
-1















Preparation of diol 1.98 . To a solution of 1.90  (0.186 g, 0.336 mmol) in 
THF (10 mL) at 0 °C was added a solution of HF•Py (0.67 mL of 1.0 M solution in THF, 
0.67 mmol) dropwise. After stirring for 2 h, the reaction was quenched with sat. NaHCO3 
(aq., 10 mL). The aqueous phase was extracted with ethyl acetate (3 x 10 mL), and the 
organic extracts were combined, dried (Na2SO4), and concentrated. Flash 
chromatography (2:1 to 1:1 hexanes:ethyl acetate) provided 0.117 g of diol 1.98  (85%) 
as a colorless oil. Rf 0.20 (1:1 hexanes:ethyl acetate); [!]
20
D = +24.7° (c = 0.49, THF); 
1
H 
NMR (500 MHz, CDCl3) " 7.42-7.30 (m, 5H), 7.26 (d, J = 8.3 Hz, 2H), 6.89 (d, J = 8.3 
Hz, 2H), 5.90 (dddd, J = 17.1, 10.3, 7.3, 7.3 Hz, 1H), 5.14 (d, J = 17.1 Hz, 1H), 5.10 (d, J 
= 10.3 Hz, 1H), 4.96 (d, J = 11.7 Hz, 1H), 4.86 (d, J = 11.7 Hz, 1H), 4.83 (d, J = 10.3 Hz, 
1H), 4.60 (d, J = 10.3 Hz, 1H), 3.85-3.80 (partially obscured m, 1 H), 3.82 (s, 3 H), 3.72 
(broad dd, J = 11.7, 4.4 Hz, 1H), 3.57 (broad dd, J = 9.3, 9.3 Hz, 1H), 3.54 (dd, J = 8.8, 
8.8 Hz, 1H), 3.40 (ddd, J = 9.8, 7.8, 2.9 Hz, 1H), 3.30-3.24 (m, 2H), 3.13 (broad s, 1H), 
2.66-2.58 (m, 2H), 2.28 (ddd, J = 15.1, 7.3, 7.3 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) " 
159.6, 138.9, 134.9, 130.5, 129.9, 128.9, 128.1, 128.0, 117.5, 114.2, 87.0, 81.4, 79.1, 
78.8, 75.5, 75.0, 71.3, 62.8, 55.5, 36.2; IR (neat) 3318 (broad), 2930, 1613, 1514, 1456, 
1359, 1303, 1248, 1093, 1037 cm
-1













Preparation of triflate 1.99 . To a solution of diol 1.98  (0.116 g, 0.280 
mmol) and 2,6-lutidine (0.13 mL, 1.1 mmol) in CH2Cl2 (10 mL) at -78 °C was added 
trifluoromethanesulfonic anhydride (0.050 mL, 0.29 mmol). TESOTf (0.082 mL, 0.36 
mmol) was added after 30 min, and the resulting mixture was slowly warmed to rt before 
the reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL), the extracts were combined, dried (Na2SO4), and 
concentrated. Flash chromatography (10:1 hexanes:ethyl acetate) gave 0.154 g 1.99 
(83%) as a colorless oil. Rf 0.40 (10:1 hexanes:ethyl acetate); [!]
20
D = +36.5° (c = 0.53, 
THF); 
1
H NMR (500 MHz, C6D6) " 7.30 (d, J = 7.3 Hz, 2H), 7.18 (t, J = 7.3 Hz, 2H), 
7.07 (t, J = 7.3 Hz, 1H), 6.99 (d, J = 8.8 Hz, 2H), 6.63 (d, J = 8.8 Hz, 2H), 5.98 (dddd, J = 
17.1, 10.3, 7.3, 7.3 Hz, 1H), 5.08 (d, J = 17.1 Hz, 1H), 5.05 (d, J = 10.3 Hz, 1H), 5.00 (d, 
J = 11.7 Hz, 1H), 4.66 (d, J = 11.7 Hz, 1H), 4.50 (d, J = 10.3 Hz, 2H), 4.37-4.33 (m, 2H), 
3.56 (dd, J = 9.2, 9.2 Hz, 1H), 3.28-3.21 (m, 4H), 3.17 (ddd, J = 12.2, 7.3, 2.9 Hz, 1H), 
3.10 (dd, J = 10.3, 10.3 Hz, 1H), 2.96 (ddd, J = 9.2, 4.3, 1.9 Hz, 1H), 2.54-2.48 (m, 1H), 
2.20 (ddd, J = 14.7, 7.3, 7.3 Hz, 1H), 0.86 (t, J = 7.8 Hz, 9H), 0.60-0.49 (m, 6H); 
13
C 
NMR (125 MHz, C6D6) " 159.7, 139.2, 134.3, 130.5, 129.4, 128.4, 127.3, 126.4, 119.2 
(q, J = 325 Hz), 117.5, 113.9, 86.6, 81.8, 79.0, 77.3, 75.1, 74.8, 74.7, 70.6, 54.6, 36.0, 
6.9, 5.2; IR (neat) 2957, 2879, 1613, 1515, 1459, 1415, 1302, 1248, 1145, 1114 cm
-1
; 
ESI/MS (m/z) calcd for C31H43F3O8SSiNa 683.2 (M+Na
+










Preparation of alkyne 1.100 . To a solution of trimethylsilylacetylene (1.37 
mL, 9.75 mmol) in THF (20 mL) at 0 °C was added nBuLi (3.9 mL of 2.5 M solution in 
hexanes, 9.8 mmol). After 30 min, the reaction mixture was cooled to -78 °C and to this 
was transferred a solution of 1.99  (1.29 g, 1.95 mmol) and HMPA (1.68 mL, 9.75 mmol) 
in THF (5 mL). The reaction mixture was slowly warmed to rt over 2 h before the 
reaction was quenched with sat. NH4Cl (aq., 20 mL). The aqueous phase was extracted 
with CH2Cl2 (3 x 20 mL) and the organic extracts were combined, dried (Na2SO4), and 
concentrated to give a dark brown syrup that was taken directly into the next step without 
additional purification.  
To a solution of the residue from above in methanol (30 mL) was added CSA 
(0.87 g, 3.9 mmol). After 1 h, the reaction was quenched with potassium carbonate (1.08 
g, 7.80 mmol). The resulting mixture was stirred for another 12 h and then concentrated. 
Flash chromatography (6:1 hexanes:ethyl acetate) provided 0.72 g 1.100  (88%, 3 steps) 
as a colorless oil. Rf 0.40 (5:1 hexanes:ethyl acetate); [!]
20
D = +16.1° (c = 0.79, THF); 
1
H 
NMR (500 MHz, CDCl3) " 7.50-7.38 (m, 5H), 7.34 (d, J = 8.8 Hz, 2H), 6.98 (d, J = 8.8 
Hz, 2H), 6.09 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.26 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 
10.2 Hz, 1H), 5.07 (d, J = 11.3 Hz, 1H), 4.93 (d, J = 11.3 Hz, 1H), 4.89 (d, J = 11.7 Hz, 
1H), 4.70 (d, J = 11.7 Hz, 1H), 3.84 (s, 3H), 3.61 (p, J = 8.8 Hz, 2H), 3.49-3.44 (m, 1H), 
3.43-3.36 (m, 2H), 2.87 (s, 1H), 2.77-2.67 (m, 2H), 2.60 (ddd, J = 17.1, 6.4, 2.4 Hz, 1H), 
2.43 (dt, J = 14.6, 7.3 Hz, 1H), 2.14 (t, J = 2.4 Hz, 1H); 
13








159.7, 139.1, 135.1, 130.7, 129.9, 129.0, 128.7, 128.1, 117.4, 114.3, 87.0, 81.5, 81.0, 
79.0, 77.1, 75.5, 75.0, 73.6, 70.7, 55.5, 36.1, 22.4; IR (neat) 3449, 3291, 3070, 2907, 
1641, 1514, 1457, 1422, 1360, 1249, 1090, 1034, 821 cm
-1
; ESI/MS (m/z) calcd for 
C26H30O5Na 445.2 (M+Na
 +
), found 445.1. 
 
Preparation of alcohol 1.101. To a solution of 1.100 (0.50 g, 1.2 mmol) in 
ethyl acetate (20 mL) was added quinoline (0.070 mL, 0.59 mmol,) and Lindlar’s Pd 
catalyst (50 mg). The reaction mixture was stirred under a balloon of H2 (1 atm) for 2 h 
before it was passed through a celite plug using ethyl acetate. The filtrate was 
concentrated and flash chromatography (5:1 hexanes:ethyl acetate) gave 0.48 g 1.101  
(95%) as a white solid. Rf 0.40 (3:1 hexanes:ethyl acetate); m.p. 70-72 °C; [!]
20
D = 
+22.1° (c = 0.67, THF); 
1
H NMR (500 MHz, C6D6) " 7.43-7.31 (m, 5H), 7.27 (d, J = 8.8 
Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 5.98-5.87 (m, 2H), 5.15-5.06 (m, 4H), 5.00 (d, J = 11.7 
Hz, 1H), 4.81 (d, J = 10.2 Hz, 1H), 4.78 (d, J = 11.7 Hz, 1H), 4.63 (d, J = 10.2 Hz, 1H), 
3.81 (s, 3H), 3.48 (t, J = 8.8 Hz, 1H), 3.38-3.25 (m, 3H), 3.22 (td, J = 8.3, 3.4 Hz, 1H), 
2.63-2.53 (m, 2H), 2.31-2.21 (m, 3H); 
13
C NMR (125 MHz, C6D6) " 159.6, 139.4, 135.2, 
135.1, 131.0, 129.5, 128.6, 127.7, 116.9, 113.9, 87.3, 81.7, 78.9, 78.8, 75.0, 74.5, 74.2, 
54.7, 36.4, 36.3; IR (neat) 3420, 3073, 2904, 1641, 1514, 1458, 1433, 1361, 1249, 1090, 
1034, 821 cm
-1
; ESI/MS (m/z) calcd for C26H32O5Na 447.2 (M+Na
 +









Preparation of ester 1.103 . To a solution of 1.101  (0.10 g, 0.24 mmol) in 
CH2Cl2 (10 mL) was added 5,5-dimethoxypentanoic acid (1.102
56
, 57 mg, 0.35 mmol), 
DCC (0.10 g, 0.47 mmol) and DMAP (29 mg, 0.24 mmol). The reaction mixture was 
stirred at rt for 2 h before the reaction was quenched with sat. NaHCO3 (aq., 10 mL). The 
aqueous phase was extracted with CH2Cl2 (3 x 15 mL), the extracts were combined, dried 
(Na2SO4), and concentrated. Flash chromatography (3:1, hexanes:ethyl acetate) provided 
0.131 g 1.103  (98%) as a colorless oil. Rf 0.40 (3:1 hexanes:ethyl acetate); [!]
20
D = 
+14.9° (c = 1.16, THF); 
1
H NMR (500 MHz, CDCl3) " 7.36-7.25 (m, 5H), 7.22 (d, J = 
8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 5.95-5.78 (m, 2H), 5.13-5.02 (m, 4H), 4.91 (t, J = 
9.3 Hz, 1H), 4.84 (d, J = 11.2 Hz, 1H), 4.76 (d, J = 10.7 Hz, 1H), 4.67 (d, J = 11.2 Hz, 
1H), 4.57 (d, J = 10.7 Hz, 1H), 4.32 (t, J = 4.9 Hz, 1H), 3.78 (s, 3H), 3.62 (t, J = 8.3 Hz, 
1H), 3.38-3.26 (m, 9H), 2.58 (dd, J = 13.5, 5.4 Hz, 1H), 2.30-2.12 (m, 5H), 1.68-1.56 (m, 
4H); 
13
C NMR (125 MHz, CDCl3) " 172.4, 159.6, 138.7, 134.8, 134.2, 130.4, 129.9, 
128.6, 127.8, 117.3, 114.1, 104.4, 85.0, 81.6, 78.8, 77.4, 75.3, 75.0, 74.1, 55.5, 53.0, 36.4, 
36.1, 34.1, 32.1, 20.1; IR (neat) 3074, 2951, 2858, 1740, 1643, 1586, 1459, 1362, 1249, 
1125, 1081, 917 cm
-1
; ESI/MS (m/z) calcd for C33H44O8Na 591.3 (M+Na
+























Preparation of diester 1.105 . To a mixture of 1.103  (49 mg, 0.086 mmol) in 
CH2Cl2 (9 mL) and pH 7 phosphate buffer (1 mL) was added DDQ (22 mg, 0.095 mmol). 
The reaction mixture was stirred for 12 h before the reaction was quenched with sat. 
NaHCO3 (aq., 10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL) and 
the organic extracts were combined, dried (Na2SO4) and concentrated. Flash 
chromatography (5:1 hexanes:ethyl acetate) provided 38 mg the free alcohol (99%) as a 
colorless oil. Rf 0.35 (3:1 hexanes:ethyl acetate); [!]
20
D = -12.1° (c = 0.43, THF); 
1
H 
NMR (500 MHz, C6D6) " 7.33 (d, J = 7.8 Hz, 2H), 7.20 (t, J = 7.8 Hz, 2H), 7.10 (t, J = 
7.8 Hz, 1H), 6.02 (dddd, J = 17.2, 10.3, 7.3, 7.3 Hz, 1H), 5.96 (dddd, J = 17.1, 10.3, 6.8, 
6.8 Hz, 1H), 5.19-5.04 (m, 5H), 4.70 (d, J = 11.7 Hz, 1H), 4.67 (d, J = 11.7 Hz, 1H), 4.19 
(t, J = 5.9 Hz, 1H), 3.41 (dd, J = 9.3, 9.3 Hz, 1H), 3.33 (dd, J = 9.3, 9.3 Hz, 1H), 3.23 
(ddd, J = 9.8, 6.8, 4.4 Hz, 1H), 3.17 (ddd, J = 9.3, 7.8, 3.4 Hz, 1H), 3.09 (s, 3H), 3.08 (s, 
3H), 2.61 (m, 1H), 2.36-2.24 (m, 4H), 2.08 (ddd, J = 7.3, 7.3, 3.9 Hz, 2H), 1.68-1.61 (m, 
2H), 1.58-1.53 (m, 2H); 
13
C NMR (125 MHz, C6D6) " 172.0, 139.1, 134.9, 134.3, 128.6, 
127.7, 127.6, 117.1, 117.0, 114.2, 84.7, 79.1, 77.4, 74.2, 73.7, 73.6, 52.2, 36.5, 36.3, 33.9, 
31.9, 20.2; IR (neat) 3449, 3076, 2949, 1743, 1643, 1456, 1364, 1127, 1092, 916 cm
-1
; 
ESI/MS (m/z) calcd for C25H36O7Na 471.3 (M+Na
+
), found 471.1. 
To a solution of the alcohol from above (82 mg, 0.18 mmol) in CH2Cl2 (10 mL) 
was added 4, 4-dimethoxybutanoic acid (1.104
57
, 54 mg, 0.36 mmol), DCC (0.15 g, 0.73 
mmol) and DMAP (44 mg, 0.36 mmol). The reaction mixture was stirred at rt for 2 h 
before the reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase 
was extracted with CH2Cl2 (3 x 15 mL) and the extracts were combined, dried (Na2SO4), 
and concentrated. Flash chromatography (3:1 hexanes:ethyl acetate) provided 84 mg 
 53 
1.105  (80%) as a colorless oil. Rf 0.33 (3:1 hexanes:ethyl acetate); [!]
20
D = +1.1° (c = 
0.66, THF); 
1
H NMR (500 MHz, C6D6) " 7.28 (d, J = 7.3 Hz, 2H), 7.13 (t, J = 7.3 Hz, 
2H), 7.02 (dt, J = 7.3, 2.0 Hz, 1H), 5.86 (dddd, J = 17.1, 10.2, 6.3, 6.3 Hz, 2H), 5.15 (dd, 
J = 9.6, 9.6 Hz, 1H), 5.14 (dd, J = 9.6, 9.6 Hz, 1H), 5.05 (d, J = 17.1 Hz, 2H), 5.01 (d, J = 
10.2 Hz, 2H), 4.58 (d, J = 11.7 Hz, 1H), 4.55 (d, J = 11.2 Hz, 1H), 4.19 (dd, J = 5.6, 5.6 
Hz, 1H), 4.14 (dd, J = 5.6, 5.6 Hz, 1H), 3.56 (dd, J = 9.5, 9.5 Hz, 1H), 3.18-3.14 (m, 2H), 
3.05 (s, 3H), 3.04 (s, 3H), 3.01 (s, 3H), 3.00 (s, 3H), 2.32-2.18 (m, 6H), 2.08-1.98 (m, 
2H), 1.92-1.81 (m, 2H), 1.64-1.48 (m, 4H); 
13
C NMR (125 MHz, C6D6) " 171.6, 138.8, 
134.2, 134.1, 128.4, 127.5, 127.5, 117.2, 117.1, 104.2, 103.5, 82.2, 77.6, 73.3, 73.1, 73.0, 
52.7, 52.6, 52.2, 36.4, 36.3, 33.9, 31.9, 29.2, 27.8, 20.2; IR (neat) 3073, 2937, 2832, 
1745, 1646, 1435, 1367, 1156, 1126, 1084 cm
-1
; ESI/MS (m/z) calcd for C31H46O10Na 
601.3 (M+Na
+
), found 601.1. 
 
Preparation of tricycle 1.106. The general two-directional olefinic ester 
cyclization reaction protocol was carried out on diester 1.105  (77 mg, 0.13 mmol) to 
give 41 mg 1.106  (60%) as a colorless oil. Rf 0.45 (3:1 hexanes:ethyl acetate); [!]
20
D = 
0° (c = 0.51, THF); 
1
H NMR (500 MHz, C6D6) " 7.57 (d, J = 7.8 Hz, 2H), 7.26 (t, J = 7.6 
Hz, 2H), 7.13-7.10 (m, 1H), 5.04 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 4.33 
(dd, J = 5.9, 5.9 Hz, 1H), 4.31-4.24 (m, 3H), 3.68-3.58 (m, 3H), 3.30-3.22 (m, 2H), 3.11 
(s, 6H), 3.10 (s, 6H), 2.19-2.10 (m, 4H), 2.08-1.88 (m, 6H), 1.64-1.60 (m, 4H); 
13
C NMR 












80.5, 79.3, 79.2, 74.3, 72.5, 72.4, 52.2, 52.1, 52.2, 33.4, 32.0, 30.3, 29.0, 27.7, 22.3; IR 
(neat) 3066, 2929, 2830, 1677, 1452, 1384, 1322, 1167, 1125, 1098 cm-1; ESI/MS (m/z) 
calcd for C29H42O8Na 541.3 (M+Na
+), found 541.1. 
 
  Preparation of diketone 1.108. To a solution of 1.106  (10.3 mg, 0.0200     
mmol) in CH2Cl2 (3 mL) at -78 °C was added DMDO (0.8 mL of 0.1 M solution in 
acetone, 0.08 mmol) dropwise. After warming to 0 °C the reaction mixture was 
concentrated. To a solution of the resulting residue in THF (3 mL) at -78 °C was added 
iBu2AlH (0.24 mL of 1.0 M solution in hexane, 0.24 mmol). The reaction mixture was 
stirred for 1 h at -78 °C before the reaction was quenched with sat. NH4Cl (aq., 10 mL). 
The resulting mixture was warmed to rt and the aqueous phase was extracted with ethyl 
acetate (3 x 10 mL). The organic extracts were combined, dried (Na2SO4), and 
concentrated to give a colorless oil which was taken to the next step without additional 
purification.  
To a solution of the residue from above in CH2Cl2 (5 mL) was added 4Å MS (10 
mg), NMO (47 mg, 0.40 mmol) and TPAP (2 mg, 6 µmol). The reaction mixture was 
stirred at rt for 2 h and then concentrated. Flash chromatography (1:1 hexanes: ethyl 
acetate) gave 7.3 mg of diketones (67%, 2 steps) as a 1:1 mixture of diastereomers.  
To a solution of the diketones obtained above (7.3 mg, 13 mmol) from above in 
toluene (5 mL) was added DBU (1 drop). The reaction mixture was heated at reflux for 














mL). The organic phase was washed with H2O (2 x 5 mL), dried (Na2SO4), and 
concentrated. Flash chromatography (1:1 hexanes:ethyl acetate) gave 5.5 mg (75%) of an 





(c = 0.36, THF); 
1
H NMR (500 MHz, CD2Cl2) " 7.43 (d, J = 7.3 Hz, 2H), 7.36 (t, J = 7.3 
Hz, 2H), 7.29 (t, J = 7.3 Hz, 1H), 4.92 (d, J = 11.7 Hz, 1H), 4.88 (d, J = 11.7 Hz, 1H), 
4.40 (t, J = 5.4 Hz, 1H), 4.35 (t, J = 5.4 Hz, 1H), 3.90 (dd, J = 7.8, 3.9 Hz, 1H), 3.86 (dd, 
J = 7.8, 3.4 Hz, 1H), 3.70-3.54 (m, 5H), 3.31 (s, 3H), 3.30 (s, 3H), 3.29 (s, 3H), 3.29 (s, 
3H), 2.92 (dd, J = 15.6, 5.4 Hz, 2H), 2.51 (dd, J = 15.6, 11.2 Hz, 2H), 2.00-1.88 (m, 2H), 
1.84-1.42 (m, 8H); 
13
C NMR (125 MHz, CD2Cl2) " 204.5, 204.3, 139.0, 128.4, 128.0, 
127.8, 104.7, 104.5, 83.3, 82.9, 81.1, 81.0, 80.1, 74.8, 52.8, 52.8, 52.6, 45.0, 32.7, 29.3, 
28.3, 24.7, 20.8; IR (neat) !max 2930, 1718, 1456, 1367, 1322, 1104 cm
-1
; ESI/MS (m/z) 
calcd for C29H42O10Na 573.3 (M+Na
+
), found 573.2. 
 
Preparation of pentacycle 1.110. To a solution of 1.108  (1.3 mg, 2.4 
mmol) in EtOH (1 mL) at -78 °C was added CeCl3•7H2O (12 mg, 34 µmol) and NaBH4 
(2.1 mg, 58 µmol). The reaction mixture was stirred at -78 
o
C for 1 h before it was 
warmed to 0 °C and the reaction quenched with acetone (2 mL). After stirring for another 
2 h, the reaction mixture was concentrated. Flash chromatography (2:1 hexanes:ethyl 
acetate) gave a mixture of diols as a colorless oil. The mixture was taken into the next 











  To a solution of the diols from above in chlorobenzene (3 mL) was added PPTS 
(9.1 mg, 36 µmol) and pyridine (4 µL, 50 µmol). The reaction mixture was heated at 
reflux for 12 h before it was cooled to rt and the reaction was quenched with sat. 
NaHCO3 (aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL). The 
organic extracts were combined, dried (Na2SO4), and concentrated. Flash 
chromatography (5:1 hexanes: ethyl acetate) provided 0.6 mg of 1.110 (61%, 2 steps) as 
a colorless film. Rf 0.65 (3:1 hexanes:ethyl acetate); [!]
20
D = +20.0° (c = 0.11, THF); 
1
H 
NMR (500 MHz, C7D8) " 7.43 (d, J = 7.3 Hz, 2H), 7.17 (t, J = 7.3 Hz, 2H), 7.08 (t, J = 
7.3 Hz, 1H), 6.24 (dd, J = 6.4, 2.4 Hz, 1H), 6.15 (d, J = 5.9 Hz, 1H), 4.88 (s, 2H), 4.69 
(ddd, J = 6.8, 6.8, 4.9 Hz, 1H), 4.39 (ddd, J = 5.9, 5.9, 2.0 Hz, 1H), 3.32 (dd, J = 8.8, 8.8 
Hz, 1H), 3.23 (ddd, J = 11.2, 9.3, 4.4 Hz, 1H), 3.20 (ddd, J = 11.7, 9.3, 4.9 Hz, 1H), 3.12 
(ddd, J = 9.3, 9.3, 5.9 Hz, 1H), 3.07 (dd, J = 9.3, 9.3 Hz, 1H), 3.05 (ddd, J = 8.8, 8.8, 3.9 
Hz, 1H), 3.02 (dd, J = 9.3, 9.3 Hz, 1H), 2.85 (ddd, J = 11.2, 9.3, 3.9 Hz, 1H), 2.80 (ddd, J 
= 11.7, 9.8, 4.4 Hz, 1H), 2.36 (dd, J = 9.3, 4.4 Hz, 1H), 2.34 (dd, J = 9.7, 4.9 Hz, 1H), 
2.12-2.06 (m, 1H), 2.04-1.88 (m, 2H), 1.85 (ddd, J = 7.3, 7.3, 3.4 Hz, 1H), 1.82-1.74 (m, 
1H), 1.65 (ddd, J = 11.7, 11.7, 11.7  Hz, 1H), 1.56 (ddd, J = 11.2, 11.2, 11.2 Hz, 1H), 
1.43-1.34 (m, 1H);!
13
C NMR (125 MHz, C6D6) " 147.9, 143.5, 140.0, 128.2, 128.0, 
127.3, 111.7, 98.4, 82.5, 82.3, 82.1, 80.3, 78.8, 75.1, 74.8, 74.7, 74.3, 73.7, 36.9, 35.4, 
32.9, 27.1, 20.9; IR (neat) 2924, 2856, 1647, 1458, 1375, 1268, 1238, 1101, 1032 cm
-1
; 
ESI/MS (m/z) calcd for C25H30O6Na 449.2 (M+Na
+


















J4,5 = 9.3 Hz
J13,14 = 8.8 Hz
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Summary of COSY spectrum for 1.110 (500 MHz, C7D8): 
1. Proton at 6.24 ppm (C-18) showed a cross peak with the proton at 4.69 ppm (C-17). 
2. Proton at 4.69 ppm (C-17) showed a cross peak with the protons at 1.78 ppm (C-16) 
and 1.86 ppm (C-16’). 
3. Proton at 1.86 ppm (C-16’) showed a cross peak with the proton at 1.38 ppm (C-15). 
4. Proton at 1.38 ppm (C-15) showed a cross peak with the protons at 1.96 ppm (C-15’) 
and 3.05 (C-14). 
5. Proton at 6.15 ppm (C-1) showed a cross peak with the proton at 4.39 ppm (C-2). 
6. Proton at 4.39 ppm (C-2) showed a cross peak with the protons at 2.08 ppm (C-3) and 
1.96 (C-3’). 
7. Proton at 2.08ppm (C-3) showed a cross peak with the proton at 3.12 ppm (C-4). 
 
Preparation of alcohol 1.123 . To a solution of 1.122  (0.34 g, 0.75 mmol) in 
CH2Cl2 (5 mL) at -78 °C was added DMDO (15 mL of a 0.10 M solution in CH2Cl2, 1.5 
mmol) dropwise. The reaction mixture was warmed to 0 °C and then concentrated. To a 
solution of the resulting residue in CH2Cl2 (5 mL) at -78 °C was added iBu2AlH (4.5 mL 
of a 1.0 M solution in hexanes, 4.5 mmol). The reaction mixture was stirred for 2 h at -78 
o
C before the reaction was quenched with sat. NH4Cl (aq., 10 mL). The resulting mixture 
was warmed to rt and sat. potassium sodium tartrate solution (aq., 20 mL) was added. 
After stirring for 30 min, the aqueous phase was extracted with CH2Cl2 (3 x 20 mL) and 















 (c = 2.09, THF); 
1
H NMR (500 MHz, CDCl3) " 
7.43-7.30 (m, 5H), 5.13 (d, J = 11.2 Hz, 1H), 4.76 (d, J = 11.2 Hz, 1H), 4.18 (dd, J = 
10.3, 4.9 Hz, 1H), 3.97 (dd, J = 10.7, 5.4 Hz, 1H), 3.90 (dd, J = 8.8, 8.8 Hz, 1H), 3.85 
(dd, J = 10.3, 10.3 Hz, 1H), 3.70-3.63 (m, 1H), 3.40-3.34 (partially obscured m, 1H), 3.36 
(dd, J = 10.6, 10.6 Hz, 1 H), 3.25 (dd, J = 10.7, 10.7 Hz, 1H), 2.58 (d, J = 2.0 Hz, 1H), 
1.08 (s, 9H), 1.04 (s, 9H); 
13
C NMR (125 MHz, CDCl3) " 138.9, 128.8, 128.4, 128.2, 
86.1, 78.5, 75.8, 75.2, 69.9, 69.4, 66.8, 27.7, 27.3, 22.9, 20.2; IR (neat) 3421, 2934, 2860, 
1595, 1471, 1364, 1161, 1104, 1034 cm
-1
; ESI/MS (m/z) calcd for C21H35O5Si 395.2 
(M+H
+
), found 395.3. 
 
Preparation of diol 1.124.  To a solution of 1.123  (0.17 g, 0.44 mmol) in 
THF (10 mL) at rt was added tBuOK (0.88 mL of 1.0 M solution in THF, 0.88 mmol). 
After stirring for 30 min, the reaction mixture was cooled to 0 °C and benzyl bromide 
(0.21 mL, 1.8 mmol) and tetrabutylammonium iodide (16 mg, 0.044 mmol) were added. 
The reaction mixture was slowly warmed to rt over 2 h before the reaction was quenched 
with sat. NH4Cl (aq., 10 mL). The aqueous phase was extracted with ether (3 x 10 mL) 
and the extracts were dried (Na2SO4) and concentrated to give a light yellow oil which 
was taken to the next step without additional purification. 
To a solution of the residue from above in 10 mL THF at 0 °C was added HF•Py 








stirred for 2 h at 0 °C before the reaction was quenched with sat. NaHCO3 (aq., 10 mL). 
The aqueous phase was extracted with ethyl acetate (3 x 10 mL) and the extracts were 
dried (Na2SO4) and concentrated. Flash chromatography (2:1 hexanes:ethyl acetate) 
provided 0.13 g diol 1.124  (87%, 2 steps) as a white solid. Rf 0.15 (2:1 hexanes:ethyl 




 (c = 0.45, THF); 
1
H NMR (500 MHz, CDCl3) 
" 7.40-7.25 (m, 10H), 5.01 (d, J = 11.5 Hz, 1H), 4.79 (d, J = 11.5 Hz, 1H), 4.69 (d, J = 
11.0 Hz, 1H), 4.62 (d, J = 11.0 Hz, 1H), 4.02 (dd, J = 11.2, 5.4 Hz, 1H), 3.81 (dd, J = 
12.2, 2.9 Hz, 1H), 3.70 (dd, J = 11.7, 4.4 Hz, 1H), 3.60 (ddd, J = 9.5, 9.5, 5.4 Hz, 1H), 
3.52 (dd, J = 8.7, 8.7 Hz, 1H), 3.46 (dd, J = 8.8, 8.8 Hz, 1H), 3.27-3.20 (m, 2H), 3.04 (s, 
1H), 2.62 (s, 1H); 
13
C NMR (125 MHz, CDCl3) " 138.9, 138.3, 128.8, 128.8, 128.2, 
128.1, 128.1, 85.7, 80.0, 78.5, 75.4, 73.3, 70.5, 68.2, 62.7; IR (neat) 3468, 3333, 3031, 
2926, 2860, 1603, 1455, 1363, 1119, 1096, 1057 cm
-1
; ESI/MS (m/z) calcd for 
C20H24O5Na 367.2 (M+Na
+
), found 367.1. 
 
Preparation of triflate 1.125 . To a solution of diol 1.124  (0.15 g, 0.45 
mmol) and 2,6-lutidine (0.16 mL, 1.4 mmol) in CH2Cl2 (10 mL) at -78 °C was added 
trifluoromethanesulfonic anhydride (0.079 mL, 0.47 mmol). After 30 min TBSOTf (0.11 
mL, 0.50 mmol) was added, and the reaction mixture was slowly warmed to rt before the 
reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was extracted 
with CH2Cl2 (3 x 20 mL) and the extracts were combined, dried (Na2SO4) and 












 (c = 0.60, 
THF); 
1
H NMR (500 MHz, C6D6) " 7.31 (d, J = 6.9 Hz, 2H), 7.17 (t, J = 7.3 Hz, 2H), 
7.13-7.04 (m, 6H), 5.07 (d, J = 11.7 Hz, 1H), 4.63 (d, J = 11.7 Hz, 1H), 4.59 (dd, J = 
10.7, 1.4 Hz, 1H), 4.33 (dd, J = 10.8, 4.9 Hz, 1H), 4.17 (d, J = 11.7 Hz, 1H), 4.13 (d, J = 
11.8 Hz, 1H), 3.76 (dd, J = 11.2, 5.4 Hz, 1H), 3.43 (dd, J = 8.8, 8.8 Hz, 1H), 3.35 (ddd, J 
= 10.3, 8.8, 5.4 Hz, 1H), 3.19 (dd, J = 8.8, 8.8 Hz, 1H), 2.96 (ddd, J = 9.8, 5.4, 2.0 Hz, 
1H), 2.88 (dd, J = 10.7, 10.7 Hz, 1H), 0.89 (s, 9H), 0.00 (s, 3H), -0.02 (s, 3H); 
13
C NMR 
(125 MHz, C6D6) " 139.3, 138.3, 128.4, 128.3, 127.8, 127.8, 127.3, 127.0, 119.0, 85.1, 
78.9, 78.2, 75.3, 74.6, 72.6, 70.2, 67.6, 25.8, 18.0, -3.8, -5.2; IR (neat) 3033, 2931, 2859, 
1601, 1458, 1416, 1248, 1209, 1145, 1097 cm
-1
; ESI/MS (m/z) calcd for C27H38F3O7SSi 
591.2 (M+H
+
), found 591.0. 
 
Preparation of alkene 1.127 . To a solution of trimethylsilylacetylene (0.23 
mL, 1.6 mmol) in THF (10 mL) at 0 °C was added nBuLi (0.65 mL of 2.5 M solution in 
hexanes, 1.62 mmol). After 30 min the reaction mixture was cooled to -78 °C. To this 
was transferred a solution of 1.125  (0.19 g, 0.32 mmol) and HMPA (0.28 mL, 1.6 
mmol) in THF (4 mL). The reaction mixture was slowly warmed to rt over 2 h before the 
reaction was quenched with sat. NH4Cl (aq., 10 mL). The aqueous phase was extracted 
with CH2Cl2 (3 x 10 mL) and the organic extracts were dried (Na2SO4) and concentrated.  
To a solution of the resulting residue in methanol (20 mL) was added potassium 







concentrated. Flash chromatography (10:1 hexanes-ethyl acetate) provided 0.13 g 1.126  
(85%) as a colorless oil.  
To a solution of 1.126  (0.13 g, 0.29 mmol) in ethyl acetate (10 mL) was added 
quinoline (17 µL, 0.14 mmol) and Lindlar’s Pd catalyst (15 mg). The reaction mixture 
was stirred under a balloon of H2 (1 atm.) for 2 h before it was passed through a celite 
column using ethyl acetate and concentrated. Flash chromatography (10:1 hexanes-ethyl 





 (c = 0.55, THF); 
1
H NMR (500 MHz, CDCl3) " 7.40-7.23 (m, 
10H), 5.88 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1H), 5.12 (dd, J = 17.1, 1.4 Hz, 1H), 5.10 
(partially obscured d, J = 10.2 Hz, 1H), 5.08 (d, J = 11.7 Hz, 1H), 4.78 (d, J = 11.7 Hz, 
1H), 4.61 (d, J = 11.7 Hz, 1H), 4.56 (d, J = 11.7 Hz, 1H), 4.00 (dd, J = 11.2, 5.4 Hz, 1H), 
3.62 (ddd, J = 10.3, 8.8, 4.9 Hz, 1H), 3.43 (dd, J = 8.4, 8.4 Hz, 1H), 3.36 (dd, J = 8.8, 8.8 
Hz, 1H), 3.22-3.16 (m, 2H), 2.67-2.60 (m, 1H), 2.12-2.08 (m, 1H), 0.92 (s, 9H), 0.09 (s, 
3H), 0.02 (s, 3H); 
13
C NMR (125 MHz, CDCl3) " 139.4, 138.4, 135.4, 128.7, 128.4, 
128.1, 128.0, 127.5, 127.4, 117.0, 86.0, 81.1, 79.7, 75.0, 74.7, 73.3, 68.2, 36.8, 26.3, 18.4, 
-3.3, -4.1; IR (neat) 3067, 2956, 2929, 2856, 1497, 1363, 1253, 1093 cm
-1
; ESI/MS (m/z) 
calcd for C28H40O4SiNa 491.3 (M+Na
+
), found 491.2. 
 
Preparation of acid 1.120 .  O3 was bubbled through a solution of 1.127          
(0.14 g, 0.30 mmol) in CH2Cl2 (20 mL) at -78 
o
C until the reaction mixture was a light 










blue color dissipated. Triphenylphosphine (0.24 g, 0.90 mmol) was then added and the 
mixture was allowed to slowly warm to rt. After 12 h, the solution was concentrated 
under reduced pressure. Flash chromatography (50:1 to 5:1 hexanes:ethyl acetate) 
provided 0.12 g aldehyde 1.128  (81%) as a colorless oil.  
A mixture of 1.128  (0.12 g, 0.25 mmol), THF (3 mL), tBuOH (3 mL), H2O (3 
mL), 2-Me-2-butene (0.60 mL, 5.7 mmol), NaH2PO4 (0.15 g, 1.2 mmol) and NaClO2 
(0.11 g, 1.25 mmol) was stirred at rt for 2 h. To this was added H2O (8 mL) and the 
resulting mixture was extracted with ethyl acetate (3 x 10 mL). The extracts were dried 
(Na2SO4) and concentrated. Flash chromatography (1:1 hexanes:ethyl acetate to pure 





 (c = 0.33, THF); 
1
H NMR (500 MHz, CDCl3) " 
7.44-7.28 (m, 10H), 5.12 (d, J = 11.2 Hz, 1H), 4.82 (d, J = 11.2 Hz, 1H), 4.64 (d, J = 11.7 
Hz, 1H), 4.59 (d, J = 11.7 Hz, 1H), 4.03 (dd, J = 11.2, 4.9 Hz, 1H), 3.70-3.64 (m, 2H), 
3.50 (dd, J = 8.3, 8.3 Hz, 1H), 3.45 (dd, J = 8.8, 8.8 Hz, 1H), 3.28 (dd, J = 11.0, 11.0 Hz, 
1H), 2.94 (dd, J = 15.1, 1.9 Hz, 1H), 2.41 (dd, J = 15.1, 9.8 Hz, 1H), 0.96 (s, 9H), 0.12 (s, 
3H), 0.80 (s, 3H); 
13
C NMR (125 MHz, CDCl3) " 177.8, 139.2, 138.3, 128.7, 128.6, 
128.4, 128.2, 128.2, 127.5, 85.8, 79.5, 78.2, 75.2, 74.2, 73.4, 68.3, 38.2, 26.3, 18.3, -3.4, -
4.2; IR (neat) 3500-2660 (broad), 3064, 2930, 2858, 1714, 1497, 1458, 1324, 1255, 1131, 
1093 cm
-1
; ESI/MS (m/z) calcd for C27H39O6 487.2 (M+H
+










Preparation of alkene 1.130 . To a solution of 1.129  (0.22 g, 0.47 mmol) 
and 2,6-lutidine (0.17 mL, 1.4 mmol) in CH2Cl2 (10 mL) at 0 °C was added TBSOTf 
(0.13 mL, 0.57 mmol) dropwise. The reaction mixture was stirred overnight before the 
reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was extracted 
with CH2Cl2 (3 x 10 mL) and the extracts were dried (Na2SO4) and concentrated. Flash 
chromatography (10:1 hexanes:ethyl acetate) provided 0.25 g 1.130  (90%) as a colorless 




 (c = 0.76, THF); 
1
H NMR (500 
MHz, CDCl3) " 7.43-7.25 (m, 13H), 7.10-7.08 (m, 2H), 6.02 (dddd, J = 17.1, 10.3, 6.8, 
6.8 Hz, 1H), 5.18 (dd, J = 17.1, 1.0 Hz, 1H), 5.14 (dd, J = 10.2, 1.0 Hz, 1H), 5.05 (d, J = 
12.2 Hz, 1H), 4.88 (d, J = 11.7 Hz, 1H), 4.75 (d, J = 10.7 Hz, 1H), 4.70 (d, J = 12.2 Hz, 
1H), 4.63 (d, J = 12.2 Hz, 1H), 4.59 (d, J = 10.8 Hz, 1H), 3.79 (dd, J = 11.2, 2.0 Hz, 1H), 
3.76 (dd, J = 10.8, 4.0 Hz, 1H), 3.71 (dd, J = 8.8, 8.8 Hz, 1H), 3.52 (dd, J = 8.8, 8.8 Hz, 
1H), 3.50-3.46 (m, 2H), 3.26 (ddd, J = 9.2, 9.2, 2.1 Hz, 1H), 2.65 (dd, J = 13.2, 6.3 Hz, 
1H), 2.24 (ddd, J = 15.2, 9.3, 6.4 Hz, 1H), 0.96 (s, 9H), 0.15 (s, 3H), 0.06 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) " 139.3, 138.6, 138.3, 135.7, 128.6, 128.6, 128.4, 128.2, 128.1, 
127.9, 127.8, 127.3, 126.9, 116.8, 87.2, 80.9, 79.4, 79.3, 75.2, 75.1, 75.0, 73.7, 69.1, 36.5, 
26.3, 18.4, -3.3, -3.9; IR (neat) 3066, 3031, 2929, 2857, 1456, 1360, 1254, 1104, 1063 
cm
-1
; ESI/MS (m/z) calcd for C36H49O5Si 589.3 (M+H
+
), found 589.1. 
 
Preparation of acid 1.121 . O3 was bubbled through a solution of 1.120  (0.24 











blue color. Excess O3 was purged from the reaction mixture by bubbling N2 through it for 
20 min until the light blue color dissipated. Triphenylphosphine (0.32 g, 1.23 mmol) was 
then added and the mixture was allowed to slowly warm to rt. After 12 h, the solution 
was concentrated. Flash chromatography (50:1 to 5:1 hexanes:ethyl acetate) provided 
0.22 g aldehyde 1.131  (91%) as a colorless oil.  
A mixture of 1.131  (0.22 g, 0.37 mmol), THF (3 mL), tBuOH (3 mL), H2O (3 
mL), 2-Me-2-butene (0.60 mL, 5.7 mmol), NaH2PO4 (0.22 g, 1.9 mmol) and NaClO2 
(0.17 g, 1.9 mmol) was stirred at rt for 2 h before the mixture was diluted with additional 
H2O (10 mL). The resulting mixture was extracted with ethyl acetate (3 x 15 mL) and the 
extracts were combined, dried (Na2SO4) and concentrated. Flash chromatography (1:1 
hexanes:ethyl acetate to 100% ethyl acetate) provided 0.22 g of acid 1.121  (96%) as a 




 (c = 0.83, 
THF); 
1
H NMR (500 MHz, CDCl3) " 7.41-7.24 (m, 13H), 7.07-7.04 (m, 2H), 5.03 (d, J = 
11.7 Hz, 1H), 4.86 (d, J = 11.7 Hz, 1H), 4.73 (d, J = 10.7 Hz, 1H), 4.66 (d, J = 12.2 Hz, 
1H), 4.55 (d, J = 11.3 Hz, 2H), 3.77-3.70 (m, 4H), 3.56-3.46 (m, 3H), 2.90 (d, J = 15.6 
Hz, 1H), 2.51 (dd, J = 15.6, 10.3 Hz, 1H), 0.92 (s, 9H), 0.12 (s, 3H), 0.04 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) " 176.9, 139.1, 138.2, 138.1, 128.7, 128.6, 128.5, 128.2, 128.2, 
128.0, 128.0, 127.4, 126.9, 86.9, 79.3, 79.0, 77.5, 75.3, 75.1, 74.2, 73.6, 68.7, 37.8, 26.2, 
18.3, -3.4, -3.9; IR (neat) 3450-2700 (broad), 3032, 2930, 2893, 2858, 1714, 1497, 1406, 
1255, 1098 cm
-1
; ESI/MS (m/z) calcd for C35H47O7Si 607.3 (M+H
+
), found 607.1. 
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Preparation of ester 1.132 . To a solution of acid 1.121  (0.69 g, 1.1 mmol) in 
THF (20 mL) was added triethylamine (0.57 mL, 4.1 mmol) and 2,4,6-trichlorobenzoyl 
chloride (0.44 mL, 2.8 mmol). The reaction mixture was heated at 40 °C for 2 h and then 
concentrated. To the resulting residue was transferred a solution of alcohol 1.101  (0.48 
g, 1.1 mmol) in toluene (10 mL) followed by DMAP (0.53 g, 4.3 mmol). The reaction 
mixture was then heated at 40 °C for 12 h and then the reaction was quenched with sat. 
NaHCO3 (aq., 20 mL). The aqueous phase was extracted with CH2Cl2 (3 x 20 mL) and 
the extracts were dried (Na2SO4) and concentrated. Flash chromatography (10:1 





 (c = 1.1, THF); 
1
H NMR (500 MHz, CD2Cl2) " 
7.51-7.30 (m, 20H), 7.20-7.17 (m, 2H), 6.98 (d, J = 8.8 Hz, 2H), 6.10-5.93 (m, 2H), 5.27-
5.07 (m, 6H), 4.96 (d, J = 12.2 Hz, 1H), 4.90-4.82 (m, 4H), 4.69 (d, J = 10.3 Hz, 1H), 
4.68 (d, J = 10.8 Hz, 1H), 4.58 (d, J = 11.7 Hz, 1H), 4.50 (d, J = 11.7 Hz, 1H), 3.94-3.77 
(partially obscured m, 4H), 3.87 (s, 3 H), 3.68-3.42 (m, 7H), 3.03 (d, J = 13.7 Hz, 1H), 
2.71 (dd, J = 14.2, 5.9 Hz, 1H), 2.58 (dd, J = 15.1, 10.2 Hz, 1H), 2.47-2.27 (m, 3H), 1.00 
(s, 9H), 0.20 (s, 3H), 0.14 (s, 3H); 
13
C NMR (125 MHz, CD2Cl2) " 170.4, 159.7, 139.4, 
138.9, 138.6, 138.5, 135.1, 134.5, 132.9, 130.8, 128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 
127.9, 127.9, 127.3, 126.9, 117.2, 117.0, 114.0, 86.8, 84.8, 81.5, 79.4, 79.0, 78.9, 77.9, 
















-4.2; IR (neat) 3066, 2931, 2858, 1749, 1514, 1456, 1361, 1250, 1094 cm
-1
; ESI/MS 
(m/z) calcd for C61H76O11SiNa 1035.5 (M+Na
+
), found 1035.3. 
 
Preparation of alcohol 1.133 . To a mixture of 1.132  (0.25 g, 0.24 mmol) in 
CH2Cl2 (18 mL) and pH 7 phosphate buffer (2 mL) was added DDQ (0.073 g, 0.32 
mmol). The reaction mixture was stirred for 2 h at rt before the reaction was quenched 
with sat. NaHCO3 (aq., 10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 
mL) and the extracts were dried (Na2SO4) and concentrated. Flash chromatography (10:1 
hexanes:ethyl acetate) provided 0.20 g 1.133  (90%) as a colorless oil. Rf 0.30 (5:1 
hexanes:ethyl acetate); [!]
20
D = -12.4° (c = 1.2, THF); 
1
H NMR (500 MHz, CD2Cl2) " 
7.41-7.22 (m, 18H), 7.09-7.05 (m, 2H), 5.93 (partially obscured dddd, J = 17.1, 9.8, 6.9, 
6.9 Hz, 1H), 5.84 (partially obscured dddd, J = 17.6, 10.8, 6.8, 6.8 Hz, 1H), 5.16-5.01 (m, 
5H), 4.94 (dd, J = 9.3, 9.3 Hz, 1H), 4.84 (d, J = 12.2 Hz, 1H), 4.81 (d, J = 11.7 Hz, 1H), 
4.72 (d, J = 10.2 Hz, 1H), 4.60 (d, J = 11.7 Hz, 1H), 4.56 (d, J = 10.3 Hz, 1H), 4.44 (d, J 
= 11.7 Hz, 1H), 4.37 (d, J = 11.7 Hz, 1H), 3.79 (ddd, J = 9.3, 2.0 Hz, 1H), 3.74 (dd, J = 
9.3, 9.3 Hz, 1H), 3.69 (dd, J = 10.7, 2.9 Hz, 1H), 3.57-3.37 (m, 7H), 3.26 (ddd, J = 8.3, 
8.3, 3.5 Hz, 1H), 2.92 (dd, J = 15.1, 1.5 Hz, 1H), 2.60-2.54 (m, 1H), 2.47 (dd, J = 15.1, 
10.3 Hz, 1H), 2.34-2.14 (m, 4H), 0.89 (s, 9H), 0.10 (s, 3H), 0.02 (s, 3H); 
13
C NMR (125 
MHz, CD2Cl2) " 170.4, 139.3, 138.7, 138.5, 138.4, 134.9, 134.8, 134.4, 134.4, 128.8, 
















84.2, 79.2, 78.8, 78.7, 77.8, 77.3, 75.0, 75.0, 74.7, 74.1, 73.5, 68.8, 38.6, 36.2, 35.8, 25.9, 
18.1, -3.7, -4.3; IR (neat) 3420 (broad), 2930, 2858, 1748, 1455, 1361, 1255, 1095 cm
-1
; 
ESI/MS (m/z) calcd for C53H68O10SiNa 915.5 (M+Na
+
), found 915.3. 
 
Preparation of diester 1.119 . To a solution of acid 1.120  (0.12 g, 0.25 
mmol) in THF (10 mL) was added triethylamine (0.13 mL, 0.93 mmol) and 2,4,6-
trichlorobenzoyl chloride (0.10 mL, 0.64 mmol). The reaction mixture was heated at 40 
°C for 2 h and then concentrated. To the resulting residue was transferred a solution of 
alcohol 1.133  (0.17 g, 0.19 mmol) in toluene (10 mL) followed by DMAP (0.12 g, 0.98 
mmol). The mixture was heated at 40 
o
C for 12 h after which the reaction was quenched 
with sat. NaHCO3 (aq., 10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 
mL) and the extracts were dried (Na2SO4) and concentrated. Flash chromatography (10:1 
hexanes:ethyl acetate) provided 0.21 g 1.119  (99%) as a colorless oil. Rf 0.45 (5:1 
hexanes:ethyl acetate); [!]
20
D = +6.6° (c = 0.86, THF); 
1
H NMR (500 MHz, CD2Cl2) " 
7.55-7.35 (m, 28H), 7.24-7.21 (m, 2H), 6.10-5.97 (m, 2H), 5.28-5.16 (m, 8H), 5.01 (d, J 
= 12.2 Hz, 1H), 4.94 (d, J = 11.2, 1H), 4.88 (d, J = 10.2 Hz, 1H), 4.80 (s, 2H), 4.74 (d, J = 
10.7 Hz, 1H), 4.70 (d, J = 11.7 Hz, 1H), 4.66 (d, J = 11.7 Hz, 1H), 4.6 (d, J = 11.7 Hz, 
1H), 4.56 (d, J = 11.7 Hz, 1H), 4.00 (dd, J = 11.2, 5.4 Hz, 1H), 3.96-3.53 (m, 14H), 3.30 
(dd, J = 11.0, 11.0 Hz, 1H), 3.06 (dd, J = 15.1, 2.0 Hz, 1H), 3.02 (dd, J = 14.6, 2.0 Hz, 




















1.07 (s, 9H), 0.25 (s, 3H), 0.24 (s, 3H), 0.21 (s, 3H), 0.19 (s, 3H); 
13
C NMR (125 MHz, 
CD2Cl2) ! 170.2, 170.1, 139.6, 139.4, 138.7, 138.6, 134.4, 134.3, 128.7, 128.6, 128.5, 
128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.6, 127.5, 127.4, 127.0, 117.5, 117.3, 86.9, 
85.7, 81.7, 79.6, 79.4, 79.0, 78.5, 77.9, 77.8, 77.7, 75.2, 75.1, 74.4, 74.3, 74.2, 73.8, 73.8, 
73.7, 73.2, 68.9, 68.1, 38.7, 38.6, 35.9, 35.8, 26.1, 26.0, 18.3, 18.2, -3.6, -3.6, -4.2, -4.4; 
IR (neat) 2955, 2858, 1752, 1649, 1457, 1362, 1254, 1093 cm
-1
; ESI/MS (m/z) calcd for 
C80H104O15Si2Na 1383.7 (M+Na
+
), found 1383.4. 
 
Preparation of tricycle 1.134. The general two-directional olefinic ester 
cyclization reaction protocol was carried out on diester 1.119  (0.21 g, 0.15 mmol) to 





 (c = 0.60, THF); 
1
H NMR (500 MHz, CD2Cl2) ! 7.50 (d, J = 7.7 Hz, 2H), 7.44-7.24 
(m, 26H), 7.14-7.11 (m, 2H), 5.08 (d, J = 11.7 Hz, 1H), 5.02 (d, J = 11.7, 1H), 4.94 (s, 
2H), 4.89 (d, J = 11.7 Hz, 1H), 4.80 (d, J = 11.7 Hz, 1H), 4.74 (d, J = 11.7 Hz, 1H), 4.64 
(broad d, J = 4.4 Hz, 1H), 4.61-4.54 (m, 6H), 3.97 (dd, J = 11.2, 5.3 Hz, 1H), 3.74 (dd, J 
= 10.7, 1.5 Hz, 1H), 3.69-3.60 (m, 6H), 3.54 (dd, J = 8.3, 8.3 Hz, 1H), 3.52-3.38 (m, 7H), 
3.33 (dd, J = 8.3, 8.3 Hz, 1H), 3.13 (dd, J = 10.8, 10.8 Hz, 1H), 2.70 (d, J = 14.5 Hz, 2H), 
2.31-2.23 (m, 2H), 2.12-2.04 (m, 3H), 1.97 (dd, J = 14.7, 10.2 Hz, 1H), 0.93 (s, 9H), 0.92 
(s, 9H), 0.13 (s, 3H), 0.10 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H); 
13
C NMR (125 MHz, 
CD2Cl2) ! 151.1, 151.0, 139.6, 139.4, 139.3, 138.8, 138.7, 138.6, 128.5, 128.4, 128.3, 
















87.2, 85.9, 79.7, 79.5, 79.5, 79.1, 79.0, 78.4, 77.7, 75.1, 75.1, 75.0, 74.9, 74.9, 73.8, 73.3, 
73.0, 72.4, 72.3, 69.4, 68.0, 36.9, 36.6, 27.7, 27.6, 26.1, 26.0, 18.2, 18.1, -3.6, -3.7, -4.1, -
4.3; IR (neat) 3031, 2929, 2857, 1680, 1456, 1362, 1254, 1094 cm
-1
; ESI/MS (m/z) calcd 
for C78H100O13Si2Na 1323.7 (M+Na
+
), found 1323.1. 
 
Preparation of diol 1.135. To a solution of 1.134  (18.7 mg, 0.0138 mmol) 
in CH2Cl2 (5 mL) at -78 
o
C was added of DMDO (0.55 mL of a 0.10 M solution in 
CH2Cl2, 0.055 mmol) dropwise. The reaction mixture was warmed to 0 °C and then 
concentrated. The a solution of the resulting residue in CH2Cl2 (5 mL) at -78 
o
C was 
added iBu2AlH (0.17 mL of a 1.0 M solution in hexanes, 0.17 mmol). After stirring for 2 
h, the reaction was quenched with sat. NH4Cl (aq., 5 mL) and allowed to warm to rt. Sat. 
potassium sodium tartrate solution (aq., 10 mL) was added and the mixture was stirred 
for 30 min. The aqueous phase was extracted with CH2Cl2 (3 x 10 mL) and the extracts 
were dried (Na2SO4) and concentrated. Flash chromatography (2:1 hexanes:ethyl acetate) 
provided 12.5 mg 1.135  (65%) as a colorless oil. Rf 0.50 (1:1 hexanes:ethyl acetate); 
[!]
20
D = +4.9° (c = 0.37, THF); 
1
H NMR (500 MHz, CD2Cl2) " 7.44-7.24 (m, 28H), 7.12-
7.06 (m, 2H), 5.08 (d, J = 11.7 Hz, 1H), 5.02 (d, J = 11.7, 1H), 4.90-4.85 (m, 3H), 4.78 
(d, J = 11.7 Hz, 1H), 4.71 (d, J = 11.7 Hz, 1H), 4.59-4.48 (m, 5H), 3.98 (dd, J = 11.2, 5.3 
Hz, 1H), 3.69 (dd, J = 10.7, 2.0 Hz, 1H), 3.65-3.30 (m, 14H), 3.24-3.10 (m, 5H), 2.77 (d, 
J = 4.4 Hz, 1H), 2.34 (ddd, J = 11.2, 3.9, 3.9 Hz, 1H), 2.30-2.19 (m, 3H), 1.96 (ddd, J = 



















2H), 0.86 (s, 9H), 0.85 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H); 
13
C 
NMR (125 MHz, CD2Cl2) ! 139.6, 139.4, 138.6, 138.4, 128.5, 128.4, 128.3, 128.2, 128.1, 
128.1, 128.0, 127.9, 127.8, 127.4, 127.2, 127.1, 126.8, 87.1, 85.9, 82.7, 82.7, 80.4, 79.6, 
79.5, 78.9, 78.7, 78.4, 77.4, 75.2, 75.0, 74.8, 74.5, 73.6, 73.4, 73.0, 69.7, 68.9, 68.2, 67.8, 
38.2, 34.3, 34.0, 26.1, 26.0, 18.2, -3.6, -3.7, -4.0, -4.1; IR (neat) 3420 (broad), 2929, 
2858, 1456, 1363, 1253, 1090 cm
-1
; ESI/MS (m/z) calcd for C78H104O15Si2Na 1359.7 
(M+Na
+
), found 1359.5. 
 
Preparation of diacetate 1.136. To a solution of 1.135  (10 mg, 7.5 µmol) 
in CH2Cl2 (3 mL) at rt was added acetic anhydride (0.014 mL, 0.15 mmol) and 
triethylamine (0.042 mL, 0.30 mmol). After 2 h the reaction was quenched with sat. 
NaHCO3 (aq., 5 mL). The aqueous phase was extract with CH2Cl2 (3 x 5 mL) and the 
organic extracts were combined, dried (Na2SO4) and concentrated. Flash chromatography 





 (c = 0.32, THF); 
1
H NMR (500 MHz, toluene) ! 
7.65 (d, J = 7.3 Hz, 2H), 7.37-7.28 (m, 7H), 7.18-6.97 (m, 21 Hz), 5.16 (d, J = 12.2 Hz, 
1H), 5.09 (d, J = 12.2, 1H), 5.06 (d, J = 11.7, 1H), 5.05 (ddd, J = 11.2, 11.2, 4.9 Hz, 1H), 
5.00 (d, J = 12.2, 1H), 4.83 (ddd, J = 10.7, 10.7, 4.4 Hz, 1H), 4.75 (d, J = 12.2 Hz, 1H), 
4.68 (d, J = 11.7 Hz, 1H), 4.61 (d, J = 11.2 Hz, 1H), 4.55 (d, J = 12.2 Hz, 1H), 4.51 (d, J 
= 12.2 Hz, 1H), 4.44 (d, J = 11.7 Hz, 1H), 4.16 (s, 2H), 3.84 (dd, J = 11.2, 5.3 Hz, 1H), 





















J7,8  =  11.2 Hz
J16,17  =  10.7 Hz
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1H), 3.16 (ddd, J = 9.8, 9.8, 9.8 Hz, 2H), 3.02 (dd, J = 10.7, 10.7 Hz, 1H), 2.86 (ddd, J = 
11.2, 9.3, 3.9 Hz, 1H), 2.77 (ddd, J = 11.7, 9.7, 3.9 Hz, 1H), 2.66 (ddd, J = 11.2, 4.4, 4.4 
Hz, 1H), 2.57 (ddd, J = 10.7, 4.4, 4.4 Hz, 1H), 2.35-2.26 (m, 2H), 1.91 (ddd, J = 13.7, 
8.8, 4.9 Hz, 1H), 1.83-1.75 (m, 1H), 1.72 (s, 6H), 1.41 (m, 2H), 0.93 (s, 9H), 0.92 (s, 9H), 
0.09 (s, 6H), 0.07 (s, 3H), 0.05 (s, 3H); 13C NMR (125 MHz, CD2Cl2) ! 169.7, 169.6, 
139.6, 139.5, 138.7, 138.6, 128.4, 128.4, 128.3, 128.2, 128.2, 128.1, 127.9, 127.9, 127.8, 
127.8, 127.7, 127.6, 127.4, 127.3, 127.1, 127.0, 126.8, 87.2, 86.0, 82.6, 82.2, 79.6, 79.2, 
79.0, 78.9, 78.6, 77.5, 77.2, 76.9, 75.2, 74.9, 74.8, 74.7, 74.2, 74.1, 73.5, 73.2, 72.8, 71.4, 
71.2, 69.5, 67.9, 35.5, 35.4, 34.8, 34.0, 26.1, 21.2, 18.2, 18.1, -3.7, -3.9, -4.1; IR (neat) 
3032, 2927, 2856, 1742, 1457, 1364, 1237, 1093 cm-1; ESI/MS (m/z) calcd for 
C82H108O17Si2Na 1443.7 (M+Na
+), found 1443.6. 
 
Preparation of diketone 1.118. To a solution of 1.135  (53 mg, 0.040 
mmol) in CH2Cl2 (5 mL) was added 4Å MS (10 mg), NMO (34 mg, 0.24 mmol) and 
TPAP (3 mg, 0.008 mmol). After stirring for 3 h, the reaction mixture was concentrated. 
Flash chromatography (3:1 hexanes:ethyl acetate) gave 1.118 (48 mg, 92%) as a 
colorless oil. Rf 0.65 (2:1 hexanes:ethyl acetate); ["]
20
D = +7.8° (c = 0.23, THF); 
1H 
NMR (500 MHz, C6D6) ! 7.64 (d, J = 7.8 Hz, 2H), 7.40-7.32 (m, 5H), 7.28 (d, J = 7.3 
Hz, 2H), 7.25-7.00 (m, 21H), 5.15 (d, J = 12.2 Hz, 1H), 5.12 (s, 2H), 5.03 (d, J = 11.7 Hz, 



















(d, J = 10.7 Hz, 1H), 4.35 (d, J = 12.2 Hz, 1H), 4.32 (d, J = 12.2 Hz, 1H), 4.30 (d, J = 
11.7 Hz, 1H), 4.25 (d, J = 11.7 Hz, 1H), 4.00-3.95 (m, 2H), 3.87 (dd, J = 11.2, 5.4 Hz, 
1H), 3.76 (ddd, J = 9.6, 9.6, 2.5 Hz, 1H), 3.65 (dd, J = 8.7, 8.7 Hz, 1H), 3.64-3.42 (m, 
11H), 3.36-3.30 (m, 2H), 3.15 (ddd, J = 11.2, 9.7, 6.3 Hz, 1H), 3.07 (dd, J = 10.7, 10.7 
Hz, 1H), 3.03 (partially obscured dd, J = 16.6, 5.8 Hz, 1H), 2.84 (dd, J = 16.0, 5.4 Hz, 
1H), 2.73 (ddd, J = 13.7, 6.8, 2.4 Hz, 1H), 2.62 (ddd, J = 13.7, 7.3, 2.4 Hz, 1H), 2.34 
(ddd, J = 12.2, 10.8, 2.0 Hz, 1H), 2.23-2.11 (m, 3H), 1.05 (s, 9H), 1.02 (s, 9H), 0.15 (s, 
3H), 0.13 (s, 3H), 0.11 (s, 3H), 0.10 (s, 3H); 
13
C NMR (125 MHz, CD2Cl2) ! 205.9, 
205.6, 139.5, 139.4, 139.1, 138.6, 138.5, 138.4, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 
128.0, 128.0, 127.9, 127.8, 127.8, 127.8, 127.7, 12.4, 127.2, 127.1, 126.9, 87.1, 85.9, 
80.8, 80.2, 79.9, 79.6, 79.5, 79.3, 79.3, 77.4, 76.1, 75.2, 75.1, 75.0, 74.1, 73.6, 73.5, 73.4, 
73.0, 69.8, 68.0, 44.2, 44.0, 33.9, 33.6, 26.0, 18.2, 18.1, -3.7, -3.7, -4.0, -4.3; IR (neat) 
3031, 2954, 2929, 2857, 1726, 1497, 1454, 1361, 1252, 1095 cm
-1
; ESI/MS (m/z) calcd 
for C78H100O15Si2Na 1355.7 (M+Na
+
), found 1355.3. 
 
Preparation of dihemiacetal 1.137. To a solution of 1.118  (18.3 mg, 0.014 
mmol) in THF (10 mL) was added HF•Py (2 mL, 0.11 mol). The reaction mixture was 
stirred at rt overnight before the reaction was quenched with sat. NaHCO3 (20 mL). The 
aqueous phase was extract with ethyl acetate (3 x 10 mL). The organic extracts were 
combined, dried (Na2SO4) and concentrated. Flash chromatography (1:1 hexanes:ethyl 




















m.p. 148-150 °C; [!]
20
D = -3.1° (c = 0.16, THF); 
1
H NMR (500 MHz, C6D6) " 7.51 (d, J 
= 7.3 Hz, 2H), 7.45 (t, J = 6.8 Hz, 4H), 7.31-7.26 (m, 4H), 7.22-7.06 (m, 20H), 5.06 (d, J 
= 8.3 Hz, 1H), 5.04 (s, 2H), 5.01 (d, J = 12.7 Hz, 2H), 4.94 (d, J = 12.7 Hz, 1H), 4.90 (d, 
J = 12.2 Hz, 1H), 4.65 (d, J = 11.3 Hz, 1H), 4.60 (d, J = 11.7 Hz, 1H), 4.46 (d, J = 12.2 
Hz, 1H), 4.41 (d, J = 11.7 Hz, 2H), 4.04 (dd, J = 9.8, 9.8 Hz, 1H), 4.00-3.96 (m, 2H), 3.82 
(dd, J = 8.3, 8.3 Hz, 1H), 3.80 (dd, J = 9.3, 9.3 Hz, 1H), 3.73-3.49 (m, 8H), 3.36 (ddd, J = 
9.3, 9.3, 4.9 Hz, 2H), 3.16 (dd, J = 10.7, 10.7 Hz, 1H), 3.09-3.04 (m, 2H), 2.96 (ddd, J = 
8.5, 8.5, 8.5 Hz, 1H), 2.87 (ddd, J = 9.2, 9.2, 9.2 Hz, 1H), 2.57 (broad s, 1H), 2.48 (broad 
s, 1H), 2.28-2.16 (m, 6H), 1.82 (ddd, J = 11.7, 11.7, 11.7 Hz, 2H); 
13
C NMR (125 MHz, 
CD2Cl2) " 139.5, 139.4, 139.3, 138.7, 138.7, 138.5, 128.5, 128.4, 128.4, 128.3, 128.2, 
128.1, 128.0, 128.0, 127.9, 127.8, 127.8, 127.8, 127.6, 127.5, 93.6, 83.7, 83.5, 83.4, 82.8, 
80.1, 79.7, 78.3, 78.1, 77.7, 75.3, 75.2, 74.9, 74.7, 74.6, 74.6, 74.4, 74.1, 73.9, 73.7, 73.5, 
69.5, 69.0, 41.6, 30.0, 29.9; IR (neat) 3386 (broad), 3030, 2873, 1454, 1364, 1280, 1088 
cm
-1
; ESI/MS (m/z) calcd for C66H72O15Na 1127.5 (M+Na
+
), found 1127.2. 
 
Preparation of heptacycle 1.117. To a solution of 1.137  (4.1 mg, 3.7 
µmol) in CH2Cl2 (4 mL) and EtSH (1.0 mL, 14 mmol) at rt was added Zn(OTf)2 (27 mg, 
0.074 mmol). The reaction mixture was heated at reflux overnight and then cooled to rt. 
The reaction was quenched with triethylamine (1 mL). Filtration through a silica plug 
(2:1 hexanes:ethyl acetate) and concentration gave a colorless oil which was taken 




















   To a mixture of the residue from above and Ph3SnH (26 mg, 0.074 mmol) in 
toluene (5 mL) at 110 
o
C was added AIBN (2 mL of a 0.002 M solution in toluene, 4 
µmol) via syringe pump over 12 h. The reaction mixture was then cooled to rt and 
concentrated. Flash chromatography (3:1 hexanes:ethyl acetate) afforded 2.4 mg 1.117  
as a white solid (61%, 2 steps). Rf 0.55 (2:1 hexanes:ethyl acetate); mp 250-253 °C; 
[!]
20
D = +11.6° (c = 0.16, THF); 
1
H NMR (500 MHz, C6D6) " 7.54 (d, J = 7.9 Hz, 2H), 
7.47 (d, J = 7.8 Hz, 2H), 7.44 (d, J = 7.3 Hz, 2H), 7.32-7.06 (m, 24H), 5.08 (d, J = 11.7 
Hz, 1H), 5.04 (d, J = 12.2 Hz, 1H), 5.04 (d, J = 11.3 Hz, 1H), 4.98 (s, 2H), 4.88 (d, J = 
11.7 Hz, 1H), 4.83 (d, J = 11.7 Hz, 1H), 4.66 (d, J = 11.2 Hz, 1H), 4.62 (d, J = 12.2 Hz, 
1H), 4.47 (d, J = 12.6 Hz, 1H), 4.44 (d, J = 12.2 Hz, 1H), 4.38 (d, J = 12.2 Hz, 1H), 3.94 
(dd, J = 11.2, 5.9 Hz, 1H), 3.84 (dd, J = 9.3, 9.3 Hz, 1H), 3.75-3.69 (m, 2H), 3.64 (dd, J = 
8.8, 8.8 Hz, 1H), 3.61-3.43 (m, 4H), 3.28-3.22 (m, 3H), 3.17 (dd, J = 9.3, 9.3 Hz, 1H), 
3.14 (dd, J = 11.0, 11.0 Hz, 1H), 2.98-2.80 (m, 8H), 2.43-2.30 (m, 4H), 1.68-1.56 (m, 
4H); 
13
C NMR (125 MHz, CD2Cl2) " 139.4, 139.4, 139.3, 138.8, 138.7, 138.5, 128.5, 
128.4, 128.4, 128.3, 128.2, 128.1, 128.0, 128.0, 127.8, 127.8, 127.7, 127.6, 127.5, 84.0, 
83.1, 82.7, 82.6, 82.5, 82.4, 80.1, 79.6, 78.1, 77.9, 76.9, 76.7, 76.6, 75.2, 75.1, 74.9, 74.8, 
74.3, 73.6, 73.5, 69.6, 68.9, 35.3, 35.3; IR (neat) 2921, 2857, 1650, 1455, 1430, 1091 cm
-
1
; ESI/MS (m/z) calcd for C66H72O13Ag 1179.5 (M+Ag
+
), found 1179.1. 
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TOTAL SYNTHESIS OF (-)-BREVENAL 
 
Introduction 
The dinoflagellate-derived marine polycyclic ether natural products have attracted 
a lot of attention from the scientific community because of their unique structures and 
intriguing biological properties.
1
 The marine dinoflagellate, Karenia brevis, which is 
common in Gulf of Mexico waters and responsible for toxic red tides in Florida and 
Texas, is host to a number of bioactive polycyclic ether compounds (Figure 2.1).
2
 Among 
them, the members that have received the most attentions are the brevetoxins, which are a 
class of potent neurotoxins associated with the massive killings of fish and other marine 
animals, as well as human poisoning during red tide events.
3
 Human consumption of 
shellfish contaminated with the brevetoxins results in neurotoxic shellfish poisoning 
(NSP), which involves a cluster of gastrointestinal and neurological symptoms such as 
ataxia, distal paresthesias, dizziness, nausea and vomiting.
4
 In addition, inhalation of the 
airborne brevetoxins can cause respiratory irritations and bronchoconstriction in human 
and other marine mammals.
5
  
It has been shown that the brevetoxins exert their biological influence through 
binding to site 5 of voltage gated sodium channels (VGSC) in excitable membranes.
6
 
VGSC are a class of transmembrane proteins that conduct sodium ions based on electrical
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potential difference across the membrane.
7
 They play a central role in physiology by 
transmitting depolarizing impulses quickly throughout cell networks and enabling 
coordination of higher processes.
8
 VGSC consist of a highly processed pore-forming ! 
subunit that associates with auxiliary " subunits (Figure 2.2). The ! subunit in VGSC has 
four homologous domains (I-IV), each containing six transmembrane ! helices, labeled 
S1-S6. The binding of brevetoxins to VGSC takes place on S5 in a “head-down” fashion, 
which results in a prolonged mean channel open time, a shift of the channel activation 
potential to more negative values, and inhibition of channel inactivation (Figure 2.3). 






Figure 2.2. Schematic representation of the sodium channel subunits 
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Figure 2.3. Brevetoxins binding to site 5 of VGSC 
 
In 2004, Baden, Bourdelais, and co-workers isolated a new polycyclic ether 
natural product that they named brevenal (2.4) from laboratory cultures of Karenia 
brevis.
2c
 Although brevenal is co-synthesized with the neurotoxic brevetoxins, it shows 
no toxicity even at micromolar concentrations in a fish bioassay. Exposure of the fish to 
both brevenal and brevetoxin B at equimolar concentrations results in fish living 
significantly longer than fish receiving brevetoxin B alone.
2c
 In a rat brain synaptosome 
receptor binding assay, Baden, Bourdelais and co-workers showed that brevenal could 
inhibit binding of the brevetoxins to VGSC in a concentration-dependent manner.
2d
 
Gibson and co-workers also demonstrated that brevenal was able to both prevent and 
reverse the DNA damage caused by the brevetoxins in human lymphocytes.
10
 These 
results suggest that brevenal is an antagonist of the brevetoxins and could be exploited as 
a template for the development of therapeutic treatments for red tide-related 
intoxications.  
Equally interesting is that in a study conducted by Abraham and co-workers, 
brevenal was shown to be able to inhibit bronchoconstriction that was induced by 
inhalation of aerosolized brevetoxins in a sheep model.
11
 The researchers also discovered 
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that brevenal was able to increase tracheal mucus velocity at picomolar concentrations, 
which represents a million-fold lower dose than amiloride, a sodium channel blocker that 
is currently used in the treatment of cystic fibrosis.
11
 These intriguing results suggest that 
brevenal may also serve as a potential lead compound for therapeutic treatments of 
mucociliary dysfunction associated with lung disorders. 
In addition to its fascinating biological profile, brevenal is also an attractive target 
from a synthetic point of view. It has a trans-fused 6,7,6,7,7-pentacyclic polyether 
backbone, which is absent in any other marine polycyclic ether natural products. 
Although brevenal is approximately half the size of brevetoxins, it is densely 
functionalized with four methyl groups, three of them being angular, and two hydroxy 
groups on the pentacyclic core, together with a unique 3,4-dimethyl substituted 
conjugated (E,E)-dienal side chain.  
 
Previous Synthetic Studies Towards Brevenal 
Because of its unique structure and intriguing biological activity, brevenal has 
received attention from the synthetic community. In 2006, only two years after the 
isolation and structure elucidation were reported, Sasaki and co-workers completed the 
first total synthesis of the proposed structure of brevenal (2.6 , Figure 2.4), which 
ultimately led to a structure revision of the stereochemistry on C26.
12
 Later in the same 
year, Sasaki and co-workers verified the revised structure through total synthesis and 
established the absolute configuration of brevenal (2.4).
13 
So far, there have been three 
total syntheses including ours, and one partial synthesis of brevenal. The following is a 
brief summary of previous synthetic studies towards brevenal from other research groups. 
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Figure 2.4. Originally proposed and revised structure of brevenal 
 
Sasaki’s Total Synthesis of Brevenal 
Sasaki’s retrosynthetic analysis of the revised structure of brevenal is shown in 
Figure 2.5. The two side chains were to be installed at the very late stage using a Wittig 
reaction and a Stille coupling respectively.
13
 The pentacyclic core 2.7  was envisioned to 
be constructed from a Suzuki-Miyaura coupling between the AB ring enol phosphate 2.8  
and the DE ring exocyclic alkene 2.9 .  
Sasaki’s synthesis of the AB ring fragment 2.8  started with a highly 
diastereoselective Evans aldol condensation between aldehyde 2.10  and chiral 
oxazolidinone 2.11  to generate two stereocenters, which represented C8 and C9 in 
brevenal (Figure 2.6). The chiral auxiliary was subsequently removed, and allylic alcohol 
2.13  was obtained after seven steps. Sharpless epoxidation of the allylic alcohol, Parikh-


















































Figure 2.5. Sasaki’s retrosynthetic analysis of brevenal 
 
group was removed, the resulting free hydroxy group attacked the epoxide in a 6-endo 
fashion to furnish the A ring pyran 2.15  after protecting the resulting secondary alcohol 
as a TES ether. Seco-acid 2.16  was subsequently generated in five steps, which was 
subjected to the Yamaguchi lactonization to give the B ring lactone 2.17 . Finally, the 
requisite AB ring C16 enol phosphate 2.8  was obtained after treating the lactone with 















































































Figure 2.6. Sasaki’ synthesis of the AB ring coupling partner 2.8 
 
Sasaki’s approach to the DE fragment started from 2-deoxy-D-ribose (2.18 , 
Figure 2.7). In 11 steps, they obtained stannyl aldehyde 2.19 , which underwent an 
intramolecular cyclization upon treatment with BF3•OEt2 to give the D ring of brevenal 
2.20 as a single stereoisomer.
14
  Ketoester 2.21  was then formed  after nine steps, which 
when subjected to SmI2, a radical reductive cyclization proceeded smoothly to give the 
tricyclic lactone 2.22  along with its corresponding hydroxy ester 2.23  with excellent 
stereoselectivity and good overall yield. Both 2.22  and 2.23  were subsequently reduced 

























































































CH2Cl2, tBuOOH, -40 
oC
DMSO, CH2Cl2, 0 
oC
THF, 0 oC, 80% 3 steps






Figure 2.7. Sasaki’s synthesis of the DE ring coupling partner 2.9 
 
Sasaki’s coupling of the AB ring enol phosphate and the DE ring alkene was 
achieved using a Suzuki-Miyaura reaction (Figure 2.8). The obtained enol ether 2.25  
underwent a stereoselective hydroboration to give a secondary alcohol, which was 
subsequently oxidized to afford ketone 2.26  as a single stereoisomer. The C14 hydroxy 
group was installed stereoselectively using a Rubottom oxidation to give ketone 2.27 , 
which was converted into C19 ketone 2.28 in another four steps. Treatment of 2.28 
with Zn(OTf)2 and EtSH removed both TES groups and simultaneously promoted C ring 
cyclization to give O,S-mixed ketal 2.29 . After reprotecting the remaining hydroxy 
group, angular methyl installation using mCPBA and AlMe3 successfully gave the 
brevenal pentacyclic core 2.30 . It took Sasaki and co-workers another 18 steps to install 



































































































































2.9, 9-BBN, THF; aq. Cs2CO3



















i. BH3•DMS, THF; aq. NaHCO3, 30% H2O2








































H EtSH, Zn(OTf)2, CH2Cl2, 51%
i. TBSOTf, Et3N, CH2Cl2, 0 oC     rt, 86%
ii. mCPBA, CH2Cl2, -78 oC;









































































the isolation paper. Thus, Sasaki and co-workers achieved the first total synthesis of (-)-
brevenal in 64 steps (longest linear sequence, 46 steps to the pentacyclic core), and also 
corrected the originally proposed structure. 
The highlight of Sasaki’s synthesis was the highly convergent Suzuki-Miyaura 
coupling of two complex intermediates. However, Sasaki and co-workers considered that 
the routes to synthesize both the AB and the DE coupling partners were too long (23 
steps and 34 steps respectively), which had compromised the efficiency of their synthesis. 
To solve this problem, they adopted a different retrosynthetic plan in their 2
nd
 generation 
synthesis of brevenal’s pentacyclic core (Figure 2.9).
15
 In this new approach, they still 
exploited the powerful Suzuki-Miyaura reaction, but switched the roles of the two 
coupling partners, with AB ring fragment 2.32  as the exocyclic alkene and DE ring 
fragment 2.33  as the enol phosphate. In addition, the hydroxy group on C14 was 
preinstalled before the coupling. With the new synthetic plan, Sasaki and co-workers was 
able to synthesize brevenal pentacyclic core 2.31  in 32 steps, compared to 46 steps in the 
previous synthesis. 
 
Kadota’s Total Synthesis of Brevenal 
In 2009, Kadota and co-workers reported their total synthesis of brevenal (Figure 
2.10).
16
 As in Sasaki’s synthesis, Kadota also proposed a late stage installation of the two 
side chains, but with a shorter strategy using a Wittig reaction and a Horner-Wadsworth-
Emmons reaction respectively. The pentacyclic core of brevenal in their synthesis was 




Figure 2.9. Sasaki’s 2
nd
 generation retrosynthetic analysis of brevenal  
 
and ring-closing metathesis reaction sequence. The !-acetoxy ether 2.35  would in turn 
be obtained from the ABC ring acid 2.36  and alcohol 2.37 . 
Kadota and co-workers commenced their synthesis of the ABC ring coupling 
partner 2.36 from 2-deoxy-D-ribose (2.18), which was converted into hydroxy epoxide 
2.38  in 10 steps (Figure 2.11). Upon treatment with PPTS, 2.38 underwent a 6-endo 
cyclization to give the C ring of brevenal. In another 10 steps, Kadota and co-workers 























































































































































































































































































8 i. EtSH, Zn(OTf)2, THF, 89%


















was converted into B ring lactone 2.41  using Yamaguchi’s conditions. The lactone was 
then converted to enol phosphate 2.42 and coupled with iodide 2.43 using a Suzuki-
Miyaura reaction to give enol ether 2.44 . In four steps, 2.44 was transformed into 
hydroxy ketone 2.45 , which upon treatment with Zn(OTf)2 and EtSH gave an O,S-mixed 
ketal. A novel methyl addition to the mixed ketal using ZnMe2 and Zn(OTf)2 successfully 
furnished the ABC ring skeleton of brevenal as 2.46 ,
17
 which was converted into the 
coupling partner 2.36 in another seven steps. 
The coupling between acid 2.36  and known alcohol 2.37
18
 was accomplished 
using a Yamaguchi esterification to give ester 2.47  (Figure 2.12). In four steps, the C18 
TES protected alcohol was converted to stannyl enol ether 2.48 . Half reduction of the 
ester with iBu2AlH and a subsequent quench with chloroacetic anhydride afforded !-
chloroacetoxy ether 2.35 , which upon treatment with MgBr2•OEt2 underwent an 
intramolecular allylation to give the D ring of brevenal 2.49 as a single stereoisomer. 
Subsequent ring-closing metathesis using Grubbs’ 1
st
 generation catalyst 2.50 
successfully furnished the pentacyclic core of brevenal 2.34 . The side chains were 
installed in another twelve steps to complete the total synthesis of brevenal. 
Kadota’s total synthesis of brevenal required 45 steps to the pentacyclic core and 
57 steps to the final product (both for the longest linear sequence). Although the synthetic 
strategy is not as convergent as Sasaki’s, it features an efficient intramolecular allylation 
and ring-closing metathesis reaction sequence to generate the pentacyclic core of 









































































































































Crimmins’ Partial Synthesis of Brevenal 
In 2010, Crimmins and co-workers reported their efforts towards the synthesis of 
brevenal. Their retrosynthetic plan is shown in Figure 2.13.
19
 The proposed strategy was 
centered on a convergent coupling of AB ring phosphonate 2.53 and E ring aldehyde 
2.54 through a Horner-Wadsworth-Emmons reaction and an acid-catalyzed cyclization 
to generate the D ring.  
Crimmins’ synthesis of the AB ring fragment 2.53 commenced with a Horner-
Wadsworth-Emmons reaction between aldehyde 2.55  and phosphonate 2.56  to give a 
!,"-unsaturated ketone, which after 1,4-reduction and removal of the TMS group 
afforded 2.57 (Figure 2.14). An acid-catalyzed cyclization subsequently furnished the A 
ring of brevenal as enol ether 2.58 , which was converted into the acyl oxazolidinone 
2.59  in another ten steps. A highly diastereoselective glycolate alkylation at C16 
afforded nitrile 2.60 .
20
 After converting the chiral auxiliary into an alkene to give 2.61 , 
ring-closing metathesis using Grubbs’ 2
nd
 generation catalyst 2.62  successfully furnished 
the B ring of brevenal 2.63 , which was transformed into the AB ring coupling precursor 
2.53  in five steps. 
The E ring fragment synthesis started with a highly diastereoselective aldol 
reaction between oxazolidinone 2.64  and aldehyde 2.65  to generate the C26 quaternary 
center of brevenal (Figure 2.15). After eight steps, another oxazolidinone 2.67 was 
obtained, to which Crimmins and co-workers applied their glycolate alkylation strategy 
again to give nitrile 2.68 . The chiral auxiliary was then removed, and diene 2.69 was 
obtained from  2.68 in three steps. Upon treatment of  2.69  with Grubbs’ 2
nd







































































































Figure 2.14. Crimmins’ synthesis of the AB ring coupling partner 2.53 
 
catalyst 2.62 , diene 2.69 underwent ring-closing metathesis to afford the E ring of 
brevenal as nitrile 2.70 , from which the E ring coupling partner 2.54 was obtained in 
another four steps. The E ring aldehyde 2.54 was then successfully coupled with the AB 
ring phosphonate 2.53  under basic conditions to give !,"-unsaturated ketone 2.52 . 
At this point of their synthesis, Crimmins and co-workers have demonstrated the 

































































































ii. iBu2AlH, HMPA, MeCu, THF, -50 oC, 91%









Figure 2.15. Crimmins’ coupling between the AB ring and the E ring coupling partner 
 
the construction of polycyclic ether architectures. Efforts to complete the total synthesis 
of brevenal using their convergent strategy are currently ongoing in their laboratory. 
 
Results and Discussions 
The unique structure and intriguing biological properties of brevenal (2.4) have 
prompted us to initiate a program towards its total synthesis. At the outset of our 
















































































































sufficient quantities of the natural product but also be amenable to synthesize analogues 
that could be used to further study the biological activities.  
Our retrosynthetic analysis of brevenal (2.4) is shown in Figure 2.16. Central to 
our approach to brevenal was the convergent strategy that was previously described in 
Chapter 1 (Figure 1.21).
21
 As in Sasaki and Kadota’s syntheses, we planned to install the 
side chains at a late stage in the synthesis. The D ring of brevenal was envisioned to come 
from a reductive cyclization from the corresponding hydroxy ketone, which would be 
obtained from enol ether 2.72 . The C ring enol ether in turn was to be generated from an 
olefinic ester cyclization of ester 2.73 , which ultimately could be broken down to the AB 
ring alcohol 2.74  and the E ring acid 2.75 . We envisioned that both coupling precursors 
could be readily synthesized using our iterative cyclic enol ether/C-glycoside formation 
strategy depicted in Figure 1.2. 
 
Synthesis of the AB Ring and the E Ring Coupling Precursors 
The synthesis of the AB ring coupling partner 2.74 was designed and carried out 
by Dr. Karthik Iyer and Dr. John Rohanna from our group (Figure 2.17). From the 
TBDPS protected aldehyde 2.76 , a highly diastereoselective Brown crotylation with 
2.77 afforded secondary alcohol 2.78 , which was subsequently protected as its PMB 
ether.
22
 The two newly generated stereocenters would become the C8 and C9 of brevenal 
and would be used to control the formation of the remaining stereocenters in the AB ring 
precursor. A three-step alkene homologation involving hydroboration, oxidation, and 
Wittig olefination was then applied to 2.79 to afford alkene 2.80 . After removal of the 































































































































Figure 2.17. Synthesis of the A ring of brevenal 
 
to provide olefinic ester 2.83 , which upon treatment with the reduced titanium ethylidene 
reagent, successfully furnished the A ring of brevenal as enol ether 2.84 .
24
  
With the A ring enol ether in hand, a stereoselective oxidation with DMDO 
directed by the C9 methyl group afforded an epoxide, which upon in situ treatment with 
AlMe3, underwent ring opening to give alcohol 2.85  as a single stereoisomer (Figure 
2.18).
25
 Using a two-step protocol involving the initial generation of a cyclic mixed acetal 
and subsequent elimination of methanol, hydroxy acetal 2.85  was converted into the B 
ring enol ether 2.86 .
26
 From 2.86 , stereoselective epoxidation with DMDO directed by 







Me2 90%, er 95 : 5
BF3•OEt2, THF, -78 
oC;
NaOH, H2O2, -78 











i. BH3•DMS, THF, -10 
oC;
NaOH, H2O2, 0 
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ii. DMP, CH2Cl2




























TiCl4, CH2Cl2, THF, TMEDA












Figure 2.18. Synthesis of the AB ring coupling partner 2.74 
 
afforded secondary alcohol 2.87 .
27
 After oxidizing 2.87  to the corresponding ketone 
2.88 , a Rubottom oxidation was employed to stereoselectively install the C14 hydroxy 
group.
28
 Reduction of the ketone in 2.89 in the presence of the C14 free alcohol gave 
diol 2.90 with the desired stereochemistry on C15.
13 
The AB ring coupling partner 2.74 
was finally obtained after selective protection of the sterically less hindered C14 hydroxy 
group as its benzyl ether.
29









-78 oC    0 oC;














i. PPTS, benzene, 70 oC, 91%
ii. TMSOTf, iPr2NEt, CH2Cl2










DMDO, CH2Cl2,-78 oC    0 oC;













TPAP, NMO, 4Å MS






































Bu2SnO, MeOH, 70 oC;



















generated under substrate control once the C8 and C9 stereocenters had been established 
from the Brown crotylation reaction. 
The synthesis of the E ring coupling partner 2.75 was designed and carried out 
by Dr. Jie Zhou from our group (Figure 2.19). The synthesis commenced from L-
glyceraldehyde acetonide (2.91),
 
whose only stereocenter would become the C22 of 
brevenal.
30 
A chelation-controlled homoallylic Grignard reagent addition to the aldehyde 
afforded secondary alcohol 2.92 ,  which was then converted into 2.93  after deprotection 
of the acetonide and reprotection as a benzylidene acetal. Esterification of the secondary 
alcohol in 2.93 with acid 2.94
31
 afforded olefinic ester 2.95 , which when subjected to 
our modified Takai-Utimoto reaction conditions, succesfully gave the E ring of brevenal 
as enol ether 2.96 . 
With the E ring enol ether in hand, oxidation with DMDO and in situ reduction of 
the  resulting epoxide with  iBu2AlH  afforded alcohol 2.97  as a  single diastereoisomer 
(Figure 2.20).
32
  Oxidation and subsequent methyl Grignard addition gave tertiary alcohol  
 
 









78%, dr 8 : 1

















































Figure 2.20. Synthesis of the E ring coupling partner 2.75 
 
2.98 . After protecting the tertiary hydroxy group as a TBS ether, removal of the 
benzylidene protecting group afforded diol 2.99 , in which the primary alcohol was 
selectively converted into a triflate, and the secondary alcohol was protected as a TES 
ether. Allylcuprate addition to the triflate generated alkene 2.102 after protecting group 
manipulation. From 2.102 , the E ring coupling partner 2.75  was obtained after a three-
step sequence involving dihydroxylation of the alkene, oxidative cleavage of the resulting 


















i. TPAP, NMO, 4Å MS
CH2Cl2, 83%
ii. MeMgBr, toluene





















































THF, -78 oC   0 oC;




















Me i. OsO4, NMO, THF/tBuOH/H2O
ii. Pb(OAc)4, benzene
iii. NaClO2, NaH2PO4, tBuOH/H2O
2-methyl-2-butene, 54% 3 steps
2.102
! 106 
Synthetic Efforts Towards Brevenal Pentacyclic Core  
With both the AB ring and the E ring fragments in hand, we set out to study the 
coupling chemistry (Figure 2.21). Esterification between alcohol 2.74  and acid 2.75  
proceeded smoothly under Yamaguchi’s conditions to give olefinic ester 2.73 ,
34
 which 
when subjected to the modified Takai-Utimoto reaction conditions, successfully gave the 
six-membered C ring of brevenal as enol ether 2.72 in excellent yield.  
With the C ring enol ether in hand, we were ready to functionalize the C ring and 
install the C19 angular methyl group, which in the retrosynthetic plan, could be realized 
using our DMDO oxidation and AlMe3 addition protocol. We envisioned that the benzyl 
ether on C14 would control the facial selectivity in the process as was the case in our 
hemibrevetoxin  B  synthesis.
35
  However,  exposure  of  the  resulting  epoxide  from  the 
 
 













































E TiCl4, CH2Cl2, THF, TMEDA



























DMDO oxidation of enol ether 2.72  to AlMe3 resulted an inseparable 1.7:1 mixture of 
diastereomers at C18 and C19, which indicated a poor selectivity in the DMDO oxidation 
step (Figure 2.22).  
To overcome the problem, we proposed that if we could exploit the formation of 
an oxocarbenium ion, the installment of the C19 methyl group should be decoupled from 
the selectivity of the epoxidation step because of the overwhelming propensity for axial 
addition of nucleophiles to oxocarbenium ions in six-membered rings.
36
  
Dr. Jie Zhou from our group had developed a reaction system to generate !-C-
glycosides using DMDO and organozinc reagents in the presence of TBSOTf or 
TESOTf.
37
 In the example depicted in Figure 2.23, when the epoxide from enol ether 
2.105  was exposed to TESOTf and ZnMe2, C,C-ketal 2.108  was isolated as a 1.2:1 
diastereomeric mixture at  C8. The newly added methyl group on  C9  occupied  the axial 
 
 























oC    0 oC;
75% dr 1.7 : 1
AlMe3, toluene, -78 










































position in  both products, which was later  proven through  nOe studies  after  converting 
mixture 2.108  to ketone 2.109 . With this in mind, we subjected enol ether 2.78  to the 
same reaction condition. However disappointingly, the outcome from the treatment of the 
epoxide from 2.72  with TESOTf and ZnMe2 was capricious, giving only trace amounts 
of the desired product 2.110  together with other unidentifiable materials and 
decomposition (Figure 2.24).   
 
 
Figure 2.23. Axial methyl addition through an oxocarbenium ion 
 
 

































82%, dr 1.2 : 1
i. HF•Py, THF
ii. TPAP, NMO, 4Å MS






































DMDO, CH2Cl2, -78 
oC    0 oC;
ZnMe2, TESOTf, THF, -78 































The unsuccessful introduction of the C19 angular methyl group prompted us to 
examine a stepwise solution (Figure 2.25). In contrast to the result in Figure 2.22, 
treatment of the epoxide from 2.72  with EtSH and Zn(OTf)2 afforded a 1.7:1 
diastereomeric mixture of C18 secondary alcohols 2.111 .
19
 After protecting the resulting 
hydroxy group as a TES ether, the stereoselective introduction of the C19 angular methyl 

























DMDO, CH2Cl2,-78 oC    0 oC;























89%, dr 1.7 : 1
i. TESOTf, 2,6-lutidine, CH2Cl2
ii. ZnMe2, Zn(OTf)2, CH2Cl2























i. CSA, MeOH, 0 oC

























the TES group, oxidation of the C18 alcohol, and removal of the PMB group afforded 
hydroxy ketone 2.113  as a single compound. It is noteworthy that 2.113  existed 
exclusively as the hydroxy ketone tautomer and not as the corresponding hemiketal, 
which later we realized was actually a harbinger of future problems with the cyclization 
to form the D ring. 
As shown in our retrosynthetic analysis (Figure 2.16), the generation of the 
brevenal D ring from 2.113  required a reductive cyclization reaction. To this goal, 
2.113  was subjected to Et3SiH and Lewis acids. However, we were disappointed to find 
that the reaction resulted in complete decomposition of the starting material with no 
discernible product formation (Figure 2.26).  
Other approaches to the D ring were also unsuccessful. First, a more conservative 
O,S-mixed ketal radical reduction approach was tested (Figure 2.27). Treatment of 
hydroxy ketone 2.113  with EtSH and Zn(OTf)2 afforded the corresponding dithioketal, 
which was converted to O,S-mixed ketal 2.114 using a AgClO4-promoted cyclization. 
Unfortunately, all attempts to reduce the mixed ketal or the corresponding sulfone under 
either homolytic or heterolytic conditions failed. 
 
 
































Figure 2.27. Efforts to form the D ring of brevenal through an O,S-mixed ketal 
 
The studies outlined above suggested to us that the C19 angular methyl group in 
hydroxy ketone 2.113 was significantly inhibiting our efforts to the brevenal D ring. We 
attempted to solve this problem by turning our attention to the reductive cyclization of 
hydroxy ketone 2.116 , which had the alcohol and ketone functional groups at reversed 
positions compared to 2.113  (Figure 2.28). We envisioned that the sterically less 
hindered C23 ketone in 2.116 might facilitate the cyclization reaction. From the methyl 
addition product 2.115 , hydroxy ketone 2.116  was obtained after removal of the PMB 
group, oxidation, and removal of the TES group. In contrast to the two-step synthesis of 
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AIBN, Bu3SnH or Ph3SnH, 110 oCa
Zn(OTf)2, Et3SiHa
 AgClO4, 4Å MS, NaHCO3, Et3SiHb
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arecovery of starting material
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iii. CSA, MeOH, 0 oC




































































i. LiDBB, THF, -78 oC
ii. TBSOTf, 2,6-lutidiene, CH2Cl2
85% 2 steps

























with Zn(OTf)2 and EtSH gave O,S-mixed ketal 2.117  directly. More interesting was that 
the radical reduction of 2.117 with AIBN and Ph3SnH successfully afforded oxepane 
2.118  as a single stereoisomer after 4 days in refluxing toluene. Removal of the benzyl 
groups in 2.118 followed by TBS ethers formation gave 2.119 , a known intermediate in 
Sasaki’s total synthesis of brevenal.
13
 Unfortunately, although the mass spectroscopy data 
for 2.119 was correct, the 
1
H NMR data did not match that previously reported by 
Sasaki. Although not definitively established, we presume that pentacycle 2.119  differs 
from the brevenal core at C23.  
 
Successful Synthesis of Brevenal Pentacyclic Core 
While our unsuccessful efforts to the brevenal core from 2.113  and 2.116  were 
disappointing, we realized that we could easily modify our synthetic plan by switching 
the acid/alcohol coupling partners. Thus, a new retrosynthetic analysis was proposed with 
AB ring fragment 2.123 being the acid coupling partner and E ring fragment 2.124 
being the alcohol coupling partner (Figure 2.29). In the new strategy, the seven-
membered D ring was envisioned to come from olefinic ester cyclization, which would 
certainly be more challenging than the analogous reaction in the previous route to form 
the six-membered C ring. But on the other hand, we envisioned that the late-stage 
cyclization to form the C ring and installation of the C19 angular methyl group would 
help us overcome some of the problematic transformations in our previous efforts. 
With the new synthetic strategy in mind, the revised AB ring coupling partner 
2.123 was synthesized from the previous intermediate 2.90 in four steps (Figure 2.30). 
After protecting the two hydroxy groups in 2.90 as TES ethers, the acid coupling partner 
! 114 
 



























































































































Figure 2.30. Synthesis of the AB ring coupling partner 2.123 
 
2.123 was obtained after a three-step sequence involving dihydroxylation of the alkene, 
oxidative cleavage of the resulting diol, and Pinnick oxidation. The new E ring coupling 
partner 2.124  itself was a previously used intermediate in Figure 2.20.  
With both coupling partners in hand, we set out to study the new strategy (Figure 
2.31). Esterification of acid 2.123  with alcohol 2.124  was accomplished using Shiina’s 
conditions to give ester 2.122 .
38
 Yamaguchi esterification was not as effective for this 
specific reaction. After optimization of the olefinic ester cyclization conditions, we were 
pleased to find that the desired D ring enol ether 2.121  was generated in 30% yield from 
ester 2.122  along with 70% acyclic enol ether 2.126 . Fortunately, the acyclic material 
2.126  could be converted into 2.121  using Grubbs 2
nd
 generation catalyst 2.62 under 
an ethylene atmosphere in refluxing benzene. This gave an additional 42% of cyclic 
materials consisting of a 5:1 mixture of 2.121  and the corresponding dihydropyran from 
alkene isomerization under metathesis conditions. Thus, the D ring enol ether 2.121  





























ii. NaClO2, NaH2PO4, 2-methyl-2-butene




















Figure 2.31. Synthesis of D ring of brevenal using olefinic ester cyclization 
 
With the D ring in hand, oxidation of the enol ether in 2.121 with DMDO and in 
situ reduction of the resulting epoxide using iBu2AlH afforded secondary alcohol 2.127 
in 75% yield (Figure 2.32). In sharp contrast to the DMDO oxidation of the six-
membered C ring enol ether 2.72  (Figure 2.22), alcohol 2.127  was obtained as a single 
stereoisomer, which indicated that the DMDO epoxidation of 2.121  was stereoselective. 
Based on DFT calculations in a model oxepene, we believe that the high stereoselectivity 
in the generation of the C18 stereocenter is a result of unfavorable torsional interactions 


















































TiCl4, CH2Cl2, THF, TMEDA








































Figure 2.32. Formation of the C18 stereocenter 
 
With the C18 stereocenter successfully set, we were ready to generate the 
brevenal C ring. Oxidation of secondary alcohol 2.127  using Ley’s conditions gave 
ketone 2.128 , which intercepted Sasaki’s total synthesis of brevenal (Figure 2.33). All 




C, IR, MS, [!]
20
D) matched that reported previously.
13
 To 
complete the synthesis of brevenal pentacyclic core, ketone 2.128  was subjected to 
Zn(OTf)2 and EtSH, which removed both TES groups and successfully promoted 
cyclization to generate O,S-mixed ketal 2.129 . After protecting the remaining C14 
hydroxy group as a TBS ether, Sasaki had installed the C19 methyl group with a two-step 
protocol using mCPBA and subsequent treatment of the resulting sulfone with AlMe3. 
We found the more direct ZnMe2 and Zn(OTf)2 protocol was equally effective to install 
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Figure 2.33. Synthesis of the brevenal pentacyclic core 2.120 
 
Completion of the Total Synthesis of Brevenal 
With the pentacyclic core structure 2.120 in hand, we were finally prepared to 
finish the total synthesis of brevenal (Figure 2.34). To this goal, a modified Kadota end 
game protocol was employed to install the two side chains.
16
 The E-ring side chain 
incorporation started with deprotection of the C30 benzyl group, which was effected 
using hydrogenolysis in Kadota’s synthesis. In our hands, reductive deprotection with 


































































i. TBSOTf, 2,6-lutidine, CH2Cl2, 82%
14
19 ii. ZnMe2, Zn(OTf)2, CH2Cl2


























Figure 2.34. Installment of the E-ring side chain 
 
alcohol. The alcohol was subsequently converted to aldehyde 2.130 using a Parikh-
Doering oxidation.
39
 Wittig coupling using phosphonium salt 2.131  and NaHMDS 
followed by oxidative elimination of the phenyl selenoxide successfully afforded (Z)-
diene 2.132 , thus completing the E-ring side chain of brevenal.
40
 
The installment of the A-ring side chain started with the selective deprotection of 
the primary TBDPS group in the presence of two TBS groups using HOAc and TBAF to 
give 2.133 (Figure 2.35).
41
 The resulting primary alcohol was oxidized to give aldehyde 
2.134 , which following a Horner-Wadsworth-Emmons reaction with the lithium salt of 
phosphonate 2.135  successfully afforded the desired (E,E)-diene 2.136 . From the same 
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of the ester with iBu2AlH, removal of the TBS groups using TBAF, and selective 
oxidation of the C1 allylic alcohol. However in our hands, the allylic alcohol obtained 
after the first two steps was unstable to the chromatography that was required after TBAF 
deprotection. So we adopted a slightly different protocol to finish our total synthesis of 
brevenal. The two TBS groups were first removed using HF•Py, and the resulting diol 
was subjected to iBu2AlH to afford the corresponding allylic alcohol, which, without the 
need for chromatography, was directly oxidized to brevenal (2.4) using MnO2. Our 
spectral data for brevenal matched that previously reported.
2d 
 Thus, we have accomplished the total synthesis of brevenal (2.4) in 38 steps 
(longest linear sequence, 28 steps to the pentacyclic core) in 0.99% overall yield. Our 
work compared favorably to the other total syntheses of brevenal where the Sasaki group 
required 65 steps with a 0.26% overall yield and the Kadota group required 57 steps with 
a 0.84% overall yield. 
After our successful total synthesis of brevenal, we also synthesized an analogue 
of brevenal (2.139) from the pentacyclic intermediate 2.120 (Figure 2.36). Both 
compounds were sent to our collaborators for biological evaluation. The preliminary data 
have demonstrated that both brevenal and the analogue produce a concentration-
dependent antagonism of the brevetoxin B-induced calcium influx in mouse cerebral 
cortical neurons. Interestingly, the analogue is shown to be ten times more potent than 
brevenal in this assay. The concentration-dependent antagonism is presumably through 
an inhibition of the binding of brevetoxin B to VGSC by brevenal and the analogue. 




Figure 2.36. Synthesis of brevenal analogue 2.139 
 
Conclusion 
To summarize, we have achieved the total synthesis of brevenal utilizing our 
olefinic ester cyclization strategy to both build the individual AB and E ring fragments 
and to carry out their convergent coupling. Our flexible coupling strategy has allowed us 
to readily modify the coupling partners to accommodate the specific requirements in the 
synthesis. We are currently in collaboration with Prof. Thomas Murray at Creighton 
University to further investigate brevenal’s biological properties and its inhibition of the 
























i. TBAF, HOAc, THF
ii. SO3•Py, DMSO, Et3N, CH2Cl2

























nBuLi, THF, -78 oC    0 oC;





















MeO2C i. HF•Py, THF, 0 oC



























NMR spectra were recorded on Varian Inova-400 MHz, Varian Inova-500 MHz 
or Varian VXR-500 MHz spectrometers. Chemical shifts were reported in !, parts per 
million (ppm), relative to benzene (7.16), chloroform (7.27), or dichloromethane (5.32) 
as internal standards. Coupling constants, J, were reported in Hertz (Hz) and refer to 
apparent peak multiplicities and not true coupling constants. Mass spectra were recorded 
at the Mass Spectrometry Facility at the Department of Chemistry of the University of 
Utah at Salt Lake City on a Finnigan MAT 95 mass spectrometer. IR spectra were 
recorded on a Bruker Tensor 27 FT-IR spectrometer. Optical rotations were obtained on a 
Perkin-Elmer Model 343 polarimerter (Na D line) using a microcell with 1 dm path 
length. Solvents were purified according to the guidelines in Purification of Common 
Laboratory Chemicals (Perrin, Armarego, and Perrin: Oxford, 1966).  Dichloromethane, 
2,6-lutidine, triethylamine, TMEDA, chlorobenzene and pyridine were distilled from 
CaH2. Tetrahydrofuran and diethyl ether were dried from the sodium ketyl of 
benzophenone and distilled before use. Zinc dust (<10 µm, Aldrich) was activated by 
washing with 5% hydrochloric acid, H2O, methanol, and ether and dried in vacuo 
overnight. All other reagents were used without further purification. Unless otherwise 
noted, all reactions were performed under a nitrogen atmosphere in flame-dried glassware 
using standard syringe, cannula, and septa apparatus. Concentration refers to removal of 
solvent under reduced pressure (house vacuum at ca. 20mm Hg). Analytical thin–layer 
chromatography (TLC) was performed on silica gel plates (0.25 mm) precoated with a 
fluorescent indicator. Flash chromatography was performed using 40–63 µm silica gel 
(200 X 400 mesh). 
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Preparation of alcohol 2.124 . To a solution of 2.101 (20 mg, 0.035 mmol) 
in MeOH (4.0 mL) at 0
 
°C was added CSA (8.0 mg, 0.035 mmol). The reaction mixture 
was warmed to rt over 1 h at which time the reaction was quenched with sat. NaHCO3 
(aq., 2.5 mL). The aqueous phase was extracted with CH2Cl2 (5 x 5 mL), and the 
combined organic extracts were dried (Na2SO4) and concentrated. Flash chromatography 
(10:1 to 3:1 hexanes:ethyl acetate) provided the 16 mg of 2.124  (100%) as a colorless 
oil. Rf 0.40 (5:1 hexanes:ethyl acetate); [!] D
20
 = +1.8° (c = 0.22, THF); 
1
H NMR (500 
MHz, C6D6) " 7.31 (d, J = 7.3 Hz, 2H), 7.19 (t, J = 7.3 Hz, 2H), 7.10 (t, J = 7.3 Hz, 1H), 
5.88 (dddd, J = 16.6, 10.3, 6.4, 6.4 Hz, 1H), 5.12 (dd, J = 17.1, 1.5 Hz, 1H), 5.00 (d, J = 
10.3 Hz, 1H), 4.34 (s, 2H), 3.44-3.35 (m, 2H), 3.34 (d, J = 9.8 Hz, 1H), 3.22-3.13 (m, 
2H), 2.47 (dddd, J = 14.6, 8.8, 5.9, 5.9 Hz, 1H), 2.24 (dddd, J = 16.1, 6.8, 6.8, 6.8 Hz, 
1H), 2.02-1.93 (m, 1H), 1.93-1.66 (m, 5H), 1.66-1.45 (m, 5H), 1.12 (s, 3H), 0.95 (s, 9H), 
0.09 (s, 3H), 0.08 (s, 3H); 
13
C NMR (125 MHz, C6D6) " 139.2, 138.9, 128.2, 127.4, 
127.3, 114.5, 87.3, 87.1, 77.5, 76.1, 72.6, 70.6, 37.5, 34.6, 30.6, 30.0, 27.8, 27.5, 25.9, 
23.7, 18.2, -2.1, -2.1; IR (neat) 3436, 2930, 2856, 1455, 1364, 1253, 1104 cm
-1
; ESI/MS 
(m/z) calcd for C27H46O4SiNa 485.3 (M+Na
+









Preparation of ester 2.122 . To a solution of acid 2.123  (9.3 mg, 11.7 µmol) 
and alcohol 2.124  (9.1 mg, 19.7 µmol) in CH2Cl2 (1.5 mL) were added 2-methyl-6-
nitrobenzoic anhydride (8.0 mg, 23.3 µmol) and DMAP (7.1 mg, 58.2 µmol). The 
reaction mixture was stirred at rt overnight before the reaction was quenched with sat. 
NaHCO3 (aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), and the 
organic phase was combined, dried (Na2SO4) and concentrated. Flash chromatography 
(10:1 hexanes:ethyl acetate) provided 2.122 (12.6 mg, 87%) as a colorless oil. Rf 0.35 
(10:1 hexanes:ethyl acetate); [!] D
20
 = -4.6° (c = 0.32, THF); 
1
H NMR (500 MHz, C6D6) 
" 7.77-7.73 (m, 4H), 7.30 (d, J = 7.3 Hz, 2H), 7.24-7.20 (m, 6H), 7.19 (d, J = 7.5 Hz, 
2H), 7.10 (t, J = 7.3 Hz, 1H), 5.84 (dddd, J = 16.8, 10.2, 6.4, 6.4 Hz, 1H), 5.10 (dd, J = 
17.1, 1.7 Hz, 1H), 5.00 (dd, J = 10.2, 1.5 Hz, 1H), 4.91-4.86 (m, 1H), 4.36-4.31 (partially 
obscured m, 1H), 4.34 (s, 2H), 4.23 (dd, J = 11.2, 6.1 Hz, 1H), 4.05 (d, J = 11.2, 2.0 Hz, 
1H), 4.01 (s, 1H), 3.67 (ddd, J = 10.0, 6.3, 6.3 Hz, 1H), 3.61 (ddd, J = 10.0, 6.1, 6.1 Hz, 
1H), 3.52 (ddd, J = 9.3, 6.3, 2.9 Hz, 1H), 3.49-3.45 (m, 1H), 3.43-3.33 (m, 3H), 2.75 (dd, 
J = 12.2, 12.2 Hz, 1H), 2.59 (dd, J = 14.9, 8.0 Hz, 1H), 2.49-2.42 (partially obscured m, 
1H), 2.42 (partially obscured dd, J = 14.9, 6.3 Hz, 1H), 2.24 (dddd, J = 15.9, 7.6, 7.6, 7.6 
Hz, 1H), 2.00-1.45 (m, 16H), 1.36-1.28 (m, 2H), 1.28 (s, 3H), 1.14 (s, 9H), 1.10 (s, 3H), 
1.07 (t, J = 7.8 Hz, 9H), 1.00 (d, J = 8.3 Hz, 3H), 0.98 (t, J = 7.8 Hz, 9H), 0.94 (s, 9H), 























8.1 Hz, 3H), 0.08 (s, 3H), 0.07 (s, 3H); 
13
C NMR (125 MHz, C6D6) ! 170.0, 139.9, 139.0, 
136.4, 134.9, 134.9, 130.2, 128.9, 128.3, 128.0, 127.9, 115.4, 88.2, 84.4, 82.1, 80.9, 78.4, 
77.9, 74.5, 73.3, 72.9, 71.2, 71.1, 69.6, 64.7, 45.8, 40.9, 38.1, 35.1, 35.0, 33.5, 30.8, 30.2, 
29.8, 28.4, 28.1, 27.5, 26.5, 26.3, 23.6, 19.8, 18.7, 17.1, 12.9, 7.6, 7.6, 5.8, 5.5, -1.5, -1.5; 
IR (neat) 2954, 2877, 1740, 1464, 1380, 1107 cm
-1
; ESI/MS (m/z) calcd for 
C71H118O10Si4Na 1265.8 (M+Na
+
), found 1265.7. 
 
Preparation of alcohol 2.127 . To a solution of TiCl4 (0.226 mL, 2.06 mmol) 
in CH2Cl2 (14 mL) at 0 °C was added THF (1.09 mL, 12.4 mmol) dropwise. To the 
resulting yellow solution was added TMEDA (1.87 mL, 12.4 mmol) dropwise.  The ice 
bath was removed and the mixture was allowed to stir for 15 min. Activated Zn dust (301 
mg, 4.66 mmol) and PbCl2 (68.0 mg, 0.245 mmol) were then added. The resulting 
mixture went through a series of color changes from brown to green to purple and finally 
to blue-green over the course of 3-5 min. To the slurry was transferred a solution of ester 
2.122 (20.0 mg, 16.1 µmol) and CH3CHBr2 (0.185 mL, 2.06 mmol) in CH2Cl2 (3 mL). 
The reaction mixture was then heated to reflux for 2 hr before it was cooled to 0 °C and 
quenched with sat. K2CO3 (aq., 1.0 mL). After stirring for 30 min at 0 °C, the resulting 
mixture was filtered. The filtrate was concentrated and flash chromatography (3:1 
hexanes:ethyl acetate) gave a mixture of cyclic enol ether 2.121 and acyclic enol ether 
























To a solution of the mixture obtained from above in benzene (5 mL) was added 
Grubbs’ 2
nd
 generation catalyst 2.62 (3 mg, 3.53 µmol). The reaction mixture was 
heated to reflux under 1 atm. of ethylene for 16 h. A second portion of Grubbs’ 2
nd
 
generation catalyst 2.62 (3 mg, 3.53 µmol) was added and the ethylene balloon was 
removed. The reaction mixture was heated for another 16 h before it was cooled to rt. The 
solvent was removed in vacuo and the residue was quickly passed through a plug of silica 
(hexanes: ethyl acetate 20:1). The resulting 6:1 mixture of oxepene and dihydropyran was 
used in the next step without further purification. 
To a solution of enol ethers from above in CH2Cl2 (5 mL) at -78 
o
C was added a 
solution of dimethyl dioxirane (0.31 mL of 0.10 M solution in CH2Cl2, 0.031 mmol) 
dropwise. The reaction mixture was warmed to 0 °C and then concentrated. The resulting 
residue was dissolved in CH2Cl2 (5 mL) and the reaction mixture was cooled to -78 
o
C, at 
which temperature, a solution of iBu2AlH (50.0 µL of 1.0 M solution in THF, 50.0 µmol) 
was added. The reaction mixture was stirred for 2 h and the reaction was quenched with 
sat. NH4Cl (aq., 3 mL) and allowed to warm to rt. Saturated potassium sodium tartrate 
solution (10 mL) was added and the mixture was stirred for 30 min. The aqueous phase 
was extracted with CH2Cl2 (3 x 10 mL) and the organic phase was combined, dried 
(Na2SO4) and concentrated. Flash chromatography (7:1 hexanes:ethyl acetate) gave 
alcohol 2.127  (9.6 mg, 49% 3 steps). Rf 0.35 (4:1 hexanes:ethyl acetate); [!] D
20
 = -3.3° 
(c = 0.58, THF); 
1
H NMR (500 MHz, C6D6) " 7.80-7.75 (m, 4H), 7.34 (d, J = 7.6 Hz, 
2H), 7.26-7.19 (m, 8H), 7.12 (t, J = 7.3 Hz,  1H), 4.37 (s, 2H), 4.30 (dd, J = 9.0, 8.3 Hz, 
1H), 4.18 (dd, J = 8.0, 4.9 Hz, 1H), 4.10 (dd, J = 12.0, 2.2 Hz, 1H), 4.07 (s, 1H), 3.81 
(ddd, J = 6.1, 6.1, 2.7 Hz, 1H), 3.68 (ddd, J = 10.0, 6.6, 6.6 Hz, 1H), 3.66-3.60 (m, 2H), 
! 128 
3.50-3.36 (m, 6H), 2.78 (dd, J = 12.1, 12.1 Hz, 1H), 2.15-1.92 (m, 3H), 1.91-1.40 (m, 
18H), 1.40-1.25 (m, 2H), 1.28 (s, 3H), 1.16 (s, 9H), 1.13 (t, J = 8.1 Hz, 9H), 1.11 (s, 3H), 
1.01 (t, J = 8.1 Hz, 9H), 0.96 (d, J = 7.3 Hz, 3H), 0.95 (s, 9H), 0.77 (q, J = 7.8 Hz, 3H), 
0.76 (q, J = 8.0 Hz, 3H), 0.64 (q, J = 7.8 Hz, 3H), 0.63 (q, J = 8.0 Hz, 3H), 0.07 (s, 6H); 
13C NMR (125 MHz, C6D6) ! 139.6, 136.1, 134.6, 134.5, 129.9, 128.5, 128.4, 128.1, 
127.7, 127.5, 88.8, 87.6, 86.0, 83.4, 83.1, 80.7, 77.9, 74.1, 73.5, 73.0, 72.4, 70.9, 70.8, 
69.5, 64.3, 45.4, 40.6, 38.6, 34.7, 33.2, 30.2, 29.8, 29.7, 29.6, 29.5, 29.1, 27.9, 27.8, 27.2, 
26.1, 24.3, 19.5, 18.4, 16.8, 12.4, 7.4, 7.2, 5.6, 5.2, -1.9, -2.1; IR (neat) 3463, 2932, 2876, 
1458, 1380, 1251, 1083, 1005 cm-1; ESI/MS (m/z) calcd for C70H118O10Si4Na 1253.8 
(M+Na+), found 1253.8. 
 
Preparation of ketone 2.128 . To a solution of alcohol 2.128  (8.7 mg, 7.07 
µmol) in CH2Cl2 (5 mL) were added activated 4Å MS (12 mg), NMO (12.2 mg, 0.104 
mmol) and TPAP (1 mg, 0.003 mmol). The reaction mixture was stirred at rt for 2 h 
before the solvent was removed in vacuo. Flash chromatography (10:1 hexanes:ethyl 
acetate) gave 7.6 mg of ketone 2.128  (87%) as a colorless oil. Rf 0.65 (5:1 hexanes:ethyl 
acetate); ["] D
20 = -14.2° (c = 1.0, THF); 1H NMR (500 MHz, C6D6) ! 7.80-7.76 (m, 4H), 
7.34 (d, J = 7.6 Hz, 2H), 7.26-7.19 (m, 8H), 7.14 (t, J = 7.3 Hz,  1H), 4.37 (s, 2H), 4.29 
(dd, J = 11.5, 5.9 Hz, 1H), 4.19 (dd, J = 9.5, 4.4 Hz, 1H), 4.09 (dd, J = 11.2, 2.2 Hz, 1H), 























(ddd, J = 10.0, 6.4, 6.4 Hz, 1H), 3.50-3.36 (m, 5H), 2.87 (dd, J = 12.5, 12.5 Hz, 1H), 
2.80-2.73 (m, 2H), 2.31 (dd, J = 11.5, 6.6 Hz, 1H), 2.24 (ddd, J = 14.4, 9.8, 5.1 Hz, 1H), 
2.14-2.04 (m, 2H), 1.95-1.85 (m, 2H), 1.83-1.65 (m, 8H), 1.63-1.42 (m, 6H), 1.38-1.32 
(m, 1H), 1.31 (s, 3H), 1.18 (s, 9H), 1.10 (t, J = 7.8 Hz, 9H), 1.08 (s, 3H), 1.03 (t, J = 7.8 
Hz, 9H), 0.99 (d, J = 7.1 Hz, 3H), 0.95 (s, 9H), 0.74 (q, J = 7.6 Hz, 3H), 0.73 (q, J = 8.1 
Hz, 3H), 0.66 (q, J = 7.8 Hz, 3H), 0.65 (q, J = 8.1 Hz, 3H), 0.07 (s, 3H), 0.06 (s, 3H); 
13
C 
NMR (125 MHz, C6D6) ! 214.3, 139.8, 136.4, 134.9, 130.2, 129.1, 128.9, 128.7, 128.1, 
128.0, 88.7, 88.6, 87.5, 85.0, 82.8, 79.5, 78.0, 74.6, 73.4, 72.6, 71.2, 71.0, 69.6, 64.7, 
45.8, 39.4, 38.7, 38.1, 35.0, 33.5, 32.0, 30.4, 30.2, 29.8, 29.6, 28.2, 28.1, 27.5, 26.4, 24.9, 
19.8, 18.7, 17.1, 12.8, 7.6, 7.6, 5.8, 5.5, -1.7, -1.8; IR (neat) 2952, 2876, 1720, 1459, 
1430, 1380, 1251, 1106, 1005, 831, 740, 703 cm
-1
; ESI/MS (m/z) calcd for 
C70H116O10Si4Na 1251.8 (M+Na
+
), found 1251.7.  
 
Preparation of brevenal pentacyclic core 2.120 . To a solution of 2.128  
(5.9 mg, 4.80 µmol) in CH2Cl2 (1.5 mL) and EtSH (0.5 mL) was added Zn(OTf)2 (10 mg, 
27.5 µmol). The reaction mixture was stirred at rt overnight before it was quenched with 
sat. NaHCO3 (aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), and 
the combined organic phase was dried (Na2SO4) and concentrated. Flash chromatography 























To the solution of 2.129  in CH2Cl2 (3 mL) were added 2,6-lutidine (30 µL, 0.26 
mmol) and TBSOTf (30 µL, 0.13 mmol). The reaction mixture was stirred for 6 h before 
the reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 5 mL) and the combined extracts were dried (Na2SO4) and 
concentrated. Flash chromatography (15:1 hexanes:ethyl acetate) provided 2.6 mg of the 
TBS ether as a colorless oil (82%). 
To the solution of the TBS ether from above in CH2Cl2 (2 mL) at 0 °C was added 
ZnMe2 (95.0 µL of a 1.0 M solution in heptane, 95.0 µmol) and Zn(OTf)2 (10.4 mg, 28.6 
µmol). The cold bath was removed and the reaction mixture was warmed to rt and stirred 
overnight. The solvent was removed in vacuo and flash chromatography (15:1 
hexanes:ethyl acetate) provided 2.3 mg of 2.120 as a colorless oil (94%). Rf 0.50 (15:2 
hexanes:ethyl acetate); [!] D
20
 = -17.9° (c = 0.437, benzene); 
1
H NMR (500 MHz, C6D6) 
" 7.82-7.78 (m, 4H), 7.34 (d, J = 7.7 Hz, 2H), 7.26-7.22 (m, 6H), 7.20 (d, J = 7.7 Hz, 
2H), 7.10 (t, J = 7.3 Hz, 1H), 4.42 (dd, J = 12.1, 5.5 Hz, 1H), 4.38 (s, 2H), 4.04 (dd, J = 
3.9, 3.9 Hz, 1H), 3.93 (ddd, J = 11.7, 9.1, 4.3 Hz, 1H), 3.68 (ddd, J = 9.9, 6.2, 6.2 Hz, 
1H), 3.65 (ddd, J = 9.9, 6.2, 6.2 Hz, 1H), 3.56-3.38 (m, 4H), 3.37-3.31 (m, 2H), 3.24 
(ddd, J = 9.0, 9.0, 4.4 Hz, 1H), 3.18 (dd, J = 12.1, 4.1 Hz, 1H), 2.35 (ddd, J = 12.1, 4.4, 
4.4 Hz, 1H), 2.26-2.17 (m, 2H), 2.14-1.71 (m, 13H), 1.67-1.44 (m, 5H), 1.40-1.24 (m, 
2H), 1.25 (s, 3H), 1.19 (s, 9H), 1.15 (s, 3H), 1.13 (s, 3H), 1.10 (s, 9H), 1.06 (d, J = 7.0 
Hz, 3H), 0.94 (s, 9H), 0.21 (s, 3H), 0.17 (s, 3H), 0.08 (s, 3H), 0.06 (s, 3H); 
13
C NMR 
(125 MHz, C6D6) " 139.9, 136.4, 134.9, 130.2, 129.2, 129.0, 128.9, 128.4, 128.0, 127.9, 
126.7, 89.0, 86.9, 85.2, 83.4, 78.4, 78.0, 76.9, 76.5, 74.0, 73.7, 73.6, 73.4, 71.5, 71.2, 
64.7, 50.3, 38.4, 38.4, 35.9, 35.0, 33.6, 30.5, 30.2, 29.9, 29.8, 28.1, 27.5, 26.6, 26.4, 24.4, 
! 131 
21.6, 19.8, 18.9, 18.7, 16.3, 13.2, -1.6, -1.7, -3.6, -4.4; IR (neat) 2930, 2856, 1460, 1381, 
1252, 1085 cm
-1





Preparation of primary alcohol 2.133 . To a solution of 2.120 (6.0 mg, 
5.40 µmol) in THF (3 mL) at -78 °C was added excess LiDBB (ca. 0.17 M solution in 
THF (see below for experimental protocol) until the blue color of LiDBB persisted. After 
1 h, the reaction was quenched with sat. NH4Cl (aq., 5 mL). The aqueous phase was 
extracted with ethyl acetate (3 x 5 mL) and the combined organic phase was dried 
(Na2SO4) and concentrated. Flash chromatography (4:1 hexanes:ethyl acetate) provided 
the corresponding primary alcohol as a colorless oil (5.2 mg, 95%).  
0.17 M LiDBB solution in THF: To a mixture of di-tert-butylbiphenyl (0.37 g, 1.4 
mmol) in THF (8 mL) at 0 °C was added  lithium metal (60 mg, 8.6 mmol). The resulting 
mixture was sonicated at 0 °C for 1 h and then stirred at 0 °C for 1 h.  
To a solution of the primary alcohol obatined from above (5.2 mg, 5.1 µmol) and 
DMSO (0.2 mL) in CH2Cl2 (0.8 mL)  at 0 
o
C were added Et3N (65 µL, 0.467 mmol) and 
SO3•Py (37.3 mg, 0.235 mmol). The reaction mixture was stirred at rt for 1 h before the 
reaction was quenched with sat. NH4Cl (aq., 5 mL). The aqueous phase was extracted 





















concentrated. The resulting residue was passed through a plug of silica gel. Aldehyde 
2.130 was used immediately in the next step.  
To a suspension of phosphonium salt 2.131 (126.7 mg, 0.235 mmol) in THF (0.3 
mL) at -30 °C was added NaHMDS (0.19 mL of 1.0 M solution in THF, 0.19 mmol). 
After stirring for 15 min, the resulting mixture was cooled to -78 °C. To this solution was 
added a pre-cooled (-78 °C) solution of aldehyde 2.130 (5.1 µmol) in THF (1.0 mL). 
The resulting reaction mixture was allowed to slowly warmed up to rt and stirred at rt for 
15 min before the reaction was quenched with sat. NaHCO3 (aq., 5 mL). The aqueous 
phase was extracted with ethyl acetate (3 x 5 mL) and the combined extracts were dried 
(Na2SO4) and concentrated. The residue was passed through a silica gel plug and used in 
the next step without further purification.  
To the solution of the phenylselenide obtained from above in THF (0.6 mL) was 
added NaHCO3 (7.9 mg, 0.094 mmol) and H2O2 (0.2 mL of 30% aq. solution). The 
reaction mixture was warmed to 30 °C and stirred for 21 h after which the reaction was 
quenched with sat. Na2SO3 (aq., 5 mL) at 0 °C. The aqueous phase was extracted with 
ethyl acetate (3 x 5 mL) and the organic extracts were combined, dried (Na2SO4) and 
concentrated.  Flash chromatography (20:1 hexanes:ethyl acetate) provided 4.6 mg of 
diene 2.132 as a colorless oil (87% 3 steps).  
To a solution of 2.132  (6.0 mg, 5.7 µmol) in THF (0.3 mL) was added a solution 
of TBAF/AcOH (0.1 mL, prepared from 0.5 mL of TBAF (1.0 M solution in THF) and 
30 µL AcOH). After 9 h, the reaction was quenched with sat. NaHCO3 (aq., 5 mL). The 
aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the combined extracts 
were dried (Na2SO4) and concentrated. Flash chromatography (3:1 hexanes:ethyl acetate) 
! 133 
provided 4.2 mg of primary alcohol 2.133  as a colorless oil (91%). Rf 0.50 (1:1 
hexanes:ethyl acetate) [!]D
20
 = -18.0° (c = 0.10, CHCl3); 
1
H NMR (500 MHz, CDCl3) " 
6.67 (ddd, J = 16.6, 10.2, 10.2 Hz, 1H), 6.05 (dd, J = 11.2, 11.2 Hz, 1H), 5.46 (dd, J = 
18.1, 8.3 Hz, 1H), 5.21 (d, J = 17.1 Hz, 1H), 5.11 (d, J = 10.2 Hz, 1H), 4.26 (dd, J = 11.7, 
4.9 Hz, 1H), 4.01 (br s, 1H), 3.75 (ddd, J = 14.2, 12.2, 4.9 Hz, 1H), 3.68 (ddd, J = 11.2, 
6.4, 4.9 Hz, 1H), 3.60 (ddd, J = 10.8, 7.3, 5.4 Hz, 1H), 3.56-3.52 (m, 1H), 3.34-3.21 (m, 
4H), 3.15 (dd, J = 12.2, 3.9 Hz, 1H), 2.36-2.28 (m, 2H), 2.20-1.50 (m, 18H), 1.50-1.37 
(m, 3H), 1.27 (s, 3H), 1.15 (s, 3H), 1.11 (s, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.95 (s, 9H), 
0.87 (s, 9H), 0.10 (s, 6H), 0.09 (s, 3H), 0.08 (s, 3H); 
13
C NMR (100 MHz, CDCl3) " 
132.7, 132.1, 129.6, 117.1, 86.9, 86.2, 85.2, 82.0, 78.4, 77.2, 76.1, 75.5, 73.2, 72.4, 72.3, 
62.8, 49.2, 37.7, 37.6, 34.8, 33.8, 33.4, 30.5, 30.4, 30.0, 29.7, 28.7, 25.9, 25.7, 24.7, 23.9, 
20.5, 18.1, 18.0, 16.2, 12.5, -2.0, -2.2, -4.3, -5.0; IR (neat) 3421, 2929, 2854, 1733, 1464, 
1377, 1253, 1216, 1083 cm
-1





Preparation of brevenal 2.4 . To the solution of the primary alcohol 2.133  
(4.2 mg, 5.2 µmol) in CH2Cl2 (0.6 mL) and DMSO (0.2 mL) at 0 °C were added Et3N (62 
µL, 0.447 mmol) and SO3•Py (35.4 mg, 0.224 mmol). The resulting mixture was stirred 




















phase was extracted with CH2Cl2 (3 x 5 mL) and the combined extracts were dried 
(Na2SO4) and concentrated. The resulting residue that contained aldehyde 2.134  was 
passed through a sílica gel plug and used for the next step without further purification.  
To the solution of the phosphonate 2.135 (92.3 mg, 0.349 mmol) in THF (0.3 
mL) at -78 °C was added nBuLi (0.11 mL of a 2.5 M solution in THF, 0.28 mmol). After 
stirring for 10 min at -78 °C, the mixture was warmed to 0 °C and stirred for an 
additional 50 min. The reaction mixture was then cooled back to -78 °C and added a 
precooled (-78 °C) solution of the aldehyde 2.134 (5.2 µmol) obtained from above in 
THF (1.0 mL). The resulitng mixture was slowly warmed to rt and stirred for 26 h before 
it was quenched with sat. NH4Cl (aq., 5 mL). The aqueous phase was extracted with ethyl 
acetate (3 x 5 mL) and the combined extracts were dried (Na2SO4) and concentrated. 
Flash chromatography (30:1 hexanes:ethyl acetate) provided 4.0 mg of 2.136 as a 
colorless oil (85%, 2 steps).  
To a solution of 2.136 (2.4 mg, 2.6 µmol) in THF (0.2 mL) at 0 °C was added 
HF•Py (0.1 mL, 6 mmol). After 3 h, the reaction mixture was poured into a precooled (0 
°C) solution of sat. NaHCO3 (aq., 30 mL). The aqueous phase was extracted with ethyl 
acetate (3 x 5 mL) and the combined extracts were dried (Na2SO4) and concentrated. The 
residue was passed through a plug of silica gel to give a diol that was used in the next 
step without further purification. 
To a solution of the diol from above in CH2Cl2 (0.5 mL) at -78 °C was added 
iBu2AlH (10 µL of 1.0 M solution in hexanes, 10.0 µmol). The reaction mixture was 
stirred at -78 °C for 15 min before the reaction was quenched with sat. NH4Cl (aq., 5 
mL). The aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the combined 
! 135 
extracts were dried (Na2SO4) and concentrated. The resulting residue which contained the 
corresponding triol was used directly in the subsequent oxidation reaction.  
To a solution of triol from above in CH2Cl2 (0.5 mL) at rt was added MnO2 (4.0 
mg, 46 µmol). After stirring for 10 min, the mixture was directly loaded onto a silica gel 
column. Flash chromatography (2:1 hexanes:ethyl acetate) provided brevenal 2.4 as a 
colorless oil (1.4 mg, 80% 3 steps). Rf 0.45 (1:1 hexanes:ethyl acetate); [!]D
20
 = -28.6° (c 
= 0.07, benzene); 
1
H NMR (500 MHz, C6D6) " 10.09 (d, J = 6.8 Hz, 1H), 6.78 (ddd, J = 
16.6, 11.0, 11.0 Hz, 1H), 6.15 (d, J = 7.5 Hz, 1H), 6.09 (dd, J = 10.6, 10.6 Hz, 1H), 5.82 
(dd, J = 7.0, 7.0 Hz, 1H), 5.46 (ddd, J = 10.5, 8.6, 8.6 Hz, 1H), 5.17 (d, J = 16.6 Hz, 1H), 
5.06 (d, J = 10.0 Hz, 1H), 4.08 (br s, 1H), 4.01 (dd, J = 10.7, 6.1 Hz, 1H), 3.71 (ddd, J = 
11.5, 11.5, 5.4 Hz, 1H), 3.46 (dd, J = 9.7, 2.0 Hz, 1H), 3.35 (ddd, J = 7.3, 7.3, 7.3 Hz, 
1H), 3.29 (d, J = 9.3 Hz, 1H), 3.21-3.16 (m, 2H), 2.95 (dd, J = 12.2, 3.2 Hz, 1H), 2.38-
2.30 (m, 4H), 2.30-2.20 (m, 1H), 2.19-2.09 (m, 3H), 2.07-1.96 (m, 1H), 1.96-1.82 (m, 
2H), 1.80 (s, 3H), 1.80-1.71 (m, 4H), 1.71-1.56 (m, 4H), 1.56 (s, 3H), 1.56-1.40 (m, 4H), 
1.19 (s, 3H), 1.14 (s, 3H), 1.13-1.07 (m, 1H), 0.98 (s, 3H), 0.97 (d, J = 9.7 Hz, 3H), 0.55 
(br s, 1H); 
13
C NMR (125 MHz, C6D6) " 190.7, 156.3, 135.9, 134.6, 133.0, 132.7, 130.2, 
126.1, 117.3, 87.4, 86.2, 84.8, 82.0, 77.3, 76.8, 76.5, 75.1, 74.1, 73.7, 70.9, 70.0, 47.9, 
38.6, 37.7, 35.4, 34.6, 33.5, 32.7, 30.7, 29.9, 29.4, 26.5, 25.2, 23.6, 19.4, 16.2, 14.0, 13.8, 
12.9; IR (neat) 3463, 2985, 1742, 1661, 1618, 1448, 1374, 1242, 1093, 1048 cm
-1
; ESI-
TOF/HRMS (m/z) calcd for C39H60O8Na 679.4186 (M+Na
+
), found 679.4200. 
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Preparation of brevenal analogue 2.139 . 2.139  was prepared from 2.120  
according to the same procedures that were used to convert 2.132  to 2.4 (51% 6 steps). 
Rf 0.40 (1:1 hexanes:ethyl acetate); [!]
20
D = -25.0° (c = 0.10, CHCl3); 
1
H NMR (500 
MHz, C6D6) " 10.10 (d, J = 7.6 Hz, 1H), 7.35-7.30 (m, 2H), 7.20-7.15 (m, 2H), 7.10 (t, J 
= 7.1 Hz, 1H), 6.14 (d, J = 7.0 Hz, 1H), 5.82 (dd, J = 7.0, 7.0 Hz, 1H), 5.52 (br s, 1H), 
5.12 (br s, 1H), 4.40 (d, J = 12.4 Hz, 1H), 4.35 (d, J = 12.2 Hz, 1H), 4.06 (br s, 1H), 4.00 
(dd, J = 11.0, 5.9 Hz, 1H), 3.70 (ddd, J = 11.0, 9.7, 4.4 Hz, 1H), 3.47-3.34 (m, 4H), 3.29 
(d, J = 9.0 Hz, 1H), 3.21-3.16 (m, 2H), 2.93 (dd, J = 12.2, 3.9 Hz, 1H), 2.36-2.30 (m, 
2H), 2.30-2.20 (m, 2H), 2.18-1.80 (m, 6H), 1.80 (s, 3H), 1.79-1.60 (m, 7H), 1.60-1.56 
(m, 2H), 1.56 (s, 3H), 1.56-1.20 (m, 4H), 1.18 (s, 3H), 1.11 (s, 3H), 1.01 (s, 3H), 0.96 (d, 
J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, C6D6) " 190.7, 156.3, 139.5, 135.9, 134.6, 126.1, 
115.0, 88.6, 86.3, 84.8, 82.1, 77.3, 76.8, 76.5, 75.1, 74.2, 73.8, 73.2, 70.9, 69.9, 47.9, 
38.6, 37.7, 35.4, 34.6, 33.5, 32.7, 30.1, 29.8, 29.5, 27.9, 27.8, 26.5, 23.6, 19.4, 16.1, 14.0, 
13.8, 12.9; IR (neat) 3456, 3058, 2986, 1736, 1659, 1446, 1374, 1246, 1095, 1047 cm
-1
; 
ESI-TOF/HRMS (m/z) calcd for C43H64O9Na 747.5 (M+Na
+
), found 747.4. 
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CHAPTER 3 
 
EFFORTS TOWARDS THE SYNTHESIS OF  
YESSOTOXIN AND ADRIATOXIN 
 
Introduction 
Yessotoxins (YTXs) are a class of structurally related compounds that belong to 
the marine polycyclic ether natural product family.
1,2 
The parent compound of this class, 
yessotoxin (YTX, 3.1 , Figure 3.1) was first isolated in 1987 by Yasumoto and co-
workers from the digestive gland of the scallop Patinopecten yessoensis collected in 
Mutsu Bay, Japan.
3
 Later it was found that YTX is actually produced by phytoplanktonic 
dinoflagellates Protoceratium reticulatum, Lingulodinium polyedrum, and Gonyaulax 

























































relative  stereochemistry  of  YTX was  determined using  extensive nOe studies,
5
 and the 
absolute configuration was subsequently assigned using a chiral anisotropic reagent in 
NMR studies.
6
 To date, there are about 100 YTX analogues that have been reported from 
both shellfish and dinoflagellates, however, only about 40 of them have been identified 
and characterized.
2b
 It has been suggested that some YTXs are directly synthesized by 
dinoflagellates while others are shellfish metabolism products.
7
 
YTXs were originally classified as diarrhetic shellfish poisoning (DSP) toxins 
because they are often concomitantly extracted with other DSP toxins such as okadaic 
acid (OA) and dinophysistoxins (DTXs), and give positive results when tested in 
conventional bioassays for DSP toxins.
8
 However, recent evidence has suggested that 
YTXs should be excluded from the DSP toxins because they do not cause diarrhea or 
inhibit protein phosphatases as OA and DTXs.
9
 Although about 40 YTXs have been 
already identified and characterized, only very few of them have undergone thorough 
toxicological studies. As a result, the toxicological potential of YTXs is still not fully 
understood.  
YTX (3.1) is highly toxic by intraperitoneal injection (i.p.) to mice with LD50 
ranging from 80-750 µg/Kg depending on experimental conditions.
9,10
 The symptoms 
exhibited by mice injected with lethal dose of YTX include dyspnea, restlessness, 
shivering, and cramps, which are similar to those caused by paralytic shellfish poisoning 
(PSP) toxins. The target organ of YTX appears to be the cardiac muscle, where it induces 
ultrastructural changes.
9,10b
 It has also been reported that YTX produces neuronal damage 
in the brain and causes inflammatory response in the duodenum and thymus of mice.
11
 
However, contrary to the high toxicity observed in the i.p. experiments, YTX is not lethal 
! 142 
to mice after either acute oral administration at doses up to 54 mg/kg or repeated oral 
administration at 2 mg/kg/day for 7 days.
12
 Neither diarrhea nor damages of main organs 
have been observed. The vast difference between the i.p. and oral toxicity suggests that 
even though YTX is potentially toxic for humans, it is poorly absorbed in the 
gastrointestinal tract. 
In vitro studies have shown that YTX can induce apoptotic cell death in different 
types of cells, such as human Hela cells, human neuroblastoma cells, and rodent myoblast 
cells by activating different caspase isoforms.
13
 Even though several possible modes of 
action of YTX have been proposed, a precise mechanism of action is still missing. It has 
been suggested that YTX acts as a mitochondrial permeability transition pore (PTP) 
opener and causes mitochondrial membrane depolarization, thus leading to cell 
apoptosis.
14
 In addition, there is evidence suggesting that lysosomes are one of the 
cellular components that are involved in YTX-induced cell death as well.
15
  
Interestingly, unlike other marine polycyclic ether natural products such as the 
brevetoxins and ciguatoxins, which exert potent neurotoxicity by binding to site 5 of 
voltage gated sodium channels (VGSC) on excitable membranes, VGSC appear not to be 
involved in YTX-induced cell death.
16
 However, it seems YTX can exert a modest, and 
probably indirect effect on voltage-sensitive calcium channels and modulate the calcium 
homeostasis in both human lymphocytes and rat cerebellar neurons.
16b,17
 It has also been 
shown that calcium movements induced by YTX was not the cause of YTX-induced cell 
death, since in the presence of calcium channel blockers apoptosis still occurred.
16b
 
In another assay conducted by Rossini and co-workers, YTX was shown to be 




 E-cadherins are calcium-dependent transmembrane proteins 
that are involved in cell-cell and cell-substrate adhensions. Altered E-cadherins 
expression has been associated with tumor spreading and metastasis formation in human 
cancers.
19
 Thus YTX-induced disruption of E-cadherin degradation has raised some 
concern that YTX may cause the loss of the tumor-suppressing function of E-
cadherins.
12d
 It was suggested by Rossini and co-workers that YTX affects the 
degradation pathway of E-cadherin by inhibiting the internalization and complete 
degradation of E-cadherin fragments, either through direct interaction or alteration of 
effectors located on the plasma membrane.
18b
 The author also proposed that YTX-
induced cell death might be a secondary consequence stemming from the alteration of 
endocytosis and turnover of some plasma membrane proteins other than E-cadherins.
18c
 
Despite the recent progress in the toxicological studies, the full toxicological 
potential of YTXs remains to be fully elucidated. For instance, in vivo toxicity studies in 
animals other than mice, as well as pharmacokinetic studies regarding absorption and 
accumulation of YTXs are still lacking. The inadequate supply of YTXs remains a 
constraint for further biological testing despite the identification of their source 
organisms. Thus, a number of research groups including ours have become interested in 
pursuing the chemical synthesis of YTXs.  
Structurally, YTX contains an array of 11 trans-fused ether rings with a triene side 
chain and two sulfate ester groups. The undecacyclic core of YTX is decorated with five 
methyl groups, four of them being angular, and consists of a very challenging 7-6-8 EFG 
ring substructure. Thus, from a synthetic point of view, YTX is a highly intriguing target. 
! 144 
Although there have been no total syntheses of YTX or its analogue so far, syntheses of 
fragments of YTX have been reported.
20,21,22,23
 
During our synthetic program towards the total syntheses of YTX and its 
analogues, one specific analogue named adriatoxin (ATX, 3.2 , Figure 3.2) emerged 
above the others. ATX was first isolated in 1998 by Fattorusso and co-workers from the 
digestive glands of DSP-infested mussel Mytilus galloprovincialis collected in the 
Adriatic Sea.
24
 Structurally, the polycyclic backbone of ATX is identical to that of the A-
J ring system of YTX, only lacking the K-ring and the triene side chain. The biological 
activity of ATX is fundamentally unknown, except that the original isolation paper 
mentioned that ATX is slightly less toxic than YTX in a mouse assay. The very limited 
availability of ATX from the natural source has hindered the authors from further 
biological studies. It is for this reason, and because ATX represents a truncated and 
simplified analogue of YTX, that we decided to choose it as an initial synthetic target in 
our early stage studies to test our synthetic strategies. Due to the high structural 
similarities between ATX and YTX, we believe the information gathered from the ATX 
synthetic study should be applicable to the synthesis of YTX as well.  
 
 














































Previous Synthetic Studies Towards Yessotoxin and Adriatoxin 
No total synthesis of ATX has been reported to date. However, various fragments 
of ATX have already been synthesized. There are four other research groups that are 





 the Kadota group,
22
 and the Oishi group.
23
 The following is a brief 





Nakata’s Synthesis of the A-F Ring System of YTX/ATX 
In 2002, Nakata and co-workers reported their synthesis of the A-F ring system of 
YTX/ATX utilizing a convergent coupling strategy. The two coupling partners, alkyne 
3.4  and triflate 3.6 , can be synthesized from 2-deoxy-L-ribose (3.3) and 2-deoxy-D-
ribose (3.5) respectively (Figure 3.3). Nakata and co-workers employed a SmI2-induced 
radical cyclization and 6-endo epoxide opening reaction to construct the D-F ring 
coupling precursor 3.6 .
20
 Treatment of primary triflate 3.6  with the lithium acetylide 
generated from terminal alkyne 3.4 resulted in the formation of an internal alkyne, which 
after removal the acetonide protecting group and reprotection with TBS groups afforded 
alkyne 3.7 . The alkyne was subsequently oxidized using RuO2 and NaIO4 to give 
diketone 3.8 . When 3.8  was subjected to CSA and CH(OMe)3 in refluxing methanol, 
diketal 3.9 was formed, which was successfully reduced using Et3SiH and TMSOTf to 
give the A-F ring system of YTX/ATX 3.10 . 
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Mori’s Synthesis of the A-F Ring System of YTX/ATX 
Mori and co-workers have achieved the synthesis of the A-F ring system of 
YTX/ATX using two different strategies; one iterative
21b
 and one convergent.
21c
 Mori 
and co-workers began their iterative synthesis from D-glucose (3.11), which was 
converted into triflate 3.12  in twelve steps (Figure 3.4). Treatment of 3.12  with the 
sulfonyl-stabilized oxiranyl anion generated from 3.13  led to the formation of epoxide 
3.14 .
25
 When 3.14  was exposed to acid, desilylation and subsequent stereospecific 6-
endo cyclization proceeded smoothly to give the B ring of YTX/ATX as ketone 3.15 , 
which was then converted into another triflate 3.16  in three steps. The five-step reaction 
sequence was applied three times consecutively to generate pentacyclic ketone 3.17 . The 
seven-membered E ring of YTX/ATX was formed through a ring-expansion reaction 
from 3.17 using TMSCHN2 and BF3•OEt2. Primary triflate 3.19  was obtained in 
another five steps from 3.17 , and was subjected to the oxiranyl anion coupling reaction 
again. Subsequent acid-promoted cyclization gave ketone 3.21 , which was converted 
into the A-F ring system of YTX/ATX 3.22  in two steps. Although this iterative strategy 
was conceptually very simple and efficient, Mori and co-workers felt that the length of 
this synthesis had comprised its efficiency. They later adopted a revised and more 
convergent approach that was very similar to Nakata’s to construct the A-F ring system 























































































































































nBuLi, THF, HMPA, -100 oC, 90%
Me
i.



























































Kadota’s Synthesis of the A-F ring systems of YTX/ATX 
Along their pursuit of total synthesis of YTX/ATX, Kadota and co-workers have 
synthesized three individual fragments, the A-F and F-I ring systems of YTX/ATX and 
the I-K ring system of YTX.
22
 Central to their synthesis of the A-F and F-I fragments is 
an intramolecular allylation of an !-acetoxy ether and ring-closing metathesis sequence 
on top of a convergent coupling strategy, while a linear approach was employed in their 
synthesis of the I-K fragment of YTX.  
The convergent synthesis of the A-F ring system from Kadota’s laboratory is 
shown in Figure 3.5. Both coupling partners were synthesized from 2-deoxy-D-ribose 
(3.5). Yamaguchi esterification was used to couple the two fragments to give ester 3.25 , 
which in five steps was converted into allyl stannane 3.26 . Half reduction of the ester 
and a subsequent quench with chloroacetic anhydride gave stannyl !-acetoxy ether 3.27 , 
which upon treatment with BF3•OEt2, afforded the D ring of YTX/ATX 3.28 as a single 
stereoisomer. Subsequent ring-closing metathesis using Grubbs’ 1
st
 generation catalyst 
3.29 furnished the E ring and completed the synthesis of the A-F ring system of 
YTX/ATX 3.30 . Kadota’s synthesis of the F-I ring system of YTX/ATX adopted the 
same coupling strategy as in the A-F ring system, and their synthesis of the I-K ring 





Oishi’s Synthesis of the A-J Ring System of YTX 
The first report towards the synthesis of YTX/ATX from Oishi’s group appeared 
in 2005, which described their synthesis of the F-I ring system.
23a
  They have followed up 
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DIBAL-H, CH2Cl2, -78 
oC;
(ClCH2CO)2O, pyridine




with their syntheses of the A-C and C-F of YTX/ATX together with the IJ and JK ring 
system of YTX.
23b-d
 In 2008, they managed to put these fragments together to achieve the 
synthesis of the A-J ring system of YTX,  which consists of all the ring structures of ATX 
and is only one ring short from the ring structure of YTX.
23e
 The retrosynthetic analysis 
is shown in Figure 3.6. Oishi and co-workers have proposed a highly convergent strategy 
utilizing their !-cyano ether methodology based on the coupling between A-C ring 
aldehyde 3.32 and  F-J ring diol  3.33 . Diol 3.33  in  turn would  be obtained from the F 
 
 


















































































































29 steps to 3.32
23 steps to 3.34
27 steps to 3.35
metathesis cyclization
! 152 
ring diol 3.34  and the IJ ring aldehyde 3.35 using the same methodology. Interestingly, 
all of the three building blocks could be generated from 2-deoxy-D-ribose (3.5).
23b,c,26 
 
The coupling of diol 3.34  and aldehyde 3.35  was achieved using Sc(OTf)3 to 
give the cyclic acetals as a diastereomeric mixture at C28 (Figure 3.7).  Regioselective 
opening of the acetals using TMSCN and Sc(OTf)3 afforded !-cyano ether 3.37 , which 
was converted into aldehyde 3.38  in three steps. Vinyl addition to 3.38  generated diene 
3.39 as a mixture of four diastereomers. When 3.39 was subjected to Grubbs’ 2
nd
 
generation catalyst 3.40 , the eight-membered G ring of YTX was formed successfully. 
The mixture of diastereomers was subsequently converted into one single compound 
3.42 after four steps. After a stereoselective methylation at C26, an impressive reductive 
cyclization from the TES-protected hydroxy ketone successfully afforded the H ring. 
Removal of the silyl protecting groups then furnished the F-J ring coupling parnter 3.33 . 
The Sc(OTf)3-promoted coupling between A-C ring aldehyde 3.32  and F-J ring 
diol 3.33  proceeded smoothly to give cyclic acetal 3.43 , which was then converted into 
!-cyano ether 3.44  as a diastereomeric mixture at C15 (Figure 3.8). Using the same 
strategy as before, 3.44  was converted into diene 3.45  in five steps. Ring-closing 
metathesis with Grubbs’ 2
nd
 generation catalyst 3.40 successfully afforded the E ring of 
YTX, which after oxidation, hydrogenation, and equilibration at C15 furnished the ketone 
3.46  as a single compound. Finally, removal of the NAP group, reductive cyclization, 
and deprotection of the silyl groups gave the A-J ring system of YTX 3.31 .  
Oishi’s synthesis of the A-J ring system of YTX is highly convergent and has 
demonstrated the power of their !-cyano ether methodology in the synthesis of 
polycyclic ether natural products.  
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i. LiHMDS, MeI, THF, -78 oC     -30 oC, 73%
ii. Et3SiH, TMSOTf, CH2Cl2, -75 
oC     -52 oC


















































































































































































































































i. 3.40, toluene, 110 oC, 71%
ii. DMP, CH2Cl2, 92%
iii. H2, PtO2, EtOAc; DMP, CH2Cl2
iv. DBU, p-xylene, 138 oC
i. DDQ, CH2Cl2/H2O, 73%
ii. Et3SiH, BF3•OEt2, CH2Cl2
-30 oC     -10 oC,














































































































-19 oC      10 oC;
81% 2 steps
! 155 
Results and Discussions 
As mentioned earlier, as a starting point of our synthetic program toward YTXs, 
we chose ATX as our synthetic target since it represents a truncated and simplified 
analogue of YTX. Even so, ATX is still a very challenging synthetic target considering 
its decacyclic trans-fused polyether ring system, 24 stereocenters, and 4 angular methyl 
groups. Thus at the outset of our synthesis of ATX, we realized that a convergent strategy 
had to be used due to its structural complexity. Shown in Figure 3.9 is our retrosynthetic 
analysis of ATX.  
 
 































































































We envisioned that ATX would come from the coupling of three bicyclic 
substructures of similar size 3.47 , 3.48 , and 3.49 , representing the AB, EF, and IJ ring 
fragments respectively. Based on the coupling strategy shown in Figure 1.21, we expect 
that two additional rings will be generated after pairing of two subunits. Because of the 
lynchpin nature of the EF ring system, the structure of 3.48 is designed in a way that 
both sides are properly functionalized and can be flexibly modified to couple with either 
AB or IJ ring systems. All of the three subunits 3.47 , 3.48 , and 3.49  can be obtained 
from simple saccharides, and their syntheses have been previously carried out by Dr. 




Synthesis of the AB Ring Fragment 3.47 
Our synthesis of the AB ring fragment of ATX 3.47 commenced from 2-deoxy-
D-ribose (3.5 , Figure 3.10), which was converted into triol 3.52  using a Wittig 
olefination.
32
 The two stereocenters in 2-deoxy-D-ribose were transferred to become C3 
and C4 on the A ring of ATX. Selective protection of two of the three hydroxy groups 
was achieved using PhCH(OMe)2 to afford the secondary alcohol 3.53 , which was 
subsequently oxidized to give ketone 3.54 using Swern’s conditions.
33
 A stereoselective 
methyl Grignard addition to the ketone generated tertiary alcohol 3.55 , which was 
coupled with known acid 3.56
34
 to give ester 3.57 . When 3.57  was subjected to our 
modified Takai-Utimoto reaction conditions using dibromoethane as the titanium 
alkylidene source, olefinic ester cyclization proceeded smoothly to generate the A ring of 






Figure 3.10. Synthesis of the A ring of ATX 
 
With the A ring in hand, the stereochemistry at C7 was set utilizing a Lewis acid 
promoted pinacol-type rearrangement (Figure 3.11).
28
 A stereoselective oxidation of enol 
ether 3.58 with DMDO directed by the presence of the C3 methyl group afforded 
epoxide 3.59 . When the resulting epoxide 3.59  was subjected to MgCl2, oxocarbenium 
ion 3.60  was presumably formed, which underwent a syn-facial [1,2]-hydride shift to 
give ketone 3.61  as a single stereoisomer. It is noteworthy that because of the presence 
of the C3 methyl group, either hydroboration or the DMDO/iBu2AlH protocol would give 
the undesired stereochemistry at C7.  
The ketone obtained in the rearrangement was subsequently reduced using NaBH4 































































TiCl4, THF, TMEDA, Zn, PbCl2
















Figure 3.11. Pinacol-type rearrangement to set C7 stereochemistry 
 
refluxing chlorobenzene, was converted into enol ether  3.63   with the formation of the 
B ring of ATX(Figure 3.12).
27,36
  
Treatment of enol ether 3.63  with DMDO and subsequent allyl addition to the 
resulting epoxide generated a 2.3:1 mixture of secondary alcohols favoring the desired 
AB ring coupling precursor 3.47 . Though the selectivity was low, the undesired 
stereoisomer 3.64  could be recycled and converted into 3.47  using a three-step sequence 
involving oxidation, equilibration of the C9 stereocenter, and subsequent reduction. Thus, 
the functionalized AB ring system of ATX 3.47 was obtained in 13 steps from 2-deoxy-
D-ribose (3.5), which also serves as the only chirality source of the AB subunit.  
 
Synthesis of the EF Ring Fragment 3.48 
The synthesis of the EF ring system 3.48  commenced from D-mannitol (3.50), 
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i. SO3•Py, DMSO, Et3N, CH2Cl2
ii. DBU, toluene, 110 oC
iii. NaBH4, EtOH, -78 











i. Me2C(OMe)2, p-TsOH, DMSO, 58%
3.65
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i. PPTS, MeOH, 65 oC, 89%
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stereocenter in 3.65  would become the C15 of ATX. A chelation-controlled homoallylic 
Grignard addition to the aldehyde in the presence of ZnCl2 gave a 6:1 diastereomeric 
mixture favoring secondary alcohol 3.66 , which was converted into 3.67  after removal 
of the acetonide and benzylidene protection. Secondary alcohol 3.67  was subsequently 
coupled with known acid 3.68
37
 to give ester 3.69 , which when subjected to the reduced 
titanium ethylidene reagents, underwent olefinic ester cyclization to furnish the E ring of 
ATX as cyclic enol ether 3.70 .  
With the E ring enol ether in hand, oxidation with DMDO and in situ reduction of 
the resulting epoxide with iBu2AlH afforded secondary alcohol 3.71  as a single 
stereoisomer (Figure 3.14).
38,39
 Alcohol 3.71  was subsequently oxidized to ketone 3.72 , 
which upon treatment with the methyl Grignard reagent, afforded a 5:1 mixture of 
diastereoisomers favoring the desired tertiary alcohol 3.73 . When 3.73  was subjected to 
PPTS and pyridine in refluxing chlorobenzene, an acid-promoted cyclization proceeded 
smoothly to give the F ring of ATX as cyclic enol ether 3.74 .  
 
 














































































-78 oC, 92% 135 oC
PPTS
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  To convert 3.74  to the desired EF ring fragment 3.48 , a Claisen rearrangement 
was exploited to install the required stereochemistry (Figure 3.15).
29,31c
 Stereoselective 
epoxidation of the enol ether 3.74  directed by the C19 methyl group generated hydroxy 
ketal 3.75 as a 6:1 mixture at the anomeric C23. Subsequent allylation afforded 3.76 , 
which upon treatment with PPTS and pyridine in refluxing toluene, was converted into 
ketone 3.78  with high yield and excellent stereoselectivity presumably through the allyl 
vinyl ether intermediate 3.77 . The stereoselectivity in the Claisen rearrangement is 
believed to be a result of the allyl group adding from the face opposite to the C19 angular 
methyl group.
29
 Because of the presence of the C19 methyl group, the use of DMDO and 
allyl Grignard would have given the undesired stereochemistry at C23. Reduction of the 
ketone in 3.78 afforded the desired EF ring coupling precursor 3.48 . The functionalized 
EF ring system 3.48 was synthesized in 15 steps from D-mannitol (3.50), which was the 
only source of stereocenters. 
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Synthesis of the IJ Ring Fragment 3.49 
Our synthesis of the IJ ring fragment 3.49  commenced from D-glucal (3.51 , 
Figure 3.16). We envisioned that the pyran ring in 3.51 would become the I ring of 
ATX. Sequential silylene and benzyl ether formation afforded enol ether 3.79 , which 
was subjected to a stereoselective DMDO oxidation directed by the C32 benzyl ether. 
The resulting epoxide was then treated with allyl Grignard reagent to give secondary 
alcohol 3.80  as a single stereoisomer.
40
 After oxidation of alcohol 3.80 , methyl addition 
to the resulting ketone 3.81  using MeLi gave a 7:1 mixture favoring the desired tertiary 
alcohol 3.82 . To make the J ring, the tertiary alcohol on C33 was converted into a vinyl 
ether, which when subjected to Grubbs’ 2
nd
 generation catalyst 3.40 , underwent ring-
closing metathesis to give the J ring enol ether 3.84 .  
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With the J ring in place, we were ready to complete the synthesis of the IJ ring 
system 3.49 . A stereoselective epoxidation of the enol ether 3.84  with mCPBA directed 
by the C33 angular methyl group and subsequent ring opening of the resulting epoxide 
with methanol afforded acetal 3.85  as a 6:1 mixture at the anomeric position (Figure 
3.17). The resulting C36 alcohol was subsequently protected as the corresponding acetate 
3.86 . We believe that the C37 methyl acetal can be epimerized at a late stage in the 
synthesis of ATX.  
In order to synthesize the desired IJ ring coupling precursor, the stereocenter at 
C32 had to be inverted. To that end, the benzyl group was removed under hydrogenolysis 
conditions and the resulting alcohol was oxidized to the corresponding ketone 3.88 . 
Reduction with L-selectride successfully afforded the desired stereocenter at C32 through 
equatorial hydride delivery. The IJ ring fragment of ATX 3.49 was synthesized from D-
glucal in 12 steps. As with the other precursors, substrate control had been used to 
generate the IJ ring stereocenters.  
With the synthetic routes to the precursors established, we were able to obtain 
sufficient quantities of the AB, EF, and IJ ring systems of ATX and study the coupling 
chemistry. As mentioned earlier, the EF ring system in our retrosynthetic analysis acts as 
a lynchpin to connect the AB and IJ fragments. As the EF ring system 3.48  is properly 
functionalized for orthogonal coupling, we chose to initially test the coupling of the 





Figure 3.17. Synthesis of the IJ ring fragment of ATX 
 
Synthesis of the A-F Ring System of ATX 
As outlined in Figure 1.21, our proposed coupling strategy would involve an 
esterification between an acid and an alcohol. To meet this need, both structures of the 
obtained AB ring system 3.47 and the EF ring system 3.48  require modification. 
We decided to convert the AB fragment into acid 3.91 , while the EF fragment 
would be converted into alcohol 3.98 . To this goal, the secondary alcohol in 3.47  was 
protected as a TBS ether (Figure 3.18). Ozonolysis of the terminal alkene afforded 
aldehyde 3.90 , which was oxidized using Pinnick’s conditions to afford the AB ring 
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Figure 3.18. Synthesis of the AB coupling partner 3.91 
 
The synthesis of alcohol 3.98  began with a PMB ether formation of the 
secondary alcohol in 3.48 (Figure 3.19). Ozonolysis of the terminal alkene followed by 
reduction of the resulting aldehyde gave primary alcohol 3.93 , which was subsequently 
protected as a benzyl ether. The benzylidene protecting group on the E ring was removed 
using CSA in methanol to give diol 3.94 . Using a one-pot procedure, the primary alcohol 
in 3.94  was converted into a triflate, and the secondary alcohol was protected as TBS 
ether. When triflate 3.95  was subjected to lithium trimethylsilylacetylide, the primary 
triflate was substituted to afford internal alkyne 3.96 . After removal of both silyl 
protecting groups, partial hydrogenation using Lindlar’s catalyst in the presence of 
quinoline gave the EF ring coupling precursor 3.98 .
42
  
With both precursors in hand, we set out to test our coupling strategy (Figure 
3.20). Esterification between acid 3.91  and alcohol 3.98  proceeded smoothly under 
Yamaguchi’s conditions to give 3.99 .
43
 Once the olefinic ester 3.99  was subjected to 
our modified Takai-Utimoto reaction conditions using dibromoethane,
35
 cyclic enol ether 
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Figure 3.19. Synthesis of the EF ring coupling partner 3.98 
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under the reaction conditions and the reaction has to be quenched as soon as the starting 
material disappears. Significantly diminished yields were observed when the reaction was 
allowed to proceed for a logner periods of time.  
With the D ring in hand, DMDO oxidation of enol ether 3.100  and in situ 
reduction of the resulting epoxide with iBu2AlH afforded a separable 3:1 mixture of 
diastereomers favoring alcohol 3.101 that had the desired stereochemistry at C12 and 





J values after converting the obtained secondary alcohol 3.101  into the 
corresponding  acetate  3.102 .  The diastereomeric  alcohols  from  the  DMDO/iBu2AlH 
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81%
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step were separated and subsequently oxidized to the corresponding ketones. At this 
stage, the minor diastereoisomer could be recycled and converted into the desired ketone 
3.103  using DBU in refluxing toluene in 80% yield. 
With ketone 3.103 in hand, we set out to generate the C ring (Figure 3.22). The 
TBS group was removed using HF•Py, and the resulting hydroxy group simultaneously 
cyclized onto the ketone on the D ring to give hemiketal 3.104 . The disappearance of the  
 
 





















































































































ketone signal in both 
13
C NMR and IR supported this structure. Treatment of hemiketal 
3.104  with Zn(OTf)2 and EtSH in refluxing dichloromethane afforded O,S-mixed ketal 
3.105  with concomitant removal of the benzylidene and the PMB protection groups. The 
two A-ring hydroxy groups were subsequently reprotected using a cyclic silylene group 
to give alcohol 3.106 . When 3.106  was subjected to Ph3SnH and AIBN in refluxing 
toluene, we were pleased to find that the O,S-mixed ketal was successfully reduced to 
genaerate 3.107 , the hexacyclic A-F ring system of both ATX and YTX.  
To summarize, we have successfully synthesized the A-F ring system of ATX and 
YTX using our highly convergent strategy. The highlights in the synthesis include a high-
yielding esterification coupling step, a direct olefinic ester cyclization to generate the D 
ring, and an efficient radical reduction to make the C ring.  
 
Synthesis of the F-I Ring System of ATX 
When we set out to study the coupling of the EF and the IJ ring systems of ATX, 
we were aware of the difficulties associated with the formation of the eight-membered G 
ring. Based on the convergent coupling strategy shown in Figure 1.21, there were two 
options for us to construct the GH ring structure (Figure 3.23).  
One would involve the initial use of olefinic ester cyclization to make the six-
membered H ring followed by a reductive cyclization or mixed ketal radical reduction to 
form the eight-membered G ring. The advantage of this route is that six-membered ring 
formation from an olefinic ester cyclization was well documented and usually high 
yielding. The concerns about this approach were the stereoselective installment of the 
C26 methyl group and the feasibility of  formation of the G ring. Although both Nicolaou 
! 170 
 
Figure 3.23. Synthetic options for E-J ring system of ATX 
 
and Crimmins had generated related eight-membered ether ring structures in their 
syntheses of brevetoxin A, the presence of a cis-olefin in the backbone is always required 
to facilitate the cyclization.
44
 To the best of our knowledge, cyclization of structures with 
saturated backbones such as 3.109  to generate eight-membered ether rings has not been 
reported.  
The other option was to employ olefinic ester cyclization to form the eight-
membered G ring, and a subsequent cyclization to generate the six-membered H ring. 
The concern with this approach was that there were no reports of eight-membered cyclic 
enol ether formations using olefinic ester cyclization or olefinic enol ether cyclization in 
the literature. In our unpublished work obtained by Dr. Jie Zhou,
45
 we had demonstrated 
that eight-membered cyclic enol ethers could be successfully generated using our 
modified Takai-Utimoto protocol. However, the reaction was substrate-dependent and, 
























































































in the substrate. In addition, the substrates that Dr. Zhou tested were significantly less 
complex than the substrate needed for the synthesis of ATX. Thus, it still remained a 
significant question as to whether the eight-membered G ring could be generated using an 
olefinic ester cyclization. On the other hand, if the proposed G ring formation were 
successful, the advantage of this route would include a possible stereoselective 
installment of the C26 methyl group under substrate control and a facile late-stage 
cyclization to make the six-membered H ring. It is for these reasons and the desire to 
push forward the development of the olefinic ester cyclization methodology that we opted 
to pursue the second approach for the synthesis of the E-J ring system of ATX. Herein 
are reported our preliminary results leading to the successful synthesis of the F-I ring 
system of ATX and YTX. 
To carry out the strategy outlined above, both the EF and the IJ ring systems 
required modification. From the previously described intermediate 3.92 , bis-
homologation of the alkene followed by removal of the PMB group afforded the desired 
EF ring alcohol coupling precursor 3.112 (Figure 3.24).  
 
 












i. BH3•DMS, THF, 0 oC;
NaOH, H2O2, 0 oC     rt, 62%
ii. NMO, TPAP, 4Å MS, CH2Cl2











i. BH3•DMS, THF, 0 oC; NaOH, H2O2, 0 oC     rt, 73%
ii. NMO, TPAP, 4Å MS, CH2Cl2












iv. DDQ, CH2Cl2/H2O, 100%
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The previously described IJ ring precursor 3.49  was converted into the acid 
coupling partner 3.119 (Figure 3.25). The secondary alcohol was first protected as a 
TBS ether, and the acetate group on C36 was converted into a benzyl ether. Selective 
removal of the silylene group was achieved using HF•Py to give diol 3.114 . Conversion 
of the primary alcohol in 3.114 into a triflate and subsequent secondary TES ether 
formation afforded 3.115 . It is noteworthy that due to the steric environment at C31, the 
C31 hydroxy group in 3.114 could not be protected as a TBS ether. Treatment of 3.115  
with lithium  trimethylsilylacetylide successfully  generated  the desired  terminal alkyne, 
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however the TES ether on C31 underwent partial hydrolysis under reaction conditions. 
To facilitate the process, global silyl protecting group removal was accomplished using 
TBAF to afford diol 3.116 . Partial hydrogenation and reprotection of both alcohols as 
TBS ethers followed by ozonolysis and Pinnick oxidation gave the IJ ring acid coupling 
partner 3.119 .  
The coupling of alcohol 3.112  and acid 3.119  was achieved using Yamaguchi’s 
conditions (Figure 3.26). Disappointingly, when olefinic ester 3.120  was subjected to the 
modified Takai-Utimoto reaction conditions, only acyclic enol ether 3.121  was isolated 
in 65% yield. No desired cyclic enol ether product was observed. All efforts to convert 
the acyclic material 3.121 into the eight-membered G ring enol ether using ring-closing 
metathesis were futile due to problems associated with alkene isomerization. 
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TiCl4, CH2Cl2, THF, TMEDA
Zn, PbCl2, CH3CHBr2, 65 
oC, 65%
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At that point, we suspected that the steric environment around the I ring in 3.119 
due to the two TBS groups was prohibiting the formed terminal titanium alkylidene 
species from cyclizing onto the ester carbonyl. Moreover, we were concerned that the 
acetal group on the J ring might be too vulnerable for further manipulations. So we 
decided to employ an alternate I ring system 3.131 instead of 3.119 to further study the 
olefinic ester cyclization. The new I ring system would be less stereically congested and 
would have a side chain that we envisioned could be converted into the J ring at a later 
stage in the synthesis.  
Using a similar strategy for synthesizing 3.119, the synthesis of 3.131 is shown 
in Figure 3.27. From known compound 3.122 ,
46
 the secondary alcohol was converted 
into a tertiary alcohol through oxidation and methyl addition, which was followed by 
deprotection of the PMB group and oxidation to give hydroxy ketone 3.124 . After 
protection of the tertiary alcohol as a TMS ether, reduction of the ketone with L-
selectride afforded alcohol 3.125 . Hydroboration of the alkene and oxidative work-up 
concomitantly removed the TMS group to give triol 3.126 . Tris-benzyl ether formation 
and removal of the silylene group generated diol 3.127. One-pot primary triflate and 
secondary TES ether formation was followed by acetylide substitution and subsequent 
treatment with TBAF to afford hydroxy alkyne 3.129 . Reprotection of the alcohol as a 
TES ether and partial hydrogenation of the alkyne followed by ozonolysis and Pinnick 
oxidation generated the I ring system 3.131 .  
Prior to examining the eight-membered cyclic enol ether formation with the new I 
ring system, we felt that the previous EF ring coupling precursor 3.112 , which was 
obtained in  23 steps from D-mannitol, was too valuable for our model study.  As a result, 
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Figure 3.27. Synthesis of the I ring coupling partner 3.131 
 
a simpler compound  3.142   that  consisted of  the  F ring of  ATX was  synthesized  and 
employed (Figure 3.28). The left side of 3.142  was properly functionalized so that the E 
ring could be generated at a later stage.  
From the previous intermediate 3.55 , acetylation led to the formation of 3.132 , 
which upon treatment with the reduced titanium ethylidene reagent afforded the F ring of 
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i. BH3•DMS, THF, 0 oC;
NaOH, H2O2, 0 oC     rt
ii. NMO, TPAP, 4Å MS, CH2Cl2
iii. Ph3PCH3Br, tBuOK, THF
55% 3 steps
0 oC    rt, 86%
CH2Cl2/H2O
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obtained from 3.133 in three steps as a single stereoisomer. Reduction of the ketone and 
subsequent protection of the resulting alcohol as PMB ether afforded alkene 3.138 . Bis-
homologation of the alkene gave 3.140 . At this point, we converted the benzylidene 
protecting group into its p-methoxy benzylidene analogue. The benzylidene acetal in 
3.140 was removed using CSA in methanol. Subsequent removal of the PMB group 
afforded triol 3.141 , which was reprotected using anisaldehyde dimethylacetal and CSA 
to give the F ring alcohol coupling partner 3.142 . 
With both the new acid and alcohol coupling partners 3.131 and 3.142 , we 
attempted again the eight-membered cyclic enol ether formation using olefinic ester 
cyclization (Figure 3.29). Yamaguchi esterification proceeded smoothly to give olefinic 
ester 3.143 . When 3.143 was subjected to the modified Takai-Utimoto conditions, to 
our great pleasure, the desired eight-membered cyclic enol ether 3.144  was generated in 
40% yield along with 56% of the corresponding acyclic enol ether 3.145 . This result was 
in sharp contrast with our previous results shown in Figure 3.26, where no cyclic enol 
ether was obtained.  
Pleased as we were, we were very curious about the reason behind these vastly 
different results. Since the right side of the F ring systems in both 3.112 and 3.142 
where the cyclizations took place were identical, it seemed that the steric environment 
difference on the I rings in 3.119 and 3.131 was the cause of the different cyclization 
outcome. To test this argument, a control experiment was performed using the new I ring 
acid coupling partner 3.131  and the previous EF ring alcohol coupling partner 3.112 
(Table 3.1, entry 1). Interestingly, under the same reaction conditions, the eight-
membered cyclic enol ether product was obtained in 22% yield  together with 55% of  the 
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Figure 3.29. Synthesis of the G ring of ATX 
 
acyclic product from olefinic ester 3.146 .  This result implied that the steric environment 
on the I ring did play an important role in this particular cyclization. However, the lower 
yield of the cyclic product in this reaction comparing to the one shown in Figure 3.29 
(22% vs 40%) also suggested the F ring system 3.142  had a higher tendency to cyclize 
under the reaction conditions than the previous EF ring system 3.112 .  
Intrigued by the different reactivity outlined above, we also examined substrates 
having different protecting groups on the F ring (Table 3.1, entry 2-4). To our 
disappointment, no significant increase in yield of the eight-membered cyclic enol ether 
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Although the 40% yield was not ideal, we decided to carry the obtained eight-
membered G ring enol ether 3.144 on to explore the formation of the six-membered H 
ring (Figure 3.30). Starting from the G ring enol ether 3.144 , oxidation with DMDO and 
in situ reduction of the resulting epoxide with iBu2AlH afforded the corresponding 
secondary alcohol. Oxidation using Ley’s conditions gave ketone 3.150  as a single 
stereoisomer. We believe the stereoselectivity in the DMDO oxidation comes from the 
presence of the C23 methyl group. Borrowing from Oishi’s synthesis of the A-J ring 
system of YTX, a kinetically controlled methylation with LiHMDS and MeI 
stereoselectively installed  the C26 methyl group to give 3.151 .
23a
  Having  the  requisite 
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functionality in place, we planned to employ an O,S-mixed ketal radical reduction to 
form the H ring as in our synthesis of the A-F ring system of ATX. Surprisingly however, 
neither  HF•Py  nor  TBAF  led  to a clean  removal  of  the  TES  group.  Finally, a direct 
reductive cyclization of the TES-protected hydroxy ketone 3.151 using TMSOTf and 
Et3SiH successfully afforded the desired H ring with concomitant removal of the p-
methoxy benzylidene group to give diol 3.152 .
24e
 When a benzylidene group rather than 
a p-methoxy benzylidene was used on the F ring, it could not be cleanly removed under 
the reductive cyclization conditions, giving instead a mixture of benzyl protected 
alcohols. The formation of diol 3.152 represented a synthesis of the F-I ring system of 
ATX, and since the A-I ring structure of ATX is identical to YTX, it also represents a 
synthesis of the F-I ring system of YTX. 
To summarize, we have successfully synthesized the F-I ring system of ATX and 
YTX using a highly convergent strategy that employs an olefinic ester cyclization to form 
the eight-membered G ring. Although further studies on the formation of eight-membered 
cyclic enol ethers using olefinic ester cyclization are certainly needed, the synthesis 
process has provided us with useful information about the substrate scope of this 
methodology. Other highlights in this synthesis include a stereoselective installment of 
the C26 methyl group under substrate control and a highly efficient reductive cyclization 
to form the H ring.  
The future plan for the synthesis of the A-I ring system of ATX is shown in 
Figure 3.31. We envision that the E ring can be formed from the F-I ring diol 3.152  in 
three steps, and that the E-I ring coupling partner 3.154  will be generated using our C-
glycoside forming chemistry. Coupling the AB ring system 3.91  and the  E-I ring system 
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3.154  through esterification will give ester 3.155 , which will be converted to the A-I 
ring system 3.156 using the same reaction sequence as in our synthesis of the A-F ring 
system.  
The future plan to complete the total synthesis of ATX is shown in Figure 3.32. 
One carbon elongation on C2 and protecting group manipulation will give 3.157 , which 
will be subsequently converted to C37 acetal 3.158 .
47
 Removal of the benzyl groups and 
acid-promoted cyclization will give the J ring as enol ether 3.159 . Functionalization of 
the J ring, deprotection, and sulfate formation will furnish ATX (3.2). 
 
Conclusion 
In this chapter, we have described our syntheses of the A-F ring system and the F-
I ring system of ATX and YTX. Both syntheses employed a highly convergent coupling 
strategy, which relies on esterification to unify two subunits and subsequent olefinic ester 
cyclization. In addition, our iterative cyclic enol ether/C-glycoside formation sequence 
was extensively used in the synthesis of all three bicyclic coupling subunits. All the new 
stereocenters in the synthesis were generated using substrate control with the orginal 
stereocenters coming from the chiral pool.  
 
Experimentals 
NMR spectra were recorded on Varian Inova-400 MHz, Varian Inova-500 MHz 
or Varian VXR-500 MHz spectrometers. Chemical shifts were reported in !, parts per 
million (ppm), relative to benzene (7.16), chloroform (7.27), or dichloromethane (5.32) 
as  internal  standards. Coupling  constants,  J,  were  reported  in  Hertz (Hz) and  refer to 
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apparent peak multiplicities and not true coupling constants. Mass spectra were recorded 
at the Mass Spectrometry Facility at the Department of Chemistry of the University of 
Utah  at  Salt  Lake  City on  a  Finnigan  MAT  95  mass  spectrometer.  IR spectra  
wererecorded on a Bruker Tensor 27 FT-IR spectrometer. Optical rotations were obtained 
on a Perkin-Elmer Model 343 polarimerter (Na D line) using a microcell with 1 dm path 
length. Solvents were purified according to the guidelines in Purification of Common 
Laboratory Chemicals (Perrin, Armarego, and Perrin: Oxford, 1966).  Dichloromethane, 
2,6-lutidine, triethylamine, TMEDA, chlorobenzene and pyridine were distilled from 
CaH2. Tetrahydrofuran and diethyl ether were dried from the sodium ketyl of 
benzophenone and distilled before use. Zinc dust (<10 µm, Aldrich) was activated by 
washing with 5% hydrochloric acid, H2O, methanol, and ether and dried in vacuo 
overnight. All other reagents were used without further purification. Unless otherwise 
noted, all reactions were performed under a nitrogen atmosphere in flame-dried glassware 
using standard syringe, cannula, and septa apparatus. Concentration refers to removal of 
solvent under reduced pressure (house vacuum at ca. 20mm Hg). Analytical thin–layer 
chromatography (TLC) was performed on silica gel plates (0.25 mm) precoated with a 
fluorescent indicator. Flash chromatography was performed using 40–63 µm silica gel 
(200 X 400 mesh). 
 
Procedures and Characterizations 






Preparation of TBS ether 3.89 . To a solution of 3.47  (25 mg, 0.072 mmol) 
and 2,6-lutidine (25 µL, 0.22 mmol) in CH2Cl2 (10 mL) was added TBSOTf (25 µL, 0.11 
mmol). The reaction mixture was stirred for 2 h and quenched with sat. NaHCO3 (5 mL). 
The aqueous phase was extracted with CH2Cl2 (3 x 5 mL) and the extracts were 
combined, dried (Na2SO4), and concentrated. Flash chromatography (8:1 hexanes: ethyl 
acetate) provided 30 mg of 3.89  (90%) as a colorless oil. Rf 0.60 (5:1 hexanes:ethyl 
acetate); [!]
20
D = -48.9° (c = 0.47, THF); 
1
H NMR (500 MHz, C6D6) " 7.60 (d, J = 7.3 
Hz, 2H), 7.19 (t, J = 7.3 Hz, 2H), 7.13 (t, J = 7.3 Hz, 1H), 6.14 (dddd, J = 17.1, 10.2, 6.8, 
6.8 Hz, 1H), 5.40 (s, 1H), 5.22 (bd, J = 17.1 Hz, 1H), 5.13 (bd, J = 10.2 Hz, 1H), 3.92 (d, 
J = 10.0 Hz, 1H), 3.53 (d, J = 10.0 Hz, 1H), 3.47 (ddd, J = 10.7, 7.3, 4.9 Hz, 1H), 3.38 
(ddd, J = 10.2, 9.3, 3.4 Hz, 1H), 3.35 (dd, J = 12.5, 3.5 Hz, 1H), 3.26 (ddd, J = 8.8, 8.8, 
2.9 Hz, 1H), 2.94 (ddd, J = 10.2, 9.8, 4.9 Hz, 1H), 2.75-2.69 (m, 1H), 2.35 (ddd, J = 7.3, 
7.3, 7.3 Hz, 1H), 2.31 (ddd, J = 11.7, 4.4, 4.4 Hz, 1H), 2.19 (ddd, J = 11.2, 4.4, 4.4 Hz, 
1H), 1.88 (ddd, J = 11.2, 11.2, 11.2 Hz, 1H), 1.43 (s, 3H), 0.93 (s, 9H), 0.01 (s, 3H), -0.01 
(s, 3H); 
13
C NMR (125 MHz, C6D6) " 138.5, 135.3, 128.8, 128.2, 126.7, 116.8, 102.8, 
82.6, 79.9, 78.2, 76.4, 70.3, 69.9, 69.6, 40.1, 36.4, 30.9, 25.8, 18.0, 15.2, -4.0, -4.8; IR 
(neat) 2955, 2933, 2859, 1463, 1380, 1331, 1254, 1092 cm
-1
; ESI/MS (m/z) calcd for 
C26H41O5Si 461.3 (M+H
+











Preparation of acid 3.91 . To a solution of 3.89  (30 mg, 0.065 mmol) in 
CH2Cl2 (20 mL) at -78 
o
C was bubbled through O3 until the reaction developed a light 
blue color. The excess O3 was purged from the reaction mixture by bubbling N2 through 
it until the light blue color completely faded away. Triphenylphosphine (51 mg, 0.19 
mmol) was then added and the mixture was allowed to slowly warm up to rt. After 12 h, 
the solution was concentrated under reduced pressure. Flash chromatography (50:1 to 5:1 
hexanes:ethyl acetate) provided aldehyde 3.90 (28 mg, 92%) as a colorless oil.  
To a solution of 3.90  (28 mg, 0.061 mmol) in THF (3 mL) was successively 
added tBuOH (3 mL), H2O (3mL), 2-Me-2-butene (0.6 mL), NaH2PO4 (36 mg, 0.30 
mmol) and NaClO2 (27 mg, 0.30 mmol). The reaction mixture was stirred at rt for 2 h and 
H2O (3mL) was added in. The reaction mixture was extracted with ethyl acetate (3 x 5 
mL) and the organic extracts were combined, dried (Na2SO4) and concentrated. Flash 
chromatography (1:1 hexanes:ethyl acetate to ethyl acetate) provided acid 3.91  (19 mg, 
67%) as a colorless oil.! Rf 0.30 (2:1 hexanes:ethyl acetate); [!]
20
D = -52.2° (c = 0.39, 
THF); 
1
H NMR (500 MHz, CD2Cl2) " 7.51-7.47 (m, 2H), 7.41-7.37 (m, 3H), 5.58 (s, 
1H), 3.92 (d, J = 10.2 Hz, 1H), 3.69-3.60 (m, 3H), 3.55 (ddd, J = 10.7, 9.3, 4.9 Hz, 1H), 
3.48 (ddd, J = 11.2, 9.3, 3.9 Hz, 1H), 3.22 (ddd, J = 11.2, 9.8, 4.4 Hz, 1H), 2.89 (dd, J = 
15.6, 2.9 Hz, 1H), 2.42 (dd, J = 15.6, 9.3 Hz, 1H), 2.27 (ddd, J = 11.7, 4.4, 4.4 Hz, 1H), 
2.20 (ddd, J = 11.2, 4.4, 4.4 Hz, 1H), 1.78 (ddd, J = 11.7, 11.7, 11.7 Hz, 1H), 1.53 (ddd, J 














NMR (125 MHz, CD2Cl2) ! 177.2, 138.1, 129.2, 128.4, 126.5, 103.1, 79.8, 79.6, 78.2, 
76.4, 70.3, 70.0, 69.3, 39.5, 37.7, 30.6, 25.7, 17.9, 15.1, -4.1, -4.9; IR (neat) 3259, 2954, 
2861, 1714, 1463, 1377, 1256, 1093 cm
-1
; ESI/MS (m/z) calcd for C25H37O7Si 477.3 (M-
H
+
), found 477.4. 
 
Preparation of alcohol 3.93 . To a solution of 3.48  (28 mg, 0.075 mmol) in 
THF (5 mL) was added KH (30 mg 30% dispersion in mineral oil, 0.23 mmol). The 
reaction mixture was stirred for 10 min at rt and then DMPU (4.5 µL, 0.038 mmol), 
PMBBr (54 µL, 0.38 mmol) and catalytic amount of TBAI were added. The reaction 
mixture was stirred for overnight at rt before it was quenched with sat. NH4Cl (aq., 5 
mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL) and the combined organic 
extracts were dried (Na2SO4), and concentrated. Flash chromatography (10:1 
hexanes:ethyl acetate) gave a colorless oil which was brought to the next step without 
further purification. 
To a solution of the PMB ether obtained from the last step in CH2Cl2 (20 mL) at -
78 
o
C was bubbled through O3 until the reaction developed a light blue color. The excess 
O3 was purged from the reaction mixture by bubbling N2 through it for 10 min until the 
light blue color completely faded away. Triphenylphosphine (59 mg, 0.23 mmol) was 
then added and the mixture was allowed to slowly warmed up to rt. After 12 h, the 
solution was concentrated under reduced pressure. Flash chromatography (50:1 to 5:1 














To a solution of the aldehyde obtained from the last step in MeOH (5 mL) at 0 
o
C 
was added NaBH4 (8.5 mg, 0.23 mmol). The reaction mixture was quenched with acetone 
(3 mL) after stirring for 2 h at 0 
o
C. The solvent was then removed under reduced 
pressure and the residue was purified using flash chromatography (4:1 hexanes:ethyl 
acetate) to give 3.93  as a colorless oil (28 mg, 74% 3 steps). Rf 0.50 (2:1 hexanes:ethyl 
acetate); [!]
20
D = -15.5° (c = 0.45, THF); 
1
H NMR (500 MHz, CD2Cl2) " 7.54-7.51 (m, 
2H), 7.44-7.38 (m, 3H), 7.29 (d, J = 8.8 Hz, 2H), 6.94 (d, J = 8.3 Hz, 2H), 5.45 (s, 1H), 
4.64 (d, J = 11.2 Hz, 1H), 4.41 (d, J = 11.2 Hz, 1H), 4.33 (dd, J = 10.2, 4.9 Hz, 1H), 3.83 
(s, 3H), 3.84-3.78 (partially obscured m, 1H), 3.61 (dd, J = 10.3, 10.3 Hz, 1H), 3.54 (ddd, 
J = 9.8, 9.8, 4.9 Hz, 1H), 3.50 (dd, J = 11.7, 4.4 Hz, 1H), 3.37 (dd, J = 12.2, 3.4 Hz, 1H), 
3.15 (br s, 1H), 2.30-2.17 (m, 2H), 1.96-1.85 (m, 4H), 1.79 (ddd, J = 12.2, 12.2, 12.2 Hz, 
1H), 1.74 (ddd, J = 14.7, 7.8, 3.9 Hz, 1H), 1.34 (s, 3H), 1.33 (s, 3H); 
13
C NMR (125 
MHz, CD2Cl2) " 159.6, 138.3, 130.7, 129.5, 129.1, 128.4, 126.4, 113.9, 100.9, 83.2, 80.4, 
79.2, 78.9, 78.1, 74.8, 70.8, 69.7, 59.3, 55.5, 43.5, 39.5, 28.7, 28.5, 21.9, 21.0; IR (neat) 
3448, 2946, 2870, 1613, 1513, 1458, 1377, 1248, 1096 cm
-1
; ESI/MS (m/z) calcd for 
C29H38O7Na 521.2 (M+Na
+
), found 521.3. 
 
Preparation of diol 3.94 . To a solution of 3.93  (0.126 g, 0.253 mmol) in 
THF (5 mL) at rt was added tBuOK (0.50 mL of 1.0 M solution in THF, 0.50 mmol). The 
mixture was stirred for 30 min before it was cooled to 0 
o
C. Then BnBr (0.12 mL, 1.01 












quenched with sat. NH4Cl (aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 
x 5 mL) and the combined organic extracts were dried (Na2SO4), and concentrated.  
The residue from above was dissolved in MeOH (15 mL) and the mixture was 
cooled to 0 
o
C. CSA (15 mg, 0.065 mmol) was added and the reaction mixture was 
allowed to slowly warm up to rt. After 5 h, the reaction mixture was quenched with sat. 
NaHCO3 (aq., 10 mL). The aqueous phase was extracted with ethyl acetate (3 x 10 mL) 
and the combined organic extracts were dried (Na2SO4), and concentrated. Flash 
chromatography (1:1 hexanes:ethyl acetate) gave 3.94  as a colorless oil (0.112 g, 89% 2 
steps). Rf 0.60 (ethyl acetate); [!]
20
D = -19.0° (c = 0.51, THF); 
1
H NMR (500 MHz, 
CD2Cl2) " 7.40-7.30 (m, 5H), 7.28 (d, J = 8.3 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 4.59 (d, J 
= 11.2 Hz, 1H), 4.48 (s, 2H), 4.38 (d, J =10.7 Hz, 1H), 3.87 (br d, J = 5.5 Hz, 1H), 3.82 
(s, 3H), 3.71 (br s, 1H), 3.64-3.60 (m, 2H), 3.55-3.48 (m, 3H), 3.44 (dd, J = 11.2, 4.2 Hz, 
1H), 2.70 (br s, 2H), 2.17 (ddd, J = 11.7, 3.9, 3.9 Hz, 1H), 1.95-1.76 (m, 4H), 1.76-1.65 
(m, 2H), 1.54 (ddd, J = 13.7, 6.3, 2.2 Hz, 1H), 1.27 (s, 6H); 
13
C NMR (125 MHz, 
CD2Cl2) " 159.4, 139.2, 131.1, 129.4, 128.5, 127.9, 127.6, 113.9, 85.7, 79.6, 79.3, 76.5, 
75.5, 73.0, 71.7, 70.8, 66.7, 64.5, 55.4, 41.7, 36.2, 28.8, 27.9, 22.3, 20.2; IR (neat) 3383, 
2929, 2870, 1613, 1455, 1375, 1248, 1090 cm
-1
; ESI/MS (m/z) calcd for C29H40O7Na 
523.3 (M+Na
+
), found 523.3. 
 
Preparation of alkyne 3.97 . To a solution of 3.94  (0.112 g, 0.224 mmol) and 
2,6-lutidine (0.104 mL, 0.893 mmol) in CH2Cl2 (20 mL) at -78 
o











trifluoromethanesulfonic anhydride (40.0 µL, 0.234 mmol). The reaction mixture was 
stirred for 30 min at -78 
o
C and TBSOTf (77.0 µL, 0.335 mmol) was added. The reaction 
mixture was then slowly warmed to rt before it was quenched with sat. NaHCO3 (aq., 10 
mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic 
phase was dried (Na2SO4) and concentrated to give a yellow oil. The oil was quickly 
passed through a plug of silica gel (10:1 hexanes:ethyl acetate) and concentrated. The 
resulting colorless oil 3.95 was used directly in the next step without additional 
purification.  
To a solution of trimethylsilylacetylene (0.168 mL, 1.19 mmol) in THF (10 mL) 
at 0 
o
C was added nBuLi (0.474 mL of 2.5 M solution in hexanes, 1.19 mmol). The 
reaction mixture was stirred at 0 
o
C for 30 min and then cooled to -78
o
C. A solution of 
3.95 obtained from above and HMPA (0.207 mL, 1.19 mmol) in THF (5 mL) was 
cannulated into the reaction mixture. The reaction mixture was stirred at -78
o
C for 2 
hours before it was quenched with sat. NH4Cl (aq., 10 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic phase was dried (Na2SO4) and 
concentrated to give a dark brown syrup which was taken up in THF (10 mL). To the 
solution was added TBAF (1.12 mL of 1.0 M solution in THF, 1.12 mmol) and the 
mixture was stirred at rt overnight before it was quenched with sat. NH4Cl (aq., 10 mL). 
The aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic phase 
was dried (Na2SO4) and concentrated. Flash chromatography (4:1 hexanes:ethyl acetate) 
gave 3.97 as a colorless oil (85.7 mg, 75% 3 steps). Rf 0.50 (2:1 hexanes:ethyl acetate); 
[!]
20
D = -21.6° (c = 0.42, THF); 
1
H NMR (500 MHz, CD2Cl2) " 7.40-7.28 (m, 5H), 7.27 
(d, J = 8.8 Hz, 2H), 6.90 (d, J = 8.3 Hz, 2H), 4.58 (d, J = 10.8 Hz, 1H), 4.48 (s, 2H), 4.38 
! 192 
(d, J =11.2 Hz, 1H), 4.08 (br s, 1H), 3.81 (s, 3H), 3.79 (partially obscured ddd, J = 7.3, 
5.4, 1.5 Hz, 1H), 3.63-3.59 (m, 2H), 3.52 (dd, J = 12.2, 4.2 Hz, 1H), 3.42 (dd, J = 11.7, 
3.9 Hz, 1H), 3.41 (ddd, J = 16.6, 5.4, 2.4 Hz, 1H), 2.33 (ddd, J = 17.1, 7.8, 2.7 Hz, 1H), 
2.18-2.10 (partially obscured m, 1H), 2.13 (ddd, J = 12.2, 3.9, 3.9 Hz, 1H), 2.10 (t, J = 
2.4 Hz, 1H), 1.94-1.75 (m, 5H), 1.68 (ddd, J = 12.2, 12.2, 12.2 Hz, 1H), 1.51 (ddd, J = 
13.2, 5.9, 2.9 Hz, 1H), 1.25 (s, 6H); 
13
C NMR (125 MHz, CD2Cl2) ! 159.4, 139.3, 131.2, 
129.4, 128.5, 127.8, 127.6, 113.8, 83.3, 81.2, 79.5, 78.5, 76.5, 75.4, 73.3, 73.0, 70.8, 70.1, 
66.7, 55.4, 41.7, 35.9, 28.7, 26.7, 24.6, 22.2, 20.1; IR (neat) 3419, 2929, 2869, 2339, 
1613, 1454, 1374, 1248, 1089 cm
-1





Preparation of alkene 3.98 . To a solution of 3.97 (85.7 mg, 0.169 mmol) in  
ethyl acetate (10 mL) was added quinoline (10 µL, 0.085 mmol) and Lindlar’s Pd catalyst 
(10 mg). The mixture was stirred under H2 atmosphere for 2 h before it was passed 
through a Celite plug with ethyl acetate. The filtrate was concentrated and flash 
chromatography (4:1 hexanes:ethyl acetate) gave 3.98 as a colorless oil (78.8 mg, 92%). 
Rf 0.55 (2:1 hexanes:ethyl acetate); ["]
20
D = -14.9° (c = 0.43, THF); 
1
H NMR (500 MHz, 
CD2Cl2) ! 7.38-7.28 (m, 5H), 7.26 (d, J = 8.8 Hz, 2H), 6.90 (d, J = 8.3 Hz, 2H), 5.89 
(dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1H), 5.14-5.07 (m, 2H), 4.58 (d, J = 11.2 Hz, 1H), 4.47 
(s, 2H), 4.37 (d, J = 11.2 Hz, 1H), 3.89 (br d, J = 5.9 Hz, 1H), 3.80 (s, 3H), 3.68 (ddd, J = 











11.7, 3.9 Hz, 1H), 2.27-2.15 (m, 2H), 2.10 (ddd, J = 12.2, 4.4, 3.9 Hz, 1H), 1.93-1.80 (m, 
4H), 1.78-1.69 (m, 2H), 1.65 (ddd, J = 12.2, 12.2, 12.2 Hz, 1H), 1.49 (ddd, J = 13.2, 5.3, 
2.7 Hz, 1H), 1.24 (s, 6H); 
13
C NMR (125 MHz, CD2Cl2) ! 159.4, 139.3, 135.4, 131.2, 
129.4, 128.5, 127.8, 127.5, 116.9, 113.8, 84.7, 79.6, 78.5, 76.5, 75.4, 73.7, 72.9, 70.7, 
66.7, 55.4, 41.7, 39.4, 35.9, 28.8, 26.7, 22.3, 20.1; IR (neat) 3423, 2929, 1613, 1513, 
1454, 1374, 1248, 1087 cm
-1





Preparation of ester 3.99 . To a solution of acid 3.91  (36.0 mg, 0.0753        
mmol) in THF (8 mL) was added triethylamine (45.9 µL, 0.330 mmol) and 2,4,6-
trichlorobenzoyl chloride (35.3 µL, 0.223 mmol). The reaction mixture was heated at 40 
o
C for 2 h before the solvent was removed in vacuo. To the resulting residue was 
cannulated a solution of alcohol 3.98  (36.8 mg,  0.0722 mmol) in toluene (10 mL). 
DMAP (42.3 mg, 0.347 mmol) was then added and the reaction mixture was heated at 40 
o
C for 2 h. The reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous 
phase was extracted with CH2Cl2 (3 x 10 mL) and the organic extracts were combined, 
dried (Na2SO4) and concentrated. Flash chromatography (10:1 hexanes:ethyl acetate) 
provided ester 3.99  (67.8 mg, 97%) as a colorless oil. Rf 0.25 (5:1 hexanes:ethyl   
acetate); ["]
20
D = -14.8° (c = 0.30, THF); 
1
H NMR (500 MHz, CD2Cl2) ! 7.46-7.43 (m, 






















2H), 5.88 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1H), 5.52 (s, 1H), 5.13 (dd, J = 18.1, 1.0 Hz, 
1H), 5.09 (d, J = 10.7 Hz, 1H), 4.99 (d, J = 6.3 Hz, 1H), 4.57 (d, J = 10.7 Hz, 1H), 4.49 
(d, J = 11.7 Hz, 1H), 4.45 (d, J = 11.7 Hz, 1H), 4.36 (d, J = 10.7 Hz, 1H), 3.89 (d, J = 
10.3 Hz, 1H), 3.79 (s, 3H), 3.75 (dd, J = 6.2, 6.2 Hz, 1H), 3.72-3.58 (m, 5H), 3.55 (ddd, J 
= 9.8, 9.8, 4.4 Hz, 1H), 3.48 (partially obscured ddd, J =10.8, 9.3, 3.9 Hz, 1H), 3.44 
(partially obscured dd, J =11.7, 4.4 Hz, 1H), 3.36 (dd, J = 12.2, 3.9 Hz, 1H), 3.19 (ddd, J 
= 10.7, 9.3, 4.4 Hz, 1H), 2.87 (dd, J = 14.9, 2.7 Hz, 1H), 2.39 (dd, J = 14.9, 9.5 Hz, 1H), 
2.31-2.23 (m, 3H), 2.16 (ddd, J = 11.2, 3.9, 3.9 Hz, 1H), 2.12 (ddd, J = 12.2, 3.9, 3.9 Hz, 
1H), 1.97-1.64 (m, 8H), 1.59-1.48 (m, 1H), 1.50 (s, 3H), 1.25 (s, 3H), 1.24 (s, 3H), 0.92 
(s, 9H), 0.13 (s, 3H), 0.11 (s, 3H); 
13
C NMR (125 MHz, CD2Cl2) ! 170.8, 159.4, 139.3, 
138.0, 134.8, 131.1, 129.3, 129.2, 128.5, 128.4, 127.8, 127.6, 126.6, 117.2, 113.8, 103.1, 
82.6, 80.5, 80.1, 79.9, 78.9, 78.2, 77.1, 76.3, 76.2, 75.4, 73.0, 71.0, 70.4, 70.0, 69.4, 66.8, 
55.4, 42.0, 39.6, 39.2, 38.3, 36.6, 30.7, 28.9, 25.8, 23.6, 22.0, 19.8, 18.0, 15.1, -4.1, -4.8; 
IR (neat) 2932, 2859, 1735, 1613, 1514, 1456, 1378, 1250, 1092 cm
-1
; ESI/MS (m/z) 
calcd for C56H78O12SiNa 993.5 (M+Na
+
), found 993.5. 
 
Preparation of enol ether 3.100 . To a solution of TiCl4 (0.245 mL, 2.23     
mmol) in CH2Cl2 (15 mL) at 0 
o
C was added THF (1.18 mL, 13.4 mmol) dropwise. To 
the yellow solution TMEDA (2.03 mL, 13.4 mmol) was added dropwise and the solution 
turned to a red-brown color. The ice bath was then removed and the mixture was allowed 





















mmol) were then added. The resulting mixture went through a series of color changes 
from brown to green to purple and finally to blue-green over the course of 3-5 min. To 
the slurry was transferred a solution of ester 3.99  (67.8 mg, 0.0699 mmol) and  
CH3CHBr2 (0.200 mL, 2.23 mmol) in CH2Cl2 (5 mL) via cannula. The reaction mixture 
was then heated to reflux for 30 min before it was cooled to 0 °C and quenched with sat. 
K2CO3 (aq., 1.0 mL). After stirring for 30 min at 0 °C, the resulting mixture was filtered 
through a piece of filter paper. The filtrate was concentrated and flash chromatography 
(10:1 hexanes:ethyl acetate) gave 3.100 as a colorless oil (32.9 mg, 50%). Rf 0.20 (5:1 
hexanes:ethyl acetate); [!]
20
D = -40.3° (c = 0.29, THF); 
1
H NMR (500 MHz, CD2Cl2) " 
7.48-7.45 (m, 2H), 7.40-7.32 (m, 7H), 7.30-7.26 (m, 1H), 7.24 (d, J = 8.3 Hz, 2H), 6.86 
(d, J = 8.8 Hz, 2H), 5.56 (s, 1H), 4.56 (d, J = 11.2 Hz, 1H), 4.52 (br d, J = 3.4 Hz, 1H), 
4.47 (d, J = 11.7 Hz, 1H), 4.42 (d, J = 11.7 Hz, 1H), 4.37 (d, J = 11.2 Hz, 1H), 3.90 (d, J 
= 10.2 Hz, 1H), 3.78 (s, 3H), 3.67-3.60 (m, 2H), 3.60-3.52 (m, 2H), 3.50-3.40 (m, 5H), 
3.37 (dd, J = 12.2, 3.9 Hz, 1H), 3.31 (ddd, J = 9.3, 9.3, 2.0 Hz, 1H), 3.12 (ddd, J =11.2, 
9.3, 4.4 Hz, 1H), 2.54 (d, J = 15.1 Hz, 1H), 2.28 (br d, J = 16.6 Hz, 1H), 2.21 (ddd, J = 
11.2, 4.4, 4.4 Hz, 1H), 2.16 (ddd, J = 11.7, 3.9, 3.9 Hz, 1H), 2.13 (ddd, J = 12.2, 3.9, 3.9 
Hz, 1H), 2.05-1.66 (m, 10H), 1.50 (s, 3H), 1.47 (ddd, J = 10.7, 10.7, 10.7 Hz, 1H), 1.24 
(s, 3H), 1.19 (s, 3H), 0.90 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H); 
13
C NMR (125 MHz, 
CD2Cl2) " 159.4, 151.6, 139.3, 138.1, 131.1, 129.4, 129.2, 128.5, 128.4, 1279, 127.6, 
126.5, 113.8, 103.0, 94.8, 80.6, 80.0, 79.9, 79.7, 79.1, 78.8, 78.0, 77.0, 76.4, 75.6, 73.0, 
70.8, 70.7, 69.9, 69.5, 66.5, 55.4, 41.9, 40.0, 39.9, 35.9, 30.7, 29.7, 29.4, 28.8, 25.8, 23.5, 
22.5, 18.0, 15.1, -4.1, -4.8; IR (neat) 2933, 2859, 1651, 1513, 1458, 1377, 1250, 1093 cm
-
1
; ESI/MS (m/z) calcd for C55H76O11SiNa 963.5 (M+Na
+
), found 963.6. 
! 196 
 
Preparation of ketone 3.103 . To a solution of 3.100  (28.6 mg, 0.0304 
mmol) in CH2Cl2 (5 mL) at -78 
oC was added a solution of dimethyl dioxirane (0.61 mL 
of 0.10 M solution in CH2Cl2, 0.061 mmol) dropwise. The reaction mixture was warmed 
to 0 oC and the solvent was removed in vacuo. The residue was dissolved in CH2Cl2 (5 
mL) and the reaction mixture was cooled to -78 oC, at which temperature, a solution of 
DIBAL-H (0.304 mL of 1.0 M solution in THF, 0.304 mmol) was added. After stirring 
for 2 h at -78 oC, the reaction was quenched with sat. NH4Cl (aq., 3 mL) and allowed to 
warm to rt. Saturated potassium sodium tartrate solution (10 mL) was added and the 
mixture was stirred violently for 30 min. The aqueous phase was extracted with CH2Cl2 
(3 x 10 mL) and the combined organic phase was dried (Na2SO4) and concentrated. Flash 
chromatography (5:1 hexanes:ethyl acetate) provided major alcohol 3.101  (17.5 mg, 
60%) and minor alochol (6.1 mg, 21%) both as colorless oil.  
To a solution of 3.101 (17.5 mg, 0.0183 mmol) in CH2Cl2 (5 mL) was added 
activated 4Å MS (20 mg), NMO (21.4 mg, 0.183 mmol) and TPAP (1 mg, 0.003 mmol). 
The reaction mixture was stirred at rt for 2 h before the solvent was removed in vacuo. 
Flash chromatography (5:1 hexanes:ethyl acetate) gave ketone 3.103 as a colorless oil 
(17.4 mg, 100%). Rf 0.55 (3:1 hexanes:ethyl acetate); [!]
20
D = -42.0° (c = 0.10, THF); 
1H 
NMR (500 MHz, C6D6) " 7.60 (d, J = 7.8 Hz, 2H), 7.33 (d, J = 7.8 Hz, 2H), 7.26-7.06 

























Hz, 1H), 4.36 (d, J = 11.7 Hz, 1H), 4.25 (d, J = 11.2 Hz, 1H), 4.08 (dd, J = 7.3, 3.4 Hz, 
1H), 3.92 (d, J = 10.2 Hz, 1H), 3.78-3.70 (m, 2H), 3.66-3.60 (m, 1H), 3.56-3.50 (partially 
obscured m, 1H), 3.53 (partially obscured d, J = 10.2 Hz, 1H), 3.45-3.25 (m, 4H), 3.28 (s, 
3H), 3.16 (ddd, J = 8.3, 8.3, 4.4 Hz, 1H), 3.08-3.00 (m, 2H), 2.97 (dd, J = 15.6, 6.4 Hz, 
1H), 2.76 (ddd, J =13.2, 7.8, 2.4 Hz, 1H), 2.36-2.22 (m,  3H), 2.16-2.00 (m, 4H), 2.00-
1.88 (m, 2H),  1.86-1.62 (m, 6H), 1.43 (s, 3H), 1.33 (s, 3H), 1.18 (s, 3H), 0.98 (s, 9H), 
0.06 (s, 3H), 0.02 (s, 3H); 
13
C NMR (125 MHz, C6D6) ! 205.1, 159.6, 139.4, 138.4, 
131.0, 129.2, 128.9, 128.4, 128.2, 127.4, 126.7, 114.0, 102.8, 81.0, 80.2, 80.1, 79.8, 79.5, 
79.4, 78.9, 78.3, 76.9, 76.4, 75.7, 73.0, 71.7, 70.6, 69.9, 69.5, 66.5, 54.6, 46.1, 42.2, 40.2, 
39.6, 36.7, 33.3, 31.0, 30.1, 29.2, 28.8, 25.8, 24.8, 22.8, 22.6, 18.0, 15.1, -4.1, -4.8; IR 
(neat) 2931, 2858, 1727, 1513, 1460, 1377, 1250, 1092 cm
-1
; ESI/MS (m/z) calcd for 
C55H78O12SiK 995.5 (M+K
+
), found 995.5. 
 
Preparation of acetate 3.102 . To a solution of 3.101  (25.6 mg, 0.0267 
mmol) in CH2Cl2 (8 mL) were successively added Et3N (37.2 µL, 0.267 mmol), Ac2O 
(12.6 µL, 0.133 mmol), and DMAP (3.3 mg, 0.027 mmol). The reaction mixture was 
stirred for 2 h before it was quenched with sat. NaHCO3 (aq., 5 mL). The aqueous phase 
was extracted with CH2Cl2 (3 x 5 mL) and the combined organic phase was dried 
(Na2SO4) and concentrated. Flash chromatography (5:1 hexanes:ethyl acetate) provided 



























24.9° (c = 0.24, THF); 
1
H NMR (500 MHz, C6D6) ! 7.60 (d, J = 7.3 Hz, 2H), 7.33 (d, J = 
7.3 Hz, 2H), 7.24-7.08 (m, 8H), 6.79 (d, J = 7.8 Hz, 2H), 5.39 (s, 1H), 4.99 (ddd, J = 
10.7, 10.7, 4.4 Hz, 1H), 4.52 (d, J = 11.2 Hz, 1H), 4.42 (d, J = 11.2 Hz, 1H), 4.37 (d, J = 
13.2 Hz, 1H), 4.34 (d, J = 12.2 Hz, 1H), 3.92 (d, J = 9.8 Hz, 1H), 3.76 (dd, J = 15.6, 7.3 
Hz,     1H), 3.68-3.50 (m, 6H), 3.50-3.37 (m, 2H), 3.30 (s, 3H), 3.20-3.01 (m, 4H), 2.77 
(ddd, J = 11.7, 4.4, 4.4 Hz, 1H), 2.44 (ddd, J =12.2, 3.9, 3.9 Hz, 1H), 2.38-2.30 (m, 2H), 
2.16-2.02 (m, 3H), 2.02-1.94 (m, 2H), 1.90 (ddd, J = 11.7, 11.7, 11.7 Hz, 1H), 1.85-1.76 
(m, 3H), 1.75 (s, 3H), 1.72-1.53 (m, 3H), 1.45 (s, 3H), 1.32 (s, 3H), 1.20 (s, 3H), 0.98 (s, 
9H), 0.09 (s, 3H), 0.03 (s, 3H); 
13
C NMR (125 MHz, C6D6) ! 169.2, 159.6, 139.4, 138.5, 
131.2, 129.3, 128.8, 128.4, 128.2, 127.4, 126.7, 114.0, 102.8, 81.5, 81.1, 79.9, 79.7, 79.3, 
79.1, 78.3, 77.0, 76.4, 75.7, 73.0, 71.1, 70.6, 69.9, 69.6, 66.6, 54.7, 42.2, 40.4, 39.8, 37.7, 
34.5, 30.9, 30.1, 29.5, 29.0, 25.9, 22.7, 22.6, 20.7, 18.0, 15.2, -3.9, -4.6; IR (neat) 2931, 
2858, 1740, 1614, 1513, 1458, 1375, 1245, 1090 cm
-1
; ESI/MS (m/z) calcd for 
C57H80O13SiNa 1023.5 (M+Na
+
), found 1023.5. 
 
Preparation of hemiketal 3.104 . To a solution of 3.103  (17.7 mg, 0.0185 
mmol) in THF (10 mL) at 0 
o
C was slowly added HF•Py (0.60 mL, 33 mmol). The 
reaction mixture was allowed to warm up to rt and stirred for 2 d before it was quenched 
with sat. NaHCO3 (aq., 50 mL). The aqueous phase was extracted with Ethyl acetate (3 x 





















chromatography (2:1 hexanes:ethyl acetate) provided 3.104  as a colorless oil (15.5 mg, 
99%). Rf 0.35 (2:1 hexanes:ethyl acetate); [!]
20
D = -15.8° (c = 0.22, THF); 
1
H NMR (500 
MHz, CD2Cl2) " 7.48-7.45 (m, 2H), 7.39-7.24 (m, 8H), 7.23 (d, J = 8.3 Hz, 2H), 6.86 (d, 
J = 8.3 Hz, 2H), 5.56 (s, 1H), 4.55 (d, J = 11.2 Hz, 1H), 4.45 (d, J = 11.7 Hz, 1H), 4.41 
(d, J = 12.2 Hz, 1H), 4.36 (d, J = 10.7 Hz, 1H), 4.08 (br d, J = 6.8 Hz, 1H), 3.92 (d, J = 
9.8 Hz, 1H), 3.80-3.74 (m, 1H), 3.78 (s, 3H), 3.68-3.62 (m, 2H), 3.59-3.44 (m, 4H), 3.42 
(partially obscured dd, J = 11.7, 4.4 Hz, 1H), 3.33-3.27 (m, 1H), 3.22 (ddd, J = 11.7, 2.4, 
1.5 Hz, 1H), 3.17 (ddd, J = 12.7, 9.3, 3.4 Hz, 1H), 3.13 (ddd, J = 11.2, 9.3, 3.9 Hz, 1H), 
2.23-2.00 (m,  4H), 1.93-1.88 (m, 2H), 1.86-1.73 (m, 3H),  1.73-1.65 (m, 2H), 1.63-1.52 
(m, 2H), 1.50 (s, 3H), 1.45 (ddd, J = 11.7, 11.7, 11.7 Hz, 1H), 1.41-1.25 (m, 2H), 1.22 (s, 
3H), 1.18 (s, 3H), 1.16-1.95 (m, 1H); 
13
C NMR (125 MHz, CD2Cl2) " 138.0, 131.0, 
129.3, 129.2, 128.4, 127.8, 127.5, 126.5, 113.8, 103.0, 93.9, 82.2, 81.9, 79.8, 79.6, 79.3, 
78.6, 77.6, 77.0, 76.3, 75.6, 72.9, 70.8, 70.2, 68.9, 66.5, 55.4, 49.2, 43.2, 41.8, 39.7, 35.3, 
34.1, 30.6, 30.2, 29.2, 28.8, 25.8, 25.2, 22.4, 22.2, 15.0; IR (neat) 3323, 3055, 2927, 
1624, 1433, 1265, 1113 cm
-1





Preparation of the ATX A-F ring system 3.107 . To a solution of 3.104  
(15.9 mg, 0.0189 mmol) in CH2Cl2 (6 mL) and EtSH (2 mL) was added Zn(OTf)2 (140 























to rt and quenched with sat. NaHCO3 (aq., 5 mL). The aqueous phase was extracted with 
CH2Cl2 (3 x 5 mL) and the combined organic phase was dried (Na2SO4) and 
concentrated. Flash chromatography (20:1 dichloromethane:methanol) provided triol 
3.105 as a colorless oil.  
To the solution of the triol obtained above in DMF (10 mL) at  -20 
o
C was added 
tBu2Si(OTf)2 (14.0 µL, 0.0384 mmol). The reaction mixture was stirred at -20 
o
C for 1 h 
before pyridine (6.2 mL, 0.077 mmol) was added. The mixture was stirred for another 5 
min and quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was extracted with 
Et2O (3 x 10 mL) and the combined organic phase was dried (Na2SO4) and concentrated. 
Flash chromatography (3:1 hexanes:ethyl acetate) provided a colorless oil which was 
taken to the next step without further purification. 
To the solution of the colorless oil obtained above in toluene (10 mL) was added 
Ph3SnH (200 mg, 0.570 mmol). The reaction mixture was heated to reflux and AIBN 
(0.0046 M solution in toluene, 2.0 mL, 9.2 µmol) was added via syringe pump during 2 
h. The mixture was then cooled to rt and solvent was removed under reduced pressure. 
Flash chromatography (2:1 hexanes:ethyl acetate) provided 3.107 as a colorless oil (7.3 
mg, 51% 3 steps). Rf 0.20 (2:1 hexanes:ethyl acetate); [!]
20
D = -7.6° (c = 0.10, THF); 
1
H 
NMR (500 MHz, CD2Cl2) " 7.39-7.27 (m, 5H), 4.50 (s, 2H), 4.07 (dd, J = 12.2, 4.4 Hz, 
1H), 3.88 (d, J = 10.2 Hz, 1H), 3.75 (d, J = 10.2 Hz, 1H), 3.59 (dd, J = 6.4, 4.4 Hz, 1H), 
3.54 (dd, J = 12.2, 3.9 Hz, 1H), 3.40-3.35 (m, 1H), 3.33 (dd, J = 11.7, 3.9 Hz, 1H), 3.26 
(ddd, J = 10.8, 9.3, 4.4 Hz, 1H), 3.19 (ddd, J = 12.7, 8.8, 4.4 Hz, 1H), 3.13-2.95 (m, 6H), 
2.32-2.24 (m, 2H), 2.18-2.10 (m, 2H), 2.00-1.68 (m, 10H), 1.65 (ddd, J = 11.7, 11.7, 11.7 




C NMR (125 MHz, CD2Cl2) ! 138.4, 129.0, 128.4, 128.4, 81.9, 81.4, 80.4, 78.6, 
77.8, 77.7, 77.6, 77.4, 76.8, 75.0, 74.9, 74.3, 73.7, 73.2, 69.8, 67.1, 43.8, 40.5, 37.4, 35.9, 
35.7, 34.0, 32.3, 29.9, 29.3, 28.0, 23.9, 20.4, 20.1, 15.6; IR (neat) 3417, 2925, 2855, 
1652, 1457, 1375, 1080 cm
-1
; FAB/MS (m/z) calcd for C42H66O10SiAg 865.3476 
(M+Ag
+
), found 865.3475. 
 
Characterization of alcohol 3.112 . Rf 0.40 (3:1 hexanes:ethyl acetate); 
["]
20
D = +1.2° (c = 0.86, THF); 
1
H NMR (500 MHz, C6D6) ! 7.66 (dd, J = 7.7, 0.6 Hz, 
2H), 7.21 (td, J = 7.7, 0.6 Hz, 2H), 7.14 (t, J = 7.7 Hz, 1H), 5.86 (dddd, J = 16.7, 10.2, 
6.6, 6.6 Hz, 1H), 5.25 (s, 1H), 5.10 (dd, J = 16.7, 1.4 Hz, 1H), 5.02 (dd, J = 10.2, 1.4 Hz, 
1H), 4.29 (dd, J = 10.7, 5.2 Hz, 1H), 3.50-3.44 (m, 2H), 3.30 (ddd, J = 9.6, 9.6, 5.2 Hz, 
1H), 3.27-3.22 (m, 1H), 2.99-2.95 (m, 1H), 2.07-1.95 (m, 3H), 1.86-1.66 (m, 5H), 1.66-
1.47 (m, 3H), 1.40 (ddd, J = 10.7, 10.7, 3.0 Hz, 1H), 1.15 (s, 3H), 1.11 (s, 3H); 
13
C NMR 
(125 MHz, C6D6) ! 139.7, 139.2, 129.2, 128.7, 127.1, 115.0, 101.3, 83.5, 81.0, 77.3, 
77.0, 75.5, 73.2, 70.2, 42.7, 39.9, 35.1, 33.3, 29.4, 23.1, 22.1, 21.4; IR (neat) 3388, 2979, 
2870, 1496, 1297, 1214, 1101 cm
-1



























Characterization of acid 3.119 . Rf 0.40 (1:1 hexanes:ethyl acetate); [!]
20
D = 
+37.6° (c = 1.0, THF); 
1
H NMR (500 MHz, C6D6) " 7.22-7.15 (m, 4H), 7.10 (t, J = 7.8 
Hz, 1H), 4.66 (s, 1H), 4.57 (dd, J = 13.2, 3.9 Hz, 1H), 4.47 (dd, J = 8.8, 8.8, 3.4 Hz, 1H), 
4.22 (d, J = 12.2 Hz, 1H), 4.18 (d, J = 12.2 Hz, 1H), 3.90-3.88 (m, 1H), 3.86 (dd, J = 9.8, 
2.4 Hz, 1H), 3.60 (dd, J = 2.9, 2.9 Hz, 1H), 3.13 (s, 3H), 2.84 (dd, J = 15.1, 3.4 Hz, 1H), 
2.52 (dd, J = 15.1, 8.8 Hz, 1H), 2.10 (d, J = 12.7 Hz, 1H), 1.98 (ddd, J = 13.2, 13.2, 3.4 
Hz, 1H), 1.48 (s, 3H), 1.09 (s, 9H), 0.94 (s, 9H),  0.31 (s, 3H), 0.25 (s, 3H), 0.07 (s, 3H), 
0.00 (s, 3H); 
13
C NMR (125 MHz, C6D6) " 178.0, 139.0, 128.8, 128.2, 128.1, 101.4, 78.3, 
77.4, 76.8, 74.9, 72.2, 71.6, 68.6, 54.7, 38.2, 27.0, 26.9, 26.4, 19.4, 18.9, 18.8, -2.4, -2.5, -
4.0, -4.2; IR (neat) 2931, 1715, 1466, 1253, 1115, 1066 cm
-1
; ESI/MS (m/z) calcd for 
C31H53O8Si2 609.3 (M-H
+
), found 609.3. 
 
Preparation of ketone 3.124 . To a solution of (COCl)2 (0.53 mL, 6.2 mmol) 
in CH2Cl2 (40 mL) at -78 
o
C was added DMSO (0.58 mL, 8.2 mmol) dropwise. Then a 
solution of 3.122  (1.90 g, 4.08 mmol) in CH2Cl2 (10 mL) was cannulated into the 
reaction mixture. After stirring at -78 
o
C for 45 min, Et3N (2.28 mL, 16.4 mmol) was 
added and the reaction was stirred for another 5 min. The reaction was quenched with sat. 
NH4Cl (aq., 50 mL) and allowed to warm to rt. The aqueous phase was extracted with 
CH2Cl2 (3 x 50 mL) and the combined organic phase was dried (Na2SO4) and 
concentrated. Flash chromatography (20:1 hexanes:ethyl acetate) provided the 














To a solution of the ketone from above (1.80 g, 4.17 mmol) in 80 mL toluene at -
90 
o
C was added MeLi (18.3 mL of 1.6 M in diethyl ether, 29.2 mmol) dropwise. After 
stirring for 1 h at -90 
o
C, the reaction was quenched with sat. NH4Cl (aq., 50 mL) and 
allowed to warm to rt. The aqueous phase was extracted with CH2Cl2 (3 x 20 mL) and the 
combined organic phase was dried (Na2SO4) and concentrated. Flash chromatography 
(20:1 hexanes:ethyl acetate) gave tertiary alcohol 3.123 (1.56 g, 84%) as a colorless oil. 
To a solution of 3.123  (0.80 g, 1.67 mmol) in CH2Cl2 (27 mL) was added pH7 
buffer (3 mL) and DDQ (0.76 g, 3.35 mmol). The reaction mixture was stirred at rt for 2 
h before H2O (20 mL) was added. The aqueous phase was extracted with ethyl acetate (3 
x 15 mL) and the combined organic extracts were dried (Na2SO4), and concentrated. 
Flash chromatography (2:1 hexanes:ethyl acetate) gave the corresponding diol as a 
colorless oil (0.57 g, 95%). 
To a solution of the diol from above (0.11g, 0.31 mmol) in a mixture of CH2Cl2 (6 
mL) and DMSO (3 mL) were added Et3N (0.21 mL, 1.65 mmol) and SO3•Py (0.24 g, 
1.65 mmol). The reaction mixture was stirred for 3 h at rt before it was quenched with 
H2O (10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL) and the 
combined organic extracts were dried (Na2SO4), and concentrated. Flash chromatography 
(10:1 hexanes:ethyl acetate) gave 32  as a colorless oil (0.10 g, 91%). Rf 0.60 (5:1 
hexanes:ethyl acetate); [!]
20
D = -54.2° (c = 0.57, THF); 
1
H NMR (500 MHz, CDCl3) " 
5.72 (dddd, J = 17.0, 10.0, 6.6, 6.6 Hz, 1H), 4.98 (dd, J = 17.0, 1.3 Hz, 1H), 4.93 (d, J = 
10.0 Hz, 1H), 4.56 (d, J = 9.7 Hz, 1H), 4.14 (dd, J = 10.2, 4.6 Hz, 1H), 3.98 (s, 1H), 3.89 
(dd, J = 10.1, 10.1 Hz, 1H), 3.34 (ddd, J = 9.8, 9.8, 4.6 Hz, 1H), 3.18 (dd, J = 9.9, 2.1 Hz, 
1H), 2.32 (dd, J = 14.4, 7.1 Hz, 1H), 2.13 (ddd, J = 16.1, 9.8, 6.4 Hz, 1H), 1.22 (s, 3H), 
! 204 
0.93 (s, 9H), 0.87 (s, 9H); 
13
C NMR (125 MHz, CDCl3) ! 206.4, 134.8, 117.2, 85.9, 78.4, 
77.9, 77.7, 66.9, 32.9, 27.4, 27.1, 22.8, 20.2, 19.9; IR (neat) 3482, 2937, 2863, 1736, 
1473, 1390, 1162, 1112 cm
-1





Preparation of triol 3.126 . To a solution of 3.124  (1.56 g, 4.38 mmol) in 
CH2Cl2 (40 mL) at 0 
o
C was added 2,6-lutidine (3.10 mL, 26.6 mmol) and TMSOTf (2.38 
mL, 13.3 mmol). The reaction mixture was allowed to slowly warm up to rt over 2 h 
before it was quenched with H2O (20 mL). The aqueous phase was extracted with CH2Cl2 
(3 x 10 mL). The combined organic phase was dried (Na2SO4) and concentrated. Flash 
chromatography (20:1 hexanes:ethyl acetate) gave the corresponding TMS ether as a 
colorless oil (1.90 g, 100%).  
To a solution of the obtained TMS ether (1.90 g, 4.44 mmol) in THF (40 mL) at -
78 
o
C was added L-selectride (6.66 mL of 1.0 M solution in THF, 6.66 mmol). The 
reaction mixture was allowed to slowly warm up to rt over 2 h before it was quenched 
with sat. NH4Cl (aq., 20 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 
mL). The combined organic phase was dried (Na2SO4) and concentrated. The residue was 
passed through a plug of silica gel (10:1 hexanes:ethyl acetate) and concentrated. The 
resulted colorless oil was used directly in the next step without additional purification.  
To a solution of the colorless oil obtained from above in THF (15 mL) at 0 
o
C was 















was stirred for 2 h at 0 
o
C before it was quenched by addition of H2O (1.0 mL). To the 
reaction mixture was then added NaOH (25 mL of 3.0 M aq. solution,) followed by H2O2 
(30 mL of 30% aq. solution,). The reaction mixture was then allowed to warm up to rt 
overnight. The aqueous phase was extracted with ethyl acetate (3 x 20 mL). The 
combined organic phase was dried (Na2SO4) and concentrated. Flash chromatography 
gave 3.126  as a colorless oil (1.17 g, 70% over 2 steps).! Rf 0.35 (1:1 hexanes:ethyl 
acetate); [!]
20
D = -39.3° (c = 0.29, THF); 
1
H NMR (500 MHz, CDCl3) " 4.10 (dd, J = 9.5, 
4.6 Hz, 1H), 3.78 (dd, J = 9.3, 2.7 Hz, 1H), 3.73 (dd, J = 10.2, 10.2 Hz, 1H), 3.71-3.63 
(m, 2H), 3.58-3.53 (m, 2H), 3.43 (d, J = 10.2 Hz, 1H), 3.40 (br s, 1H), 3.16 (br s, 1H), 
3.07 (br s, 1H), 1.76 (ddd, J = 14.2, 7.1, 7.1 Hz, 1H), 1.71-1.62 (m, 1H), 1.60-1.50 (m, 
1H), 1.29-1.21 (m, 1H), 1.08 (s, 3H), 0.98 (s, 9H), 0.95 (s, 9H); 
13
C NMR (125 MHz, 
CDCl3) " 78.9, 75.8, 74.3, 71.8, 70.9, 67.0, 62.5, 30.1, 27.6, 27.4, 24.6, 22.9, 20.4, 18.8; 
IR (neat) 3414, 2936, 2893, 2862, 1472, 1393, 1157, 1102 cm
-1
; ESI/MS (m/z) calcd for 
C18H36O6SiNa 399.2 (M+Na
+
), found 399.3. 
 
Preparation of diol 3.127 . To a solution of 3.127  (1.17 g, 3.11 mmol) in 
THF (40 mL) was added KH (3.0 g of 30% dispersion in mineral oil, 22.5 mmol). The 
mixture was stirred at rt for 30 min before it was cooled to 0 
o
C. Then BnBr (4.22 mL, 
35.5 mmol) was added dropwise and the reaction mixture was warmed up to rt and stirred 
overnight before it was quenched with sat. NH4Cl (aq., 20 mL). The aqueous phase was 













concentrated to give a yellow oil which was taken to the next step without further 
purification. 
The residue from above was dissolved in THF (20 mL) and cooled to 0 
o
C. To the 
solution was added HF•Py (1.0 mL, 55 mmol) and the reaction mixture was allowed to 
warm up to rt overnight. The reaction was quenched with sat. NaHCO3 (aq., 20 mL). The 
aqueous phase was extracted with ethyl acetate (3 x 20 mL) and the organic extracts were 
combined, dried (Na2SO4) and concentrated. Flash chromatography (1:1 hexanes:ethyl 
acetate) provided diol 3.127  (0.98 g, 61% over 2 steps) as a colorless oil. Rf 0.40 (1:1 
hexanes:ethyl acetate); [!]
20
D = -31.4° (c = 0.18, THF); 
1
H NMR (500 MHz, CDCl3) " 
7.50-7.35 (m, 15H), 5.02 (d, J = 11.2 Hz, 1H), 4.80 (d, J = 11.2 Hz, 1H), 4.72 (d, J = 11.5 
Hz, 1H), 4.66 (d, J = 11.5 Hz, 1H), 4.62 (s, 2H), 4.08 (d, J = 3.9 Hz, 1H), 3.98 (d, J = 
10.2 Hz, 1H), 3.95 (partially obscured br d, J = 14.6 Hz, 1H), 3.88-3.76 (m, 2H), 3.70 
(ddd, J = 10.0, 3.4, 3.4 Hz, 1H), 3.66-3.62 (m, 2H), 3.14-3.04 (m, 2H), 2.10-1.98 (m, 
2H), 1.90-1.78 (m, 1H), 1.60-1.48 (m, 1H),  1.38 (s, 3H); 
13
C NMR (125 MHz, CDCl3) " 
139.2, 139.1, 139.0, 128.8, 128.7, 128.0, 127.9, 127.8, 127.7, 127.3, 81.2, 78.1, 76.9, 
76.8, 75.4, 73.1, 70.8, 68.0, 63.9, 63.2, 27.3, 25.3, 16.6; IR (neat) 3421, 2930, 2874, 
1496, 1454, 1380, 1210, 1106 cm
-1





Preparation of alkyne 3.129 . To a solution of 3.127  (0.57 g, 1.13 mmol) 
and 2,6-lutidine (0.495 mL, 4.25 mmol) in CH2Cl2 (20 mL) at -78 
o












trifluoromethanesulfonic anhydride (0.192 mL, 0.114 mmol). The reaction mixture was 
stirred for 30 min at -78 
o
C and TESOTf (0.288 mL, 0.127 mmol) was added. The 
reaction mixture was then slowly warmed to rt before it was quenched with sat. NaHCO3 
(aq., 10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined 
organic phase was dried (Na2SO4) and concentrated to give a yellow oil. The oil was 
quickly passed through a plug of silica gel (10:1 hexanes:ethyl acetate) and concentrated 
to give the crude triflate 3.128 .  
To a solution of trimethylsilylacetylene (0.690 mL, 4.88 mmol) in THF (20 mL) 
at 0 
o
C was added nBuLi (1.94 mL of 2.5 M solution in hexanes, 4.85 mmol). The 
reaction mixture was stirred at 0 
o
C for 30 min and then cooled to -78 
o
C. A solution of 
the crude 3.128  obtained from above and HMPA (0.900 mL, 5.17 mmol) in THF (10 
mL) was cannulated into the reaction mixture. The reaction mixture was allowed to warm 
up to rt over 2 h before it was quenched with sat. NH4Cl (aq., 10 mL). The aqueous phase 
was extracted with CH2Cl2 (3 x 10 mL). The combined organic phase was dried (Na2SO4) 
and concentrated to give a dark brown syrup which was taken up in THF (15 mL). To the 
solution was added TBAF (4.90 mL of 1.0 M solution in THF, 4.90 mmol) and the 
mixture was stirred at rt overnight before it was quenched with sat. NH4Cl (aq., 10 mL). 
The aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic phase 
was dried (Na2SO4) and concentrated. Flash chromatography (4:1 hexanes:ethyl acetate) 
gave 3.129  as a colorless oil (0.34 g, 59% over 3 steps). Rf 0.20 (4:1 hexanes:ethyl 
acetate); [!]
20
D = -21.6° (c = 0.45, THF); 
1
H NMR (500 MHz, CDCl3) " 7.42-7.27 (m, 
15H), 5.01 (d, J = 11.0 Hz, 1H), 4.72 (d, J = 11.5 Hz, 1H), 4.65 (d, J = 11.5 Hz, 1H), 4.56 
(s, 2H), 4.54 (d, J = 11.5 Hz, 1H), 4.02 (d, J = 1.7 Hz, 1H), 3.85 (d, J = 9.8 Hz, 1H), 3.64-
! 208 
3.58 (m, 4H), 2.67 (ddd, J = 17.1, 2.4, 2.4 Hz, 1H), 2.47 (ddd, J = 17.1, 5.9, 2.7 Hz, 1H), 
2.30-2.23 (m, 1H), 2.01 (t, J = 2.7 Hz, 1H), 2.00-1.90 (m, 2H), 1.81-1.70 (m, 1H), 1.50-
1.40 (m, 1H), 1.34 (s, 3H); 
13
C NMR (125 MHz, CDCl3) ! 139.1, 138.9, 138.7, 128.8, 
128.6, 128.5, 128.2, 128.0, 127.8, 127.6, 127.5, 127.1, 81.3, 81.2, 78.3, 77.0, 75.5, 75.2, 
73.0, 70.8, 69.9, 64.0, 27.1, 25.1, 22.4, 16.2; IR (neat) 3420, 2928, 2873, 2119, 1606, 
1496, 1454, 1378, 1209, 1104 cm
-1





Preparation of alkene 3.130 . To a solution of 3.129  (600 mg, 1.17 mmol) in 
CH2Cl2 (20 mL) at 0 
o
C was added 2,6-lutidine (0.272 mL, 2.34 mmol) and TESOTf 
(0.343 mL, 1.52 mmol). The reaction mixture was allowed to slowly warm up to rt over 3 
h before it was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL) and the combined organic phase was dried (Na2SO4) 
and concentrated. Flash chromatography (5:1 hexanes:ethyl acetate) provided the TES 
ether (732 mg, 100%) as a colorless oil. 
To a solution of the TES ether obtained from above in ethyl acetate (30 mL) was 
added quinoline (70 µL, 0.59 mmol) and Lindlar’s Pd catalyst (50 mg). The reaction 
mixture was stirred under H2 atmosphere for 2 h before it was passed through a Celite 
plug with ethyl acetate. The filtrate was concentrated and flash chromatography (10:1 
hexanes:ethyl acetate) gave 3.130  as a colorless oil (638 mg, 87%). Rf 0.50 (15:2 
hexanes:ethyl acetate); ["]
20
D = +1.2° (c = 0.45, THF); 
1












(d, J = 7.3 Hz, 2H), 7.33 (d, J = 7.3 Hz, 2H), 7.28 (d, J = 7.3 Hz, 2H), 7.20-7.04 (m, 9H), 
6.08 (dddd, J = 17.1, 11.2, 6.8, 6.8 Hz, 1H), 5.19 (dd, J = 17.1, 1.9 Hz, 1H), 5.11 (d, J = 
6.8 Hz, 1H), 5.08 (dd, J = 8.8, 1.9 Hz, 1H), 4.68 (d, J = 11.2 Hz, 1H), 4.42 (d, J = 10.7 
Hz, 1H), 4.38 (d, J = 11.3 Hz, 1H), 4.29 (s, 2H), 4.05-4.00 (m, 2H), 3.82 (d, J = 2.4 Hz, 
1H), 3.61 (dd, J = 9.3, 2.0 Hz, 1H), 3.39-3.31 (m, 2H), 2.68 (dd, J = 13.2, 6.8 Hz, 1H), 
2.24 (ddd, J = 15.6, 7.8, 7.8 Hz, 1H), 2.06-1.95 (m, 2H), 1.70-1.60 (m, 1H), 1.56-1.48 (m, 
1H), 1.19 (s, 3H), 1.00 (t, J = 7.8 Hz, 9H), 0.64 (q, J = 7.8 Hz, 6H), 0.30 (s, 3H); 
13
C 
NMR (125 MHz, C6D6) ! 140.3, 140.1, 139.9, 136.2, 128.9, 128.8, 128.8, 128.0, 127.9, 
127.8, 127.8, 127.7, 117.0, 83.0, 78.0, 77.7, 76.4, 76.0, 74.7, 73.1, 71.1, 63.9, 37.3, 27.7, 
26.0, 17.7, 7.7, 5.9; IR (neat) 2955, 2876, 1454, 1379, 1239, 1107, 1027 cm
-1
; ESI/MS 
(m/z) calcd for C39H54O5SiNa 653.4 (M+Na
+
), found 653.4. 
 
Preparation of acid 3.131 . To a solution of 3.130  (638 mg, 1.01 mmol) in 
CH2Cl2 (60 mL) at -78 
o
C was bubbled through O3 until the reaction developed a light 
blue color. The excess O3 was purged from the reaction mixture by bubbling N2 through 
it for 10 min until the light blue color completely dissappeared. Triphenylphosphine (1.33 
g, 5.08 mmol) was then added and the mixture was allowed to slowly warm to rt. After 
12 h, the solution was concentrated under reduced pressure. Flash chromatography (50:1 
to 5:1 hexanes:ethyl acetate) provided the aldehyde (600 mg, 94%) as a colorless oil.  
To a solution of the aldehyde obtained from above (600 mg, 0.949 mmol) in THF 














mL), NaH2PO4 (570 mg, 0.475 mmol) and NaClO2 (430 mg, 0.475 mmol). The reaction 
mixture was stirred at 0 
o
C for 30 min and H2O (30 mL) was added. The reaction mixture 
was extracted with ethyl acetate (3 x 15 mL) and the organic extracts were combined, 
dried (Na2SO4) and concentrated. Flash chromatography (1:1 hexanes:ethyl acetate to 
ethyl acetate) gave 3.131  (615 mg, 100%) as a colorless oil.!Rf 0.50 (2:1 hexanes:ethyl 
acetate); [!]
20
D = -9.4° (c = 0.27, THF); 
1
H NMR (500 MHz, C6D6) " 11.7 (br s, 1H), 
7.44 (d, J = 7.8 Hz, 2H), 7.32 (d, J = 7.8 Hz, 2H), 7.29 (d, J = 7.4 Hz, 2H), 7.19-7.03 (m, 
9H), 5.09 (d, J = 11.2 Hz, 1H), 4.65 (d, J = 11.2 Hz, 1H), 4.52 (ddd, J = 8.8, 8.8, 3.4 Hz, 
1H), 4.41 (d, J = 11.2 Hz, 1H), 4.37 (d, J = 11.2 Hz, 1H), 4.31 (s, 2H), 4.11 (d, J = 10.7 
Hz, 1H), 3.82 (d, J = 2.0 Hz, 1H), 3.73 (dd, J = 9.2, 2.0 Hz, 1H), 3.40-3.32 (m, 2H), 2.86 
(dd, J = 15.4, 3.2 Hz, 1H), 2.54 (dd, J = 15.4, 9.0 Hz, 1H), 2.02-1.92 (m, 2H), 1.72-1.62 
(m, 1H), 1.50 (ddd, J = 9.3, 9.3, 9.3 Hz, 1H), 1.16 (s, 3H), 0.96 (t, J = 7.8 Hz, 9H), 0.58 
(q, J = 7.8 Hz, 6H); 
13
C NMR (125 MHz, C6D6) " 178.3, 140.1, 140.0, 139.9, 128.9, 
128.8, 128.8, 128.1, 127.9, 127.8, 127.8, 127.7, 82.8, 78.0, 77.9, 76.0, 73.8, 73.8, 73.0, 
70.8, 63.9, 38.2, 27.4, 25.7, 17.6, 7.6, 5.7; IR (neat) 3330, 2956, 2877, 1713, 1454, 1241, 
1111 cm
-1
; ESI/MS (m/z) calcd for C38H52O7SiNa 671.4 (M+Na
+
), found 671.3. 
 
Preparation of acetate 3.132 . To a solution of 3.55 (1.24 g, 5.30 mmol) in 
CH2Cl2 (25 mL) were successively added Et3N (3.70 mL, 26.6 mmol), Ac2O (1.50 mL, 
15.6 mmol), and DMAP (0.646 g, 5.30 mmol). The reaction mixture was stirred for 2 h 










with CH2Cl2 (3 x 20 mL) and the combined organic phase was dried (Na2SO4) and 
concentrated. Flash chromatography (5:1 hexanes:ethyl acetate) provided 3.132 as a 
colorless oil (1.15 g, 79%). Rf 0.60 (4:1 hexanes:ethyl acetate); [!]
20
D = -71.2° (c = 0.32, 
THF); 
1
H NMR (500 MHz, C6D6) " 7.59 (d, J = 7.3 Hz, 2H), 7.18 (t, J = 7.3 Hz, 2H), 
7.12 (t, J = 7.3 Hz, 1H), 5.96 (dddd, J = 17.6, 10.3, 7.3, 6.3 Hz, 1H), 5.34 (s, 1H), 5.14 (d, 
J = 17.1 Hz, 1H), 5.08 (d, J = 10.3 Hz, 1H), 4.99 (d, J = 10.7 Hz, 1H), 3.73 (dd, J = 10.1, 
2.7 Hz, 1H), 3.64 (d, J = 10.7 Hz, 1H), 2.40-2.33 (m, 1H), 2.29-2.21 (m, 1H), 1.69 (s, 
3H), 1.56 (s, 3H); 
13
C NMR (125 MHz, C6D6) " 168.8, 138.5, 135.2, 128.8, 128.2, 126.5, 
116.8, 101.7, 81.6, 75.7, 74.2, 33.5, 21.1, 16.1; IR (neat) 2985, 2859, 1737, 1643, 1452, 
1367, 1237, 1099 cm
-1





Preparation of enol ether 3.133 . To a solution of TiCl4 (7.37 mL, 67.2 
mmol) in CH2Cl2 (440 mL) at 0 
o
C was added THF (35.5 mL, 0.404 mol) dropwise. To 
the yellow solution TMEDA (60.9 mL, 0.404 mol) was added dropwise and the solution 
turned to a red-brown color. The ice bath was then removed and the mixture was allowed 
to stir for 15 min. Activated Zn dust (9.83 g, 0.151 mol) and PbCl2 (2.22 g, 7.98 mmol) 
were then added. The resulting mixture went through a series of color changes from 
brown to green to purple and finally to blue-green over the course of 10 min. To the 
slurry was transferred a solution of ester 3.132 (1.16 g, 4.20 mmol) and CH3CHBr2 










heated to reflux for 2 h before it was cooled to 0 °C and quenched with sat. K2CO3 (aq., 
50 mL). After stirring for 30 min at 0 °C, the resulting mixture was filtered through a 
piece of filter paper. The filtrate was concentrated and flash chromatography (15:1 
hexanes:ethyl acetate) gave 3.133  as a colorless oil (0.949 g, 92%). Rf 0.70 (5:1 
hexanes:ethyl acetate); [!]
20
D = +23.0° (c = 0.43, THF); 
1
H NMR (500 MHz, C6D6) " 
7.52 (d, J = 7.3 Hz, 2H), 7.17 (t, J = 7.3 Hz, 2H), 7.12 (t, J = 7.3 Hz, 1H), 5.37 (s, 1H), 
4.22 (d, J = 4.4 Hz, 1H), 3.94 (d, J = 9.8 Hz, 1H), 3.65 (dd, J = 10.7, 6.4 Hz, 1H), 3.60 (d, 
J = 10.3 Hz, 1H), 2.12-1.98 (m, 2H), 1.61 (s, 3H), 1.34 (s, 3H); 
13
C NMR (125 MHz, 
C6D6) " 148.5, 138.5, 128.8, 128.1, 126.6, 102.3, 92.9, 77.1, 75.7, 69.6, 24.0, 19.9, 15.3; 
IR (neat) 2921, 2859, 1673, 1453, 1378, 1312, 1150, 1093 cm
-1
; ESI/MS (m/z) calcd for 
C15H18O3Na 269.1 (M+Na
+
), found 269.1. 
 
Preparation of ketone 3.136 . To a solution of 3.133  (0.576 g, 2.34 mmol) in 
MeOH (30 mL) at -78 
o
C was added mCPBA (77%, 1.57 g, 7.00 mmol). The reaction 
mixture was slowly warmed up to 0 
o
C, at which point sat. NaHCO3 (aq., 30 mL) was 
added. The mixure was extracted with CH2Cl2 (3 x 15 mL) and the combined organic 
phase was dried (Na2SO4) and concentrated. Flash chromatography (3:1 hexanes:ethyl 
acetate) provided 3.134  (0.550 g, 80%) as a white solid which was brought to the next 
step without further purification. 
To a solution of 3.134 obtained above in THF (30 mL) were added NaH (88.0  












mmol). The reaction mixture was then heated to reflux overnight. After the reaction was 
cooled to rt, sat. NH4Cl (aq., 20 mL) was added. The mixure was extracted with CH2Cl2 
(3 x 15 mL) and the combined organic phase was dried (Na2SO4) and concentrated. The 
residue was passed through a silica gel plug (5:1 hexanes:ethyl acetate). Concentration 
gave a colorless oil that was brought to the next step without further purification.  
To the colorless oil obtained above in toluene (50 mL) were added pyridine (7.40 
mL, 91.6 mmol) and PPTS (2.76 g, 11.0 mmol). The reaction mixture was heated to 
reflux for 16 h before it was cooled to rt and quenched with NaHCO3 (aq., 30 mL). The 
mixure was extracted with CH2Cl2 (3 x 20 mL) and the combined organic phase was 
dried (Na2SO4) and concentrated. Flash chromatography (5:1 hexanes:ethyl acetate) 
provided 3.136  (0.409 g, 72% 2 steps). Rf 0.70 (3:1 hexanes:ethyl acetate); [!]
20
D = 
+11.2° (c = 0.43, THF); 
1
H NMR (500 MHz, C6D6) " 7.50 (d, J = 7.3 Hz, 2H), 7.20 (t, J = 
7.3 Hz, 2H), 7.14 (t, J = 7.3 Hz, 1H), 5.77 (dddd, J = 17.6, 10.3, 7.3, 7.3 Hz, 1H), 5.31 (s, 
1H), 5.03 (d, J = 10.3 Hz, 1H), 4.99 (d, J = 17.6 Hz, 1H), 3.85 (d, J = 10.3 Hz, 1H), 3.81 
(dd, J = 12.2, 7.0 Hz, 1H), 3.47 (d, J = 10.3 Hz, 1H), 2.61 (dd, J = 18.6, 6.8 Hz, 1H), 2.41 
(dd, J = 18.6, 11.7 Hz, 1H), 2.30 (dd, J = 13.2, 7.5 Hz, 1H), 2.14 (dd, J = 13.7, 7.5 Hz, 
1H), 1.25 (s, 3H), 1.19 (s, 3H); 
13
C NMR (100 MHz, C6D6) " 208.8, 138.1, 133.0, 128.9, 
128.2, 126.5, 119.1, 101.8, 83.8, 76.3, 68.3, 46.4, 39.4, 26.5, 17.1; IR (neat) 2982, 2865, 
1716, 1521, 1456, 1372, 1143, 1114 cm
-1
; ESI/MS (m/z) calcd for C18H22O4Na 325.2 
(M+Na
+



















Summary of COSY spectrum for 3.136 
1. Proton at 5.77 ppm (C-25) shows cross peaks with protons at 5.03 ppm (C-26), 4.99 
ppm (C-26’), 2.30 ppm (C-24) and 2.14 (C-24’). 
2. Proton at 3.85 ppm (C-18) shows cross peaks with proton at 3.47 ppm (C-18’). 
3. Proton at 3.81 ppm (C-20) shows cross peaks with protons at 2.61 ppm (C-21) and 
2.41 ppm (C-21’). 
4. Proton at 2.61 ppm (C-21) shows cross peaks with proton at 2.41 ppm (C-21’). 
5. Proton at 2.30 ppm (C-24) shows cross peaks with proton at 2.14 ppm (C-24’). 
      Summary of 1D nOe spectrum for 3.136  
1.  Irradiation at 1.25 ppm (C-23 methyl) resulted in enhancement at 1.19 ppm (C-19 
methyl) and 2.30 ppm (C-24) and 2.14 ppm (C-24’). 
 
Preparation of PMB ether 3.138 . To a solution of 3.136  (378 mg, 1.25      
mmol) in MeOH (25 mL) at 0 
o
C was added NaBH4 (190 mg, 5.02 mmol). The reaction 
mixture was quenched with acetone (10 mL) after stirring for 2 h at 0 
o
C. The solvent was 
then removed under reduced pressure and the residue was purified using flash 
chromatography (3:1 hexanes:ethyl acetate) to give 3.137  as a colorless oil (382 mg, 
100%).  
To a solution of 3.137  (382 mg, 1.25 mmol) in THF (20 mL) at 0 
o
C was added 
NaH (82.4 mg, 3.43 mmol), PMBBr (0.82 mL, 5.69 mmol), HMPA (0.220 mL, 1.15 













before it was quenched with sat. NH4Cl (aq., 20 mL). The mixure was extracted with 
CH2Cl2 (3 x 15 mL) and the combined organic phase was dried (Na2SO4) and 
concentrated. Flash chromatography (10:1 hexanes:ethyl acetate) gave 3.138 as a 
colorless oil (442 mg, 83%). Rf 0.55 (5:1 hexanes:ethyl acetate); [!]
20
D = -32.8° (c = 
0.30, THF); 
1
H NMR (500 MHz, C6D6) " 7.64 (d, J = 7.8 Hz, 2H), 7.27-7.12 (m, 5H), 
6.82 (d, J = 7.8 Hz, 2H), 6.07 (dddd, J = 17.1, 9.8, 7.3, 7.3 Hz, 1H), 5.39 (s, 1H), 5.14 
(dd, J = 9.8, 1.3 Hz, 1H), 5.04 (dd, J = 17.6, 1.0 Hz, 1H), 4.44 (d, J = 11.2 Hz, 1H), 4.24 
(d, J = 11.7 Hz, 1H), 3.85 (d, J = 9.7 Hz, 1H), 3.44 (dd, J = 11.2, 4.4 Hz, 1H), 3.40 (d, J = 
9.7 Hz, 1H), 3.32 (s, 3H), 3.23 (dd, J = 12.7, 3.4 Hz, 1H), 2.46 (dd, J = 13.7, 6.4 Hz, 1H), 
2.33 (dd, J = 14.2, 7.8 Hz, 1H), 2.18 (ddd, J = 11.7, 3.9, 3.9 Hz, 1H), 1.85 (ddd, J = 11.7, 
11.7, 11.7 Hz, 1H), 1.53 (s, 3H), 1.34 (s, 3H); 
13
C NMR (125 MHz, C6D6) " 159.7, 138.7, 
135.0, 130.8, 129.3, 129.3, 128.8, 128.2, 126.7, 117.4, 114.0, 102.7, 80.6, 78.6, 77.7, 
76.9, 71.5, 70.3, 68.9, 54.7, 46.6, 26.8, 23.3, 19.1; IR (neat) 2947, 2864, 1611, 1512, 
1461, 1376, 1247, 1144, 1086 cm
-1





Preparation of PMB ether 3.139 . To a solution of 3.138  (0.245 g, 0.578 
mmol) in THF (15 mL) at 0 
o
C was added BH3•DMS (0.870 mL of 2.0 M solution in 
THF, 1.74 mmol). The reaction mixture was stirred for 2 h at 0 
o
C before it was quenched 
by addition of H2O (1.0 mL). To the reaction mixture was then added NaOH (2.0 mL of 













was then allowed to warm up to rt overnight. The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL). The combined organic phase was dried (Na2SO4) and concentrated. 
To the crude product obtained from above in CH2Cl2 (15 mL) were sequentially 
added 4Å MS (0.60 g), NMO (0.680 g, 5.78 mmol), and TPAP (5 mg, 14.2 µmol). The 
reaction mixture was stirred at rt for 2 h before the solvent was removed in vacuo. The 
residue was filtered through a short sílica gel plug (5:1 hexanes:ethyl acetate) to give the 
crude aldehyde. 
To a slurry of methyltriphenylphosphonium bromide (1.03 g, 2.88 mmol) in THF 
(10 mL) was added tBuOK (2.89 mL of 1.0 M solution in THF, 2.89 mmol). After 
stirring at rt for 30 min, the solution was transferred to a solution of the crude aldehyde 
from above in THF (10 mL). The reaction mixture was stirred at rt for 2 h before it was 
quenched with NH4Cl (aq., 10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 
10 mL). The organic phase was combined, dried (Na2SO4) and concentrated. Flash 
chromatography (10:1 hexanes:ethyl acetate) gave 3.139 as a colorless oil (0.154 g, 61% 
for 3 steps). Rf 0.60 (5:1 hexanes:ethyl acetate); [!]
20
D = -55.4° (c = 0.37, THF); 
1H 
NMR (500 MHz, C6D6) " 7.64 (d, J = 7.3 Hz, 2H), 7.22 (t, J = 7.3 Hz, 2H), 7.18-7.12 (m, 
3H), 6.81 (d, J = 8.3 Hz, 2H), 5.85 (dddd, J = 17.1, 10.2, 6.8, 6.3 Hz, 1H), 5.42 (s, 1H), 
5.09 (dd, J = 17.1, 1.5 Hz, 1H), 5.00 (dd, J = 10.2, 1.5 Hz, 1H), 4.44 (d, J = 11.2 Hz, 1H), 
4.20 (d, J = 11.7 Hz, 1H), 3.84 (d, J = 9.8 Hz, 1H), 3.39 (d, J = 10.8 Hz, 1H), 3.36 (dd, J 
= 11.2, 4.9 Hz, 1H), 3.31 (s, 3H), 3.24 (dd, J = 12.2, 3.4 Hz, 1H), 2.24-2.12 (m, 3H), 1.86 
(ddd, J = 11.7, 11.7, 11.7 Hz, 1H), 1.81 (ddd, J = 13.2, 11.2, 5.4 Hz, 1H), 1.64 (ddd, J = 
13.7, 11.2, 5.4 Hz, 1H), 1.53 (s, 3H), 1.33 (s, 3H); 13C NMR (125 MHz, C6D6) " 160.2, 
140.0, 139.2, 131.1, 129.9, 129.3, 128.7, 127.2, 114.6, 114.5, 103.2, 81.3, 79.5, 77.9, 
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77.5, 70.7, 69.3, 55.2, 42.1, 28.3, 27.1, 23.5, 19.6; IR (neat) 2943, 2863, 1639, 1513, 




Preparation of PMB ether 3.140 . To a solution of 3.139  (74.6 mg, 0.170 
mmol) in THF (5 mL) at 0 oC was added BH3•DMS (0.340 mL of 2.0 M solution in THF, 
0.680 mmol). The reaction mixture was stirred for 2 h at 0 oC before it was quenched by 
addition of H2O (1.0 mL). To the reaction mixture was then added NaOH (1.0 mL of 3.0 
M aq. solution) followed by H2O2 (3.0 mL of 30% aq. solution). The reaction mixture 
was then allowed to warm up to rt overnight. The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL). The combined organic phase was dried (Na2SO4) and concentrated. 
To the crude product obtained from above in CH2Cl2 (10 mL) were sequentially 
added 4Å MS (0.20 g), NMO (0.200 g, 1.71 mmol), and TPAP (2.0 mg, 5.7 µmol). The 
reaction mixture was stirred at rt for 2 h before the solvent was removed in vacuo. The 
residue was filtered through a short silica gel plug (5:1 hexanes:ethyl acetate) to give the 
crude aldehyde. 
To a slurry of methyltriphenylphosphonium bromide (300 mg, 0.840 mmol) in 
THF (5 mL) was added tBuOK (0.840 mL of 1.0 M solution in THF, 0.840 mmol). After 
stirring at rt for 30 min, the solution was transferred to a solution of the crude aldehyde 
from above in THF (5 mL). The reaction mixture was stirred at rt for 2 h before it was 













10 mL). The organic phase was combined, dried (Na2SO4) and concentrated. Flash 
chromatography (15:1 hexanes:ethyl acetate) gave 3.140 as a colorless oil (42.1 mg, 
55% for 3 steps). Rf 0.60 (5:1 hexanes:ethyl acetate); [!]
20
D = -24.2° (c = 0.24, THF); 
1
H 
NMR (500 MHz, C6D6) " 7.66 (d, J = 7.3 Hz, 2H), 7.22 (t, J = 7.3 Hz, 2H), 7.20-7.12 (m, 
3H), 6.82 (d, J = 8.8 Hz, 2H), 5.83 (dddd, J = 16.6, 9.8, 6.3, 6.3 Hz, 1H), 5.41 (s, 1H), 
5.08 (dd, J = 17.1, 1.5 Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 4.46 (d, J = 11.7 Hz, 1H), 4.20 
(d, J = 11.7 Hz, 1H), 3.85 (d, J = 9.8 Hz, 1H), 3.40 (d, J = 10.3 Hz, 1H), 3.37 (dd, J = 
11.2, 4.9 Hz, 1H), 3.31 (s, 3H), 3.25 (dd, J = 12.2, 3.4 Hz, 1H), 2.20 (ddd, J = 9.7, 3.9, 
3.9 Hz, 1H), 2.02-1.96 (m, 3H), 1.88 (ddd, J = 11.7, 11.7, 11.7 Hz, 1H), 1.73-1.66 (m, 
1H), 1.55 (s, 3H), 1.55-1.45 (m, 3H), 1.35 (s, 3H); 
13
C NMR (125 MHz, C6D6) " 159.7, 
139.1, 138.7, 130.7, 129.5, 128.9, 128.2, 126.7, 114.5, 114.0, 102.7, 80.8, 78.9, 77.7, 
77.1, 70.2, 68.8, 54.7, 42.0, 34.6, 26.6, 23.1, 22.6, 19.2; IR (neat) 2943, 2864, 1639, 
1513, 1461, 1375, 1248, 1086 cm
-1





Preparation of alcohol 3.142 . To a solution of 3.140  (42.1 mg, 93.1 µmol) 
in MeOH (5 mL) at 0 
o
C was added CSA (6.5 mg, 28.0 µmol). The reaction was warmed 
to rt for 5 h before it was quenched with NaHCO3 (aq., 5 mL). The aqueous phase was 













(Na2SO4), and concentrated. Flash chromatography (3:1 hexanes:ethyl acetate) gave the 
diol as a colorless oil (29.3 mg, 86%). 
To a solution of the diol in CH2Cl2 (4.5 mL) was added pH7 buffer (0.5 mL) and 
DDQ (36.5 mg, 0.161 mmol). The reaction mixture was stirred at rt for 2h before H2O (5 
mL) was added. The aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the 
combined organic extracts were dried (Na2SO4), and concentrated. Flash chromatography 
(2:1 hexanes:ethyl acetate) gave the triol 3.141 as a colorless oil (18.9 mg, 96%). 
To a solution of the triol 3.141 in CH2Cl2 (5 mL) were added anisaldehyde 
dimethylacetal (19.8 µL, 0.116 mmol) and CSA (9.0 mg, 38.7 µmol). The reaction 
mixture was stirred at rt overnight before it was quenched with NaHCO3 (aq., 5 mL). The 
aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the combined organic 
extracts were dried (Na2SO4), and concentrated. Flash chromatography (3:1 
hexanes:ethyl acetate) gave 3.142 as a colorless oil (24.8 mg, 88%). Rf 0.25 (3:1 
hexanes:ethyl acetate); [!]
20
D = -9.3° (c = 0.15, THF); 
1
H NMR (500 MHz, C6D6) " 7.57 
(d, J = 8.3 Hz, 2H), 6.83 (d, J = 8.3 Hz, 2H), 5.84 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1H), 
5.42 (s, 1H), 5.08 (d, J = 17.6 Hz, 1H), 5.02 (d, J = 10.3 Hz, 1H), 3.86 (d, J = 9.8 Hz, 
1H), 3.42 (d, J = 9.8 Hz, 1H), 3.38 (dd, J = 12.2, 4.9 Hz, 1H), 3.30-3.26 (partially 
obscured m, 1H), 3.26 (s, 3H), 2.05-2.00 (m, 2H), 1.87 (ddd, J = 11.2, 4.4, 4.4 Hz, 1H), 
1.80 (ddd, J = 11.7, 11.7, 11.7 Hz, 1H), 1.64-1.58 (m, 2H), 1.51 (s, 3H), 1.53-1.41 (m, 
2H), 1.15 (s, 3H); 
13
C NMR (125 MHz, C6D6) " 160.9, 139.6, 131.6, 128.5, 115.1, 114.2, 
103.3, 81.3, 78.6, 77.5, 73.7, 69.4, 55.1, 42.6, 35.1, 31.4, 23.1, 22.2, 19.6; IR (neat) 3483, 
2943, 2867, 1615, 1517, 1465, 1377, 1250, 1069 cm
-1
; ESI/MS (m/z) calcd for 
C21H30O5Na 385.2 (M+Na
+
), found 385.2. 
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Preparation of ester 3.143 . To a solution of acid 3.131  (53.4 mg, 82.2         
µmol) in THF (8 mL) was added triethylamine (0.100 mL, 0.719 mmol) and 2,4,6-
trichlorobenzoyl chloride (77.0 µL, 0.493 mmol). The reaction mixture was heated at 40 
o
C for 2 h before the solvent was removed in vacuo. To the resulting residue was 
cannulated a solution of alcohol 3.142  (24.8 mg,  68.5 µmol) in toluene (8 mL). DMAP 
(0.100 g, 0.820 mmol) was then added and the reaction mixture was heated at 40 
o
C for 2 
h. The reaction was quenched with sat. NaHCO3 (aq., 10 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL) and the organic extracts were combined, dried 
(Na2SO4) and concentrated. Flash chromatography (10:1 hexanes:ethyl acetate) provided 
ester 3.143  (57.4 mg, 84%) as a colorless oil. Rf 0.70 (4:1 hexanes:ethyl acetate); [!]
20
D 
= -26.2° (c = 0.29, THF); 
1
H NMR (500 MHz, C6D6) " 7.55 (d, J = 8.8 Hz, 2H), 7.44 (d, J 
= 7.3 Hz, 2H), 7.35 (d, J = 7.3 Hz, 2H), 7.29 (d, J = 7.8 Hz, 2H), 7.20-7.05 (m, 9H), 6.82 
(d, J = 8.3 Hz, 2H), 5.84 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1H), 5.32 (s, 1H), 5.22 (dd, J 
= 11.2, 4.9 Hz, 1H), 5.11 (d, J = 11.2 Hz, 1H), 5.08 (dd, J = 15.6, 1.5 Hz, 1H), 5.02 (dd, J 
= 10.3, 1.0 Hz, 1H), 4.68 (d, J = 11.2 Hz, 1H), 4.49 (ddd, J = 10.3, 7.3, 3.4 Hz, 1H), 4.43 
(d, J = 11.2 Hz, 1H), 4.38 (d, J = 11.2 Hz, 1H), 4.33 (s, 2H), 4.13 (d, J = 9.8 Hz, 1H), 
3.99 (dd, J = 9.8, 2.0 Hz, 1H), 3.88 (d, J = 2.0 Hz, 1H), 3.80 (d, J = 9.8 Hz, 1H), 3.42-
























Hz, 1H), 2.62 (dd, J = 14.7, 7.3 Hz, 1H), 2.29 (ddd, J = 11.2, 4.4, 3.9 Hz, 1H), 2.08-1.96 
(m, 5H), 1.80-1.55 (m, 6H), 1.49 (s, 3H), 1.30 (s, 3H), 1.22 (s, 3H), 1.00 (t, J = 8.3 Hz, 
9H), 0.67 (q, J = 7.8 Hz, 3H), 0.66 (q, J = 8.3 Hz, 3H); 
13
C NMR (125 MHz, C6D6) ! 
170.7, 160.8, 140.2, 140.0, 139.8, 139.5, 131.6, 128.9, 128.8, 128.8, 128.5, 128.0, 127.9, 
127.9, 127.9, 127.8, 127.7, 115.1, 114.1, 103.1, 82.6, 80.5, 78.1, 78.0, 77.3, 77.1, 76.0, 
74.3, 74.0, 73.2, 73.0, 71.0, 69.5, 63.9, 55.1, 42.4, 37.8, 34.9, 30.5, 28.2, 27.8, 26.1, 23.6, 
23.0, 19.5, 17.6, 7.6, 5.8; IR (neat) 2954, 2876, 1741, 1496, 1379, 1249, 1106 cm
-1
; 
ESI/MS (m/z) calcd for C59H80O11SiNa 1015.6 (M+Na
+
), found 1015.5. 
 
Preparation of enol ether 3.144 . To a solution of TiCl4 (0.230 mL, 2.09     
mmol) in CH2Cl2 (13 mL) at 0 
o
C was added THF (1.10 mL, 12.5 mmol) dropwise. To 
the yellow solution TMEDA (1.90 mL, 12.5 mmol) was added dropwise and the solution 
turned to a red-brown color. The ice bath was then removed and the mixture was allowed 
to stir for 15 min. Activated Zn dust (304 mg, 4.68 mmol) and PbCl2 (69.0 mg, 0.248 
mmol) were then added. The resulting mixture went through a series of color changes 
from brown to green to purple and finally to blue-green over the course of 3-5 min. To 
the slurry was transferred a solution of ester 3.143  (32.3 mg, 32.5 µmol) and CH3CHBr2 
(0.190 mL, 2.12 mmol) in CH2Cl2 (3 mL) via cannula. The reaction mixture was then 























1.0 mL). After stirring for 30 min at 0 °C, the resulting mixture was filtered through filter 
paper. The filtrate was concentrated and flash chromatography (10:1 hexanes:ethyl 
acetate) gave 3.144 as a colorless oil (12.5 mg, 40%). Rf 0.55 (5:1 hexanes:ethyl  
acetate); [!]
20
D = -14.1° (c = 0.28, THF); 
1
H NMR (500 MHz, C6D6) " 7.61 (d, J = 8.8 
Hz, 2H), 7.50 (d, J = 7.3 Hz, 2H), 7.38 (d, J = 7.3 Hz, 2H), 7.30 (d, J = 7.3 Hz, 2H), 7.21-
7.06 (m, 9H), 6.83 (d, J = 8.3 Hz, 2H), 5.48 (s, 1H), 5.16 (d, J = 11.2 Hz, 1H), 4.90 (dd, J 
= 8.3, 2.9 Hz, 1H), 4.71 (d, J = 11.2 Hz, 1H), 4.47 (d, J = 11.2 Hz, 1H), 4.41 (d, J = 11.2 
Hz, 1H), 4.31 (s, 2H), 4.14 (d, J = 9.8 Hz, 1H), 3.98 (dd, J = 9.8, 4.9 Hz, 1H), 3.89 (d, J = 
6.8 Hz, 1H), 3.88 (s, 1H), 3.69 (dd, J = 9.8, 2.2 Hz, 1H), 3.48 (d, J = 9.8 Hz, 1H), 3.44-
3.38 (m, 2H), 3.27 (s, 3H), 3.28-3.22 (partially obscured m, 1H), 2.91 (d, J = 14.6 Hz, 
1H), 2.30-1.97 (m, 8H), 1.84-1.70 (m, 2H), 1.69-1.56 (m, 3H), 1.55 (s, 3H), 1.36 (s, 3H), 
1.24 (s, 3H), 1.01 (t, J = 7.8 Hz, 9H), 0.64 (q, J = 7.8 Hz, 6H); 
13
C NMR (100 MHz, 
C6D6) " 160.8, 155.7, 140.3, 140.1, 140.0, 131.8, 128.9, 128.8, 128.5, 128.0, 127.9, 
127.9, 127.8, 127.7, 114.1, 108.1, 103.2, 84.0, 83.1, 81.3, 78.5, 78.0, 77.9, 77.8, 76.1, 
74.9, 74.5, 73.1, 71.1, 69.4, 63.9, 55.1, 46.3, 40.2, 33.6, 31.0, 30.5, 28.5, 27.8, 25.9, 28.5, 
27.8, 25.9, 22.4, 22.1, 19.8, 17.8, 7.6, 5.8; IR (neat) 2928, 2876, 1615, 1496, 1378, 1250, 
1108 cm
-1
; ESI/MS (m/z) calcd for C58H78O10SiK 1001.6 (M+K
+
), found 1001.5. 
 
Characterization of the cyclic product from 3.146 . Rf 0.45 (4:1 
hexanes:ethyl acetate); [!]
20
D = -3.0° (c = 0.20, THF); 
1

























(d, J = 7.3 Hz, 2H), 7.51 (d, J = 7.3 Hz, 2H), 7.39 (d, J = 7.3 Hz, 2H), 7.30 (d, J = 7.3 Hz, 
2H), 7.23-7.07 (m, 12H), 5.27 (s, 1H), 5.15 (d, J = 11.2 Hz, 1H), 4.88 (dd, J = 7.8, 3.4 
Hz, 1H), 4.72 (d, J = 11.2 Hz, 1H), 4.49 (d, J = 11.2 Hz, 1H), 4.43 (d, J = 11.2 Hz, 1H), 
4.41 (dd, J = 9.8, 9.8, 1H), 4.35-4.26 (m, 3H), 4.13 (d, J = 10.3 Hz, 1H), 3.90-3.84 (m, 
2H), 3.69 (dd, J = 9.3, 2.0 Hz, 1H), 3.52-3.45 (m, 2H), 3.42-3.30 (m, 3H), 3.04 (dd, J = 
10.8, 5.4 Hz, 1H), 2.90 (d, J = 14.7 Hz, 1H), 2.32-2.22 (m, 2H), 2.12-1.96 (m, 6H), 1.92-
1.52 (m, 9H), 1.34 (s, 3H), 1.24 (s, 3H), 1.22 (s, 3H), 1.02 (t, J = 7.8 Hz, 9H), 0.65 (q, J = 
7.8 Hz, 6H); 
13
C NMR (100 MHz, C6D6) ! 155.6, 140.4, 140.1, 140.1, 139.3, 136.5, 
129.2, 128.9, 128.8, 128.8, 128.0, 128.0, 127.9, 127.8, 127.7, 127.1, 108.0, 101.3, 83.4, 
83.4, 83.2, 80.9, 78.0, 77.8, 77.5, 77.0, 76.1, 75.6, 74.9, 74.4, 73.0, 71.1, 70.2, 63.9, 45.9, 
40.2, 40.1, 33.0, 29.6, 28.2, 27.8, 26.0, 22.6, 22.3, 21.5, 17.8, 7.6, 5.8; IR (neat) 2924, 
2855, 1456, 1376, 1105, 1027 cm
-1
; ESI/MS (m/z) calcd for C61H82O10SiK 1041.6 
(M+K
+
), found 1041.5. 
 
Preparation of ketone 3.150 . To a solution of 3.144  (19.7 mg, 20.4 µmol) in 
CH2Cl2 (5 mL) at -78 
o
C was added a solution of dimethyl dioxirane (0.42 mL of 0.10 M 
solution in CH2Cl2, 0.042 mmol) dropwise. The reaction mixture was warmed to 0 
o
C and 
the solvent was removed in vacuo. The residue was dissolved in CH2Cl2 (5 mL) and the 
reaction mixture was cooled to -78 
o

























(0.21 mL of 1.0 M solution in THF, 0.21 mmol) was added. After stirring for 2 h at -78 
oC, the reaction was quenched with sat. NH4Cl (aq., 3 mL) and allowed to warm to rt. 
Saturated potassium sodium tartrate solution (10 mL) was added and the mixture was 
stirred violently for 30 min. The aqueous phase was extracted with CH2Cl2 (3 x 10 mL) 
and the combined organic phase was dried (Na2SO4) and concentrated to give the crude 
alcohol.  
To a solution of the crude alcohol obtained from above in CH2Cl2 (5 mL) were 
added activated 4Å MS (20 mg), NMO (25.0 mg, 0.213 mmol) and TPAP (1 mg, 0.003 
mmol). The reaction mixture was stirred at rt for 2 h before the solvent was removed in 
vacuo. Flash chromatography (5:1 hexanes:ethyl acetate) gave ketone 3.150 as a 
colorless oil (12.2 mg, 61% 2 steps). Rf 0.55 (3:1 hexanes:ethyl acetate); [!]
20
D = -20.2° 
(c = 0.18, THF); 1H NMR (500 MHz, C6D6) " 7.58 (d, J = 8.8 Hz, 2H), 7.46 (d, J = 7.3 
Hz, 2H), 7.36 (d, J = 7.8 Hz, 2H), 7.30 (d, J = 7.8 Hz, 2H), 7.21-7.06 (m, 9H), 6.83 (d, J 
= 8.3 Hz, 2H), 5.36 (s, 1H), 5.08 (d, J = 11.2 Hz, 1H), 4.70 (d, J = 11.2 Hz, 1H), 4.50 (dd, 
J = 9.3, 6.3 Hz, 1H), 4.44 (d, J = 11.2 Hz, 1H), 4.40 (d, J = 11.2 Hz, 1H), 4.32 (s, 2H), 
4.12 (ddd, J = 9.8, 6.8, 2.9 Hz, 1H), 4.09 (dd, J = 10.3, 1.5 Hz, 1H), 3.85 (d, J = 2.0 Hz, 
1H), 3.81 (d, J = 9.8 Hz, 1H), 3.79 (dd, J = 9.8, 2.4 Hz, 1H), 3.44-3.33 (m, 4H), 3.27 (s, 
3H), 3.14 (dd, J = 12.2, 3.0 Hz, 1H),  2.87 (ddd, J = 14.2, 7.8, 4.9 Hz, 1H), 2.31-2.06 (m, 
5H), 2.04-1.94 (m, 3H), 1.84-1.70 (m, 2H), 1.64-1.54 (m, 3H), 1.52 (s, 3H), 1.34 (s, 3H), 
1.24 (s, 3H), 1.03 (t, J = 7.8 Hz, 9H), 0.69 (q, J = 7.8 Hz, 6H); 13C NMR (100 MHz, 
C6D6) " 213.9, 160.9, 140.2, 140.1, 139.9, 131.6, 128.9, 128.8, 128.5, 128.0, 127.9, 
127.9, 127.8, 127.7, 114.1, 103.1, 85.4, 83.3, 82.9, 81.4, 78.0, 77.9, 77.4, 76.0, 73.9, 73.2, 
73.2, 71.1, 69.7, 63.9, 55.1, 44.0, 40.2, 35.4, 28.9, 27.8, 26.0, 21.5, 21.1, 20.2, 17.6, 7.6, 
! 225 
5.9; IR (neat) 2934, 2876, 1704, 1616, 1496, 1378, 1249, 1105 cm
-1
; ESI/MS (m/z) calcd 
for C58H78O11SiK 1017.6 (M+K
+
), found 1017.5. 
 
Summary of COSY spectrum for 3.150  
1. Proton at 4.50 ppm (C-28) shows cross peaks with proton at 2.28 ppm (C-29). 
2. Proton at 4.12 ppm (C-30) shows cross peaks with proton at 3.79 ppm (C-31). 
3. Proton at 4.09 ppm (C-34) shows cross peaks with protons at 1.62 ppm (C-35). 
4. Proton at 3.81 ppm (C-18) shows cross peaks with proton at 3.40 ppm (C-18’). 
5. Proton at 2.06 ppm (C-21) shows cross peaks with proton at 3.36 ppm (C-22) and 
3.14 (C-20). 
      Summary of 1D nOe spectrum for 3.150  
1.  Irradiation at 4.50 ppm (C-28) resulted in enhancement at 3.36 ppm (C-22). 
2.  Irradiation at 3.14 ppm (C-20) resulted in enhancement at 5.36 ppm (C-a), 3.40 ppm 






















































Preparation of ketone 3.151 . To a solution of 3.150  (5.0 mg, 5.1 µmol) in 
THF (4 mL) at -78 
o
C was added LiHMDS (0.102 mL of 1.0 M solution in THF, 0.102 
mmol). After 10 min, MeI (16 µL, 0.254 mmol) was added and the reaction mixture was 
allowed to slowly warm up to -22 
o
C before it was quenched with NH4Cl (aq., 5 mL). 
The aqueous phase was extracted with CH2Cl2 (3 x 5 mL) and the combined organic 
phase was dried (Na2SO4) and concentrated. Flash chromatography (5:1 hexanes:ethyl 
acetate) provided 3.151  (4.7 mg, 93%) as a colorless oil. Rf 0.55 (3:1 hexanes:ethyl 
acetate). [a]
20
D = -22.3° (c = 0.14, THF); 
1
H NMR (400 MHz, CD2Cl2) ! 7.36 (d, J = 8.8 
Hz, 2H), 7.32-7.19 (m, 15H), 6.87 (d, J = 8.3 Hz, 2H), 5.44 (s, 1H), 4.96 (d, J = 10.7 Hz, 
1H), 4.58 (d, J = 11.2 Hz, 1H), 4.54 (d, J = 11.2 Hz, 1H), 4.48 (d, J = 11.2 Hz, 1H), 4.46 
(s, 2H), 4.32 (dd, J = 9.8, 5.9 Hz, 1H), 3.85 (d, J = 1.5 Hz, 1H), 3.79 (s, 3H), 3.74 (d, J = 
9.8 Hz, 1H), 3.68-3.52 (m, 3H), 3.52-3.40 (m, 5H), 2.99 (ddd, J = 7.8, 7.8, 7.8 Hz, 1H), 
2.60-2.49 (m, 1H), 2.35-2.19 (m, 2H), 2.13 (ddd, J = 11.7, 3.9, 3.9 Hz, 1H), 1.95-1.50 (m, 
8H), 1.50 (s, 3H), 1.36 (s, 3H), 1.28 (s, 3H), 1.20 (d, J = 7.3 Hz, 3H), 1.03 (t, J = 7.8 Hz, 
9H), 0.71 (q, J = 7.8 Hz, 6H); 
13
C NMR (100 MHz, C6D6) ! 214.2, 160.4, 139.6, 139.5, 
131.1, 128.4, 128.3, 128.0, 127.5, 127.4, 127.3, 127.2, 113.6, 102.6, 85.4, 83.5, 82.4, 
80.5, 77.4, 77.4, 77.0, 76.9, 75.5, 74.8, 73.1, 72.6, 70.5, 69.2, 63.4, 57.6, 54.6, 49.9, 44.7, 
35.8, 30.0, 29.2, 28.4, 27.3, 25.5, 21.6, 21.3, 19.4, 17.2, 7.1, 5.3; IR (neat) 2956, 2876, 
1718, 1616, 1496, 1377, 1249, 1104 cm
-1
; ESI/MS (m/z) calcd for C59H80O11SiNa 1015.6 
(M+Na
+
), found 1015.5. 
! 227 
 
Preparation of ATX F-I ring system 3.152 . To a solution of 3.151  (4.7 
mg, 4.7 µmol) in CH2Cl2 (3 mL) at -78 
o
C were added Et3SiH (76 µL, 0.47 mmol) and 
TMSOTf (8.6 µL, 47.0 µmol). The reaction mixture was stirred at -78 
o
C for 1 h before it 
was allowed to slowly warm up to -50 
o
C, at which temperature the reaction was 
quenched with NaHCO3 (aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (3 x 
5 mL) and the combined organic phase was dried (Na2SO4) and concentrated. Flash 
chromatography (2:1 hexanes:ethyl acetate) provided 3.152  (2.8 mg, 80%) as a colorless 
oil. Rf 0.45 (1:1 hexanes:ethyl acetate); [!]
20
D = -1.1° (c = 0.05, THF); 
1
H NMR (500 
MHz, CD2Cl2) " 7.40-7.20 (m, 15H), 4.96 (d, J = 11.2 Hz, 1H), 4.56 (d, J = 11.2 Hz, 1H), 
4.45 (d, J = 11.2 Hz, 1H), 4.43 (s, 2H), 4.40 (d, J = 11.2 Hz, 1H), 4.04 (d, J = 2.0 Hz, 
1H), 3.82 (br d, J = 11.7 Hz, 1H), 3.71-3.64 (m, 2H), 3.49-3.46 (m, 2H), 3.41-3.35 (m, 
2H), 3.29 (d, J = 10.7 Hz, 1H), 3.22 (ddd, J = 11.7, 8.8, 4.4 Hz, 1H), 3.12 (dd, J = 9.8, 2.0 
Hz, 1H), 2.76 (dd, J = 9.3, 9.3 Hz, 1H), 2.30 (ddd, J = 11.2, 4.4, 4.4 Hz, 1H), 2.06-2.00 
(m, 2H), 1.96 (ddd, J = 10.7, 4.4, 4.4 Hz, 1H), 1.95-1.35 (m, 11H), 1.28 (s, 3H), 1.22 (s, 
3H), 1.14 (s, 3H), 1.08 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, C6D6) " 140.1, 128.9, 
128.8, 128.0, 127.9, 127.8, 127.7, 88.1, 86.2, 83.8, 80.8, 78.8, 78.7, 77.7, 77.2, 76.6, 75.0, 























18.8, 17.9; IR (neat) 3500, 3028, 2925, 1599, 1494, 1451, 1264, 1077 cm
-1
; ESI/MS 
(m/z) calcd for C45H60O9K 783.4 (M+K
+
), found 783.3. 
 
Summary of COSY spectrum for 3.152  
1. Proton at 4.04 ppm (C-32) shows cross peaks with proton at 3.12 ppm (C-31). 
2. Proton at 3.12 ppm (C-31) shows cross peaks with proton at 3.66 ppm (C-30). 
3. Proton at 1.08 ppm (C-26 methyl) shows cross peaks with protons at 1.70 ppm (C-
26). 
4. Proton at 1.70 ppm (C-26) shows cross peaks with proton at 2.76 ppm (C-27). 
5. Proton at 2.76 ppm (C-27) shows cross peaks with proton at 3.22 ppm (C-28). 
6. Proton at 3.22 ppm (C-28) shows cross peaks with protons at 2.30 ppm (C-29) and 
1.50 ppm (C-29’). 
7. protons at 2.30 ppm (C-29) and 1.50 ppm (C-29’) both show cross peaks with proton 
at 3.66 ppm (C-30). 
      Summary of 1D nOe spectrum for 3.152  
1.  Irradiation at 3.22 ppm (C-28) resulted in enhancement at 3.66 ppm (C-30), 3.40 ppm 
(C-22), 2.30 ppm (C-29), and 1.70 ppm (C-26).  
2.  Irradiation at 2.76 ppm (C-27) resulted in enhancement at 3.12 ppm (C-31), 1.50 ppm 
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